This is a Validated Antibody Database (VAD) review about human CD14, based on 570 published articles (read how Labome selects the articles), using CD14 antibody in all methods. It is aimed to help Labome visitors find the most suited CD14 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
others
  • flow cytometry; human; fig 3
 CD14 antibody (eBioscience, 61D3) was used in flow cytometry on human samples (fig 3). Sci Rep (2019) ncbi
BioLegend
mouse monoclonal (M5E2)
  • flow cytometry; human; 1:100; loading ...; fig 7c
BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on human samples at 1:100 (fig 7c). J Hematol Oncol (2022) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human; loading ...; fig s1b
BioLegend CD14 antibody (Biolegend, 325605) was used in flow cytometry on human samples (fig s1b). Stem Cell Res Ther (2022) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...
BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on human samples . J Exp Med (2022) ncbi
mouse monoclonal (63D3)
  • flow cytometry; human; loading ...; fig 1f, s1b
BioLegend CD14 antibody (Biolegend, 63D3) was used in flow cytometry on human samples (fig 1f, s1b). MBio (2022) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 1d
BioLegend CD14 antibody (BioLegend, 301830) was used in flow cytometry on human samples (fig 1d). Oncoimmunology (2022) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 5a
BioLegend CD14 antibody (BioLegend, 301807) was used in flow cytometry on human samples (fig 5a). Front Mol Biosci (2021) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; 1:100; loading ...; fig 6b
BioLegend CD14 antibody (Biolegend, 301807) was used in flow cytometry on human samples at 1:100 (fig 6b). Nat Nanotechnol (2022) ncbi
mouse monoclonal (63D3)
  • flow cytometry; human; 1:50; loading ...; fig s4
BioLegend CD14 antibody (BioLegend, 367112) was used in flow cytometry on human samples at 1:50 (fig s4). Nat Med (2021) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...
BioLegend CD14 antibody (Biolegend, 301834) was used in flow cytometry on human samples . Cell (2021) ncbi
mouse monoclonal (63D3)
  • flow cytometry; human; loading ...
BioLegend CD14 antibody (Biolegend, 63, D3) was used in flow cytometry on human samples . Adv Sci (Weinh) (2021) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human
BioLegend CD14 antibody (Biolegend, 325622) was used in flow cytometry on human samples . Cell Host Microbe (2021) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human; loading ...; fig 6
BioLegend CD14 antibody (Biolegend, 325614) was used in flow cytometry on human samples (fig 6). PLoS Negl Trop Dis (2021) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig s3e, s3f
BioLegend CD14 antibody (BioLegend, 301840) was used in flow cytometry on human samples (fig s3e, s3f). Immunity (2021) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BioLegend CD14 antibody (BioLegend, 301832) was used in flow cytometry on human samples . Cell (2021) ncbi
mouse monoclonal (63D3)
  • flow cytometry; human; fig s3b
BioLegend CD14 antibody (Biolend, 63D3) was used in flow cytometry on human samples (fig s3b). Front Immunol (2021) ncbi
mouse monoclonal (63D3)
  • flow cytometry; human; loading ...; fig s14a
BioLegend CD14 antibody (BioLegend, 367126) was used in flow cytometry on human samples (fig s14a). Commun Biol (2021) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human; loading ...; fig s1b
BioLegend CD14 antibody (Biolegend, 325620) was used in flow cytometry on human samples (fig s1b). BMC Biol (2021) ncbi
mouse monoclonal (63D3)
  • flow cytometry; human; loading ...; fig s4a
BioLegend CD14 antibody (BioLegend, 367148) was used in flow cytometry on human samples (fig s4a). Immunity (2021) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on human samples . Immunity (2021) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...
BioLegend CD14 antibody (BioLegend, 301814) was used in flow cytometry on human samples . Cell (2021) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human; loading ...; fig 3c
BioLegend CD14 antibody (BioLegend, HCD14) was used in flow cytometry on human samples (fig 3c). Front Immunol (2020) ncbi
mouse monoclonal (63D3)
  • flow cytometry; human; loading ...; fig 4d
BioLegend CD14 antibody (Biolegend, 367117) was used in flow cytometry on human samples (fig 4d). Oncogene (2021) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 3e
BioLegend CD14 antibody (BioLegend, 301838) was used in flow cytometry on human samples (fig 3e). Nature (2021) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human; loading ...; fig s1d, s11
BioLegend CD14 antibody (Biolegend, 325608) was used in flow cytometry on human samples (fig s1d, s11). Sci Rep (2021) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 3s2a
BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on human samples (fig 3s2a). elife (2020) ncbi
mouse monoclonal (63D3)
  • flow cytometry; human; loading ...; fig s6
BioLegend CD14 antibody (Biolegend, 367121) was used in flow cytometry on human samples (fig s6). Am J Respir Crit Care Med (2021) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BioLegend CD14 antibody (Biolegend, 301843) was used in flow cytometry on human samples . elife (2020) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human; loading ...; fig 1b
BioLegend CD14 antibody (BioLegend, HCD14) was used in flow cytometry on human samples (fig 1b). J Immunother Cancer (2020) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human; loading ...
BioLegend CD14 antibody (BioLegend, 325604) was used in flow cytometry on human samples . J Clin Invest (2020) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human; loading ...; fig st2
BioLegend CD14 antibody (BioLegend, HCD14) was used in flow cytometry on human samples (fig st2). EBioMedicine (2020) ncbi
mouse monoclonal (63D3)
  • immunocytochemistry; human; 1:100; loading ...; fig 1a
BioLegend CD14 antibody (BioLegend, 367130) was used in immunocytochemistry on human samples at 1:100 (fig 1a). Nat Commun (2020) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human; loading ...; fig 4b
BioLegend CD14 antibody (BioLegend, HCD14) was used in flow cytometry on human samples (fig 4b). Sci Adv (2020) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig s1b
BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples (fig s1b). JCI Insight (2020) ncbi
mouse monoclonal (63D3)
  • flow cytometry; human; 1:25; loading ...; fig s2
BioLegend CD14 antibody (Miltenyi Biotec, 367115) was used in flow cytometry on human samples at 1:25 (fig s2). Stem Cell Res Ther (2020) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human; loading ...; fig 7s1b
BioLegend CD14 antibody (BioLegend, 325608) was used in flow cytometry on human samples (fig 7s1b). elife (2020) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human; loading ...; fig 5s4
BioLegend CD14 antibody (Biolegend, 325608) was used in flow cytometry on human samples (fig 5s4). elife (2020) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human; 1:200; loading ...; fig 7a
BioLegend CD14 antibody (BioLegend, 325615) was used in flow cytometry on human samples at 1:200 (fig 7a). elife (2019) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 3c
BioLegend CD14 antibody (Biolegend, 982506) was used in flow cytometry on human samples (fig 3c). Cell Rep (2019) ncbi
mouse monoclonal (63D3)
  • flow cytometry; human; loading ...; fig 3c
BioLegend CD14 antibody (Biolegend, 63D3) was used in flow cytometry on human samples (fig 3c). elife (2019) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 4a
BioLegend CD14 antibody (Biolegend, clone M5E2) was used in flow cytometry on human samples (fig 4a). Sci Rep (2019) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 7a
BioLegend CD14 antibody (BioLegend, 301807) was used in flow cytometry on human samples (fig 7a). J Exp Med (2020) ncbi
mouse monoclonal (63D3)
  • flow cytometry; human; loading ...; fig 6a
BioLegend CD14 antibody (Biolegend, 367118) was used in flow cytometry on human samples (fig 6a). Oncoimmunology (2019) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human; loading ...; fig 6a
BioLegend CD14 antibody (Biolegend, 325610) was used in flow cytometry on human samples (fig 6a). Oncoimmunology (2019) ncbi
mouse monoclonal (63D3)
  • flow cytometry; mouse; 1:500; loading ...; fig ex8d
BioLegend CD14 antibody (Biolegend, 367111) was used in flow cytometry on mouse samples at 1:500 (fig ex8d). Nature (2019) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig ex2a
BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples (fig ex2a). Nature (2019) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human; loading ...; fig s2o
BioLegend CD14 antibody (Biolegend, 325628) was used in flow cytometry on human samples (fig s2o). JCI Insight (2019) ncbi
mouse monoclonal (63D3)
  • flow cytometry; human; 1:200; loading ...; fig 2a
BioLegend CD14 antibody (Biolegend, 367128) was used in flow cytometry on human samples at 1:200 (fig 2a). elife (2019) ncbi
mouse monoclonal (HCD14)
  • immunocytochemistry; human; 1:200; fig 2h
BioLegend CD14 antibody (Biolegend, 325628) was used in immunocytochemistry on human samples at 1:200 (fig 2h). elife (2019) ncbi
mouse monoclonal (M5E2)
  • other; human; loading ...; fig 4b
BioLegend CD14 antibody (BioLegend, 301855) was used in other on human samples (fig 4b). Cell (2019) ncbi
mouse monoclonal (63D3)
  • flow cytometry; human; 1:10; loading ...; fig s9a
BioLegend CD14 antibody (Biolegend, 367114) was used in flow cytometry on human samples at 1:10 (fig s9a). Nat Commun (2019) ncbi
mouse monoclonal (63D3)
  • flow cytometry; human; loading ...; fig s10a
BioLegend CD14 antibody (BioLegend, 367111) was used in flow cytometry on human samples (fig s10a). Cancer Med (2019) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples (fig 3a). Am J Respir Crit Care Med (2019) ncbi
mouse monoclonal (M5E2)
  • mass cytometry; human; loading ...; fig s1
BioLegend CD14 antibody (BioLegend, M5E2) was used in mass cytometry on human samples (fig s1). J Exp Med (2019) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig s1b
BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples (fig s1b). J Clin Invest (2019) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 5
BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on human samples (fig 5). Front Immunol (2019) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; 1:100; loading ...; fig s1a
BioLegend CD14 antibody (Biolegend, 301842) was used in flow cytometry on human samples at 1:100 (fig s1a). Cancer Cell (2019) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 6b
BioLegend CD14 antibody (BioLegend, 301820) was used in flow cytometry on human samples (fig 6b). Immunity (2019) ncbi
mouse monoclonal (63D3)
  • flow cytometry; mouse; 2 ug/ml; loading ...; fig s11g
BioLegend CD14 antibody (BioLegend, 367109) was used in flow cytometry on mouse samples at 2 ug/ml (fig s11g). Science (2019) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human; loading ...; fig 3g
BioLegend CD14 antibody (Biolegend, 325620) was used in flow cytometry on human samples (fig 3g). Science (2019) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human; loading ...; fig s1
BioLegend CD14 antibody (BioLegend, HCD14) was used in flow cytometry on human samples (fig s1). Front Immunol (2019) ncbi
mouse monoclonal (63D3)
  • flow cytometry; human; 1:1; fig s4
BioLegend CD14 antibody (BioLegend, 367108) was used in flow cytometry on human samples at 1:1 (fig s4). Nat Commun (2019) ncbi
mouse monoclonal (63D3)
  • flow cytometry; human; loading ...; fig s7a
BioLegend CD14 antibody (BioLegend, 367116) was used in flow cytometry on human samples (fig s7a). Proc Natl Acad Sci U S A (2019) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; 1:200; loading ...; fig 1b
BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on human samples at 1:200 (fig 1b). Front Immunol (2018) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; rhesus macaque; loading ...; fig 2d
BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on rhesus macaque samples (fig 2d). J Virol (2019) ncbi
mouse monoclonal (63D3)
  • flow cytometry; human; loading ...; fig s3d
BioLegend CD14 antibody (Biolegend, 63D3) was used in flow cytometry on human samples (fig s3d). Transl Oncol (2019) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; 1:100; loading ...; fig 1j
BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples at 1:100 (fig 1j). Front Immunol (2018) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human; fig 4a
BioLegend CD14 antibody (BioLegend, 325614) was used in flow cytometry on human samples (fig 4a). J Exp Med (2018) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 1c
BioLegend CD14 antibody (BioLegend, 301824) was used in flow cytometry on human samples (fig 1c). J Exp Med (2018) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD14 antibody (Biolegend, 301802) was used in flow cytometry on human samples (fig 1a). Cell (2018) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD14 antibody (Biolegend, 325604) was used in flow cytometry on human samples (fig 1a). J Clin Invest (2018) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig s1
BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples (fig s1). J Clin Invest (2018) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 2c
BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples (fig 2c). Nat Immunol (2018) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig s1
BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples (fig s1). J Biol Chem (2018) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human; loading ...; fig 4a
BioLegend CD14 antibody (BioLegend, HCD14) was used in flow cytometry on human samples (fig 4a). Methods Mol Biol (2018) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 6a
BioLegend CD14 antibody (Biolegend, 301818) was used in flow cytometry on human samples (fig 6a). Front Immunol (2018) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human; loading ...; fig 3b
BioLegend CD14 antibody (BioLegend, HCD14) was used in flow cytometry on human samples (fig 3b). Oncol Lett (2018) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human; loading ...; fig 3e
BioLegend CD14 antibody (Biolegend, HCD14) was used in flow cytometry on human samples (fig 3e). J Biol Chem (2018) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human; fig 1a
BioLegend CD14 antibody (BioLegend, HCD14) was used in flow cytometry on human samples (fig 1a). J Exp Med (2018) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 1c
In order to study the involvement of RANKL in decidual M2 macrophage polarization, BioLegend CD14 antibody (Biolegend, 301804) was used in flow cytometry on human samples (fig 1c). Cell Death Dis (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; African green monkey; loading ...; fig 2a
BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on African green monkey samples (fig 2a). Immunology (2018) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig 5a
In order to study the involvement of Notch signaling in NK cell lineage determination, BioLegend CD14 antibody (biolegend, M5E2) was used in flow cytometry on human samples (fig 5a). J Immunol (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig s4a
BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples (fig s4a). J Immunol (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 6b
BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on human samples (fig 6b). PLoS ONE (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples (fig 1a). Sci Rep (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig 7a
BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples (fig 7a). Leuk Lymphoma (2018) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...
In order to investigate the effectiveness of a neoantigen vaccine against melanoma, BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on human samples . Nature (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 7c
In order to study the role of leukocyte antigen F in and antigen presentation and immune response, BioLegend CD14 antibody (BioLegend, 301811) was used in flow cytometry on human samples (fig 7c). Immunity (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; 1:50; loading ...; fig s2b
In order to define the transcriptional network specifies conferring microglia identity, BioLegend CD14 antibody (BioLegend, 301811) was used in flow cytometry on human samples at 1:50 (fig s2b). Science (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 3g
In order to map the lineage of human dendritic cells, BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples (fig 3g). Science (2017) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human; loading ...; fig s1
BioLegend CD14 antibody (BioLegend, HCD14) was used in flow cytometry on human samples (fig s1). J Exp Med (2017) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human; loading ...; fig 1e
BioLegend CD14 antibody (Biolegend, HCD14) was used in flow cytometry on human samples (fig 1e). Nat Med (2017) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human; loading ...; fig 2c
BioLegend CD14 antibody (Biolegend, HCD14) was used in flow cytometry on human samples (fig 2c). Oncoimmunology (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...
In order to examine AnxA1 in peripheral blood mononuclear cells from patients with coronary artery disease, BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on human samples . PLoS ONE (2017) ncbi
mouse monoclonal (HCD14)
  • mass cytometry; human; fig s8
BioLegend CD14 antibody (BioLegend, 325602) was used in mass cytometry on human samples (fig s8). Nature (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; tbl s9
In order to optimize and assess potential malaria vaccine regimens, BioLegend CD14 antibody (BioLegend, 301842) was used in flow cytometry on human samples (tbl s9). Nature (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...
In order to show T cell immunoglobulin and ITIM domain expression increases over time despite early initiation of antiretroviral treatment, BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on human samples . Sci Rep (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; rhesus macaque; loading ...
In order to examine the kinetics of SIV-specific CD8+ T cell cytolytic factor expression in peripheral blood, lymph node, spleen, and gut mucosa from early acute infection through chronic infection, BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on rhesus macaque samples . PLoS Pathog (2016) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human; loading ...; fig 4a
BioLegend CD14 antibody (BioLegend, HCD14) was used in flow cytometry on human samples (fig 4a). Sci Rep (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 4a
BioLegend CD14 antibody (BioLegend, 301842) was used in flow cytometry on human samples (fig 4a). PLoS ONE (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; mouse; loading ...; fig s4
In order to study the impact of modulating IFN-I signaling during suppressive combined antiretroviral therapy, BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on mouse samples (fig s4). J Clin Invest (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig s4
BioLegend CD14 antibody (Biologend, M5E2) was used in flow cytometry on human samples (fig s4). Cell Death Dis (2016) ncbi
mouse monoclonal (63D3)
  • flow cytometry; human; loading ...; fig 4a
In order to compare the effect of CXCL4 and its variant CXCL4L1 on the differentiation of monocytes into macrophages and into immature monocyte-derived dendritic cells, BioLegend CD14 antibody (Biolegend, 63D3) was used in flow cytometry on human samples (fig 4a). PLoS ONE (2016) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human; 1:100; loading ...; fig 5f
BioLegend CD14 antibody (BioLegend, 325618) was used in flow cytometry on human samples at 1:100 (fig 5f). Nat Commun (2016) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human; loading ...; fig 1a
In order to study the contribution of T follicular helper cells to islet autoimmunity, BioLegend CD14 antibody (Biolegend, HCD14) was used in flow cytometry on human samples (fig 1a). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (HCD14)
  • blocking or activating experiments; human; loading ...; fig 2a
BioLegend CD14 antibody (BioLegend, HCD14) was used in blocking or activating experiments on human samples (fig 2a). Sci Rep (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 2
In order to identify cells that respond to interferon lambda, BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on human samples (fig 2). J Interferon Cytokine Res (2016) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human; fig s5
BioLegend CD14 antibody (Biolegend, HCD14) was used in flow cytometry on human samples (fig s5). PLoS Pathog (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 2a
BioLegend CD14 antibody (BioLegend, 301804) was used in flow cytometry on human samples (fig 2a). Oncogene (2017) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human; loading ...; fig s5a
BioLegend CD14 antibody (Biolegend, 325611) was used in flow cytometry on human samples (fig s5a). Sci Rep (2016) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human
In order to optimize the generation of therapeutic extracellular vesicles and identify molecules involved in their clearance, BioLegend CD14 antibody (Biolegend, HCD14) was used in flow cytometry on human samples . Biomaterials (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...
In order to study the cytolytic effector capacity of HIV-specific CD8+ T cells, BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on human samples . PLoS Pathog (2016) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human; loading ...
In order to study the cytolytic effector capacity of HIV-specific CD8+ T cells, BioLegend CD14 antibody (Biolegend, HCD14) was used in flow cytometry on human samples . PLoS Pathog (2016) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human; loading ...; fig 2a
BioLegend CD14 antibody (Biolegend, HCD14) was used in flow cytometry on human samples (fig 2a). Eur J Immunol (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on human samples (fig 1a). PLoS ONE (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 2a
BioLegend CD14 antibody (BioLegend, 301804) was used in flow cytometry on human samples (fig 2a). Oncotarget (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; rhesus macaque; loading ...
In order to optimize vaccination with Aventis Pasteur's canarypox vector-HIV, BioLegend CD14 antibody (BioLegend, 301842) was used in flow cytometry on rhesus macaque samples . Nat Med (2016) ncbi
mouse monoclonal (M5E2)
  • mass cytometry; human; loading ...; tbl 1, 2
In order to use elemental metal isotopes conjugated to monoclonal antibodies and study intracellular functional markers and surface phenotypic markers on natural killer cells, BioLegend CD14 antibody (Biolegend, M5E2) was used in mass cytometry on human samples (tbl 1, 2). Methods Mol Biol (2016) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD14 antibody (BioLegend, HCD14) was used in flow cytometry on human samples (fig 1a). Nat Immunol (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 1b
In order to develop a method to detect circulating B cells that recognize nuclear antigens in patients, BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples (fig 1b). Arthritis Rheumatol (2016) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human; loading ...; fig s6c
In order to report how the parallel networks of necroptosis-induced CXCL1 and Mincle signaling promote pancreatic ductal adenocarcinoma progression, BioLegend CD14 antibody (Biolegend, HCD14) was used in flow cytometry on human samples (fig s6c). Nature (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig 2
BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on human samples (fig 2). J Virol (2016) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; mouse; 1:100
In order to assess the role of NLRC5 to NK-T-cell crosstalk, BioLegend CD14 antibody (BioLegend, HCD14) was used in flow cytometry on mouse samples at 1:100. Nat Commun (2016) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human; loading ...; fig 1a
In order to characterize innate lymphoid cell subpopulations isolated from patients with systemic sclerosis, BioLegend CD14 antibody (biolegend, HCD14) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human; loading ...; fig 3a
In order to study complement C1s and C1q binding in apoptotic cell phagocytosis, BioLegend CD14 antibody (BioLegend, HCD14) was used in flow cytometry on human samples (fig 3a). Clin Immunol (2016) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human; loading ...
In order to study the role of human head and neck squamous cell carcinoma-associated semaphorin 4d in myeloid-derived suppressor cells, BioLegend CD14 antibody (BioLegend, 325604) was used in flow cytometry on human samples . J Immunol (2016) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human; fig 1
In order to study B cells migration in vivo, BioLegend CD14 antibody (Biolegend;, 325617) was used in flow cytometry on human samples (fig 1). Oncoimmunology (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
In order to identify the cell surface markers in synovial mesenchymal stem cells, BioLegend CD14 antibody (Biolegend, 301808) was used in flow cytometry on human samples . Cytometry A (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BioLegend CD14 antibody (Biolegend, 301808) was used in flow cytometry on human samples . Thromb Res (2015) ncbi
mouse monoclonal (HCD14)
In order to elucidate the mechanism by which IFN-beta1b suppresses relapsing-remitting multiple sclerosis, BioLegend CD14 antibody (Biolegend, HCD14) was used . Clin Exp Immunol (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; mouse
In order to compare the initial systemic Env-specific B cell responses of AGMs and rhesus macaques, BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on mouse samples . J Virol (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig s5
In order to identify the response to anti-MPO antibodies in the form of increased surface expression of ANCA autoantigens and IL-1beta secretion acting as intermediate monocytes in ANCA vasculitis, BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on human samples (fig s5). Sci Rep (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig S2
In order to look at patterns of S. Typhi-specific modulation of the homing potential of circulating Treg in patients with typhoid compared to healthy individuals, BioLegend CD14 antibody (biolegend, 301831) was used in flow cytometry on human samples (fig S2). PLoS Pathog (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; 1:100; fig 3
BioLegend CD14 antibody (Biolegend, 301814) was used in flow cytometry on human samples at 1:100 (fig 3). Nat Commun (2015) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; mouse; fig 1
BioLegend CD14 antibody (BioLegend, clone HCD14) was used in flow cytometry on mouse samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BioLegend CD14 antibody (Biolegend, 301820) was used in flow cytometry on human samples . Cytometry A (2015) ncbi
mouse monoclonal (HCD14)
  • immunohistochemistry - frozen section; human; fig s1
  • flow cytometry; human
BioLegend CD14 antibody (Biolegend, 325618) was used in immunohistochemistry - frozen section on human samples (fig s1) and in flow cytometry on human samples . Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human
BioLegend CD14 antibody (Biolegend, 325615) was used in flow cytometry on human samples . Hum Immunol (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig 1
BioLegend CD14 antibody (Biolegend, M5E2) was used in flow cytometry on human samples (fig 1). J Infect Dis (2015) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human; fig 2
BioLegend CD14 antibody (BioLegend, HCD14) was used in flow cytometry on human samples (fig 2). Blood Cells Mol Dis (2015) ncbi
mouse monoclonal (MHN4-2)
  • flow cytometry; human; fig 3
BioLegend CD14 antibody (BioLegend, MHN4-2) was used in flow cytometry on human samples (fig 3). Cytotherapy (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples . Immun Inflamm Dis (2014) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; rhesus macaque
BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on rhesus macaque samples . J Infect Dis (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples . J Immunol (2015) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human
BioLegend CD14 antibody (Biolegend, HCD14) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human
BioLegend CD14 antibody (Biolegend, HCD14) was used in flow cytometry on human samples . Eur J Immunol (2015) ncbi
mouse monoclonal (HCD14)
BioLegend CD14 antibody (BioLegend, HCD14) was used . J Exp Med (2014) ncbi
mouse monoclonal (HCD14)
BioLegend CD14 antibody (BioLegend, HCD14) was used . Sci Rep (2014) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig S1
  • immunocytochemistry; human
In order to discuss blood gammadeltaT subsets and their potential role in cancer immunotherapy, BioLegend CD14 antibody (BioLegend, 301806) was used in flow cytometry on human samples (fig S1) and in immunocytochemistry on human samples . Clin Cancer Res (2014) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human
In order to determine the presence, frequency, association to other immune parameters, and functional properties of circulating CD14(+) cells lacking HLA-DR expression in patients with untreated chronic lymphocytic leukemia, BioLegend CD14 antibody (Biolegend, HCD14) was used in flow cytometry on human samples . Blood (2014) ncbi
mouse monoclonal (HCD14)
BioLegend CD14 antibody (Biolegend, HCD14) was used . J Immunol (2014) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human
In order to develop methods to isolate inducible PMLC (HLA-DR(+)CD14(++)CD16(-) cells) and then characterize these cells, BioLegend CD14 antibody (BioLegend, 325622) was used in flow cytometry on human samples . J Inflamm (Lond) (2014) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human; tbl 1
In order to study the effect of innate lymphoid cells on B cells, BioLegend CD14 antibody (Biolegend, HCD14) was used in flow cytometry on human samples (tbl 1). Nat Immunol (2014) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 1
In order to test if hip fracture and depressive symptoms had additive effects upon the aged immune system, BioLegend CD14 antibody (BioLegend, M5E2) was used in flow cytometry on human samples (fig 1). Exp Gerontol (2014) ncbi
mouse monoclonal (HCD14)
  • flow cytometry; human; loading ...; fig 2a
In order to assess how different concentrations of IFN-gamma affect dendritic cells, BioLegend CD14 antibody (BioLegend, HCD14) was used in flow cytometry on human samples (fig 2a). J Leukoc Biol (2014) ncbi
Invitrogen
domestic rabbit recombinant (SC69-02)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 3c
Invitrogen CD14 antibody (Invitrogen, MA5-32248) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 3c). EBioMedicine (2022) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; loading ...; fig s14b
Invitrogen CD14 antibody (Thermo Fisher, 61D3) was used in flow cytometry on human samples (fig s14b). Mol Ther Methods Clin Dev (2022) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; 5:100; loading ...; fig 4a
Invitrogen CD14 antibody (Invitrogen, MHCD1430) was used in flow cytometry on human samples at 5:100 (fig 4a). Nat Commun (2021) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; 1:200; loading ...
Invitrogen CD14 antibody (Invitrogen, 47-0149-42) was used in flow cytometry on human samples at 1:200. Nature (2021) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human
Invitrogen CD14 antibody (Thermo Fisher Scientific, 61D3) was used in flow cytometry on human samples . ACS Synth Biol (2021) ncbi
mouse monoclonal (61D3)
  • flow cytometry; mouse; loading ...; fig 2c
Invitrogen CD14 antibody (ThermoFisher Scientific, 17-0149-42) was used in flow cytometry on mouse samples (fig 2c). J Autoimmun (2021) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; loading ...; fig s3
Invitrogen CD14 antibody (Invitrogen, 47-0149-42) was used in flow cytometry on human samples (fig s3). Nature (2021) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; 1:25; loading ...
Invitrogen CD14 antibody (eBioscience, 61D3) was used in flow cytometry on human samples at 1:25. elife (2020) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; mouse; loading ...; fig s2v
Invitrogen CD14 antibody (Invitrogen, TuK4) was used in flow cytometry on mouse samples (fig s2v). Cell (2020) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; 1:50; loading ...; fig 1d
Invitrogen CD14 antibody (eBioscience, 61D3) was used in flow cytometry on human samples at 1:50 (fig 1d). elife (2020) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; loading ...
Invitrogen CD14 antibody (ThermoFisher, Q22137) was used in flow cytometry on human samples . Nature (2020) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; loading ...; fig 2a
Invitrogen CD14 antibody (eBioscience, 61D3) was used in flow cytometry on human samples (fig 2a). BMC Infect Dis (2019) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; loading ...; fig s14b
Invitrogen CD14 antibody (eBioscience, 61D3) was used in flow cytometry on human samples (fig s14b). Science (2019) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; fig 3
Invitrogen CD14 antibody (eBioscience, 61D3) was used in flow cytometry on human samples (fig 3). Sci Rep (2019) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; 1:200; loading ...; fig 3s1
Invitrogen CD14 antibody (eBioscience, 12-0149-42) was used in flow cytometry on human samples at 1:200 (fig 3s1). elife (2019) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; loading ...; fig 6
Invitrogen CD14 antibody (eBioscience, 17-0149-41) was used in flow cytometry on human samples (fig 6). Gastroenterol Res Pract (2019) ncbi
mouse monoclonal (61D3)
  • flow cytometry; rhesus macaque; 1:200; loading ...; fig 3g
Invitrogen CD14 antibody (eBiosciences, 47-0149-41) was used in flow cytometry on rhesus macaque samples at 1:200 (fig 3g). Nature (2019) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; 1:100; loading ...; fig s1d, s2a
Invitrogen CD14 antibody (Thermofisher, MHCD1401) was used in flow cytometry on human samples at 1:100 (fig s1d, s2a). Cancer Cell (2019) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; loading ...; fig s2c
Invitrogen CD14 antibody (Invitrogen, TuK4) was used in flow cytometry on human samples (fig s2c). Immunol Cell Biol (2019) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; 1:100; loading ...; fig 1
Invitrogen CD14 antibody (Invitrogen/ThermoFisher Scientific, TuK4) was used in flow cytometry on human samples at 1:100 (fig 1). Molecules (2019) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; fig s4g
Invitrogen CD14 antibody (eBioscience, 15-0149-41) was used in flow cytometry on human samples (fig s4g). Cell Death Differ (2019) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; fig 1d
Invitrogen CD14 antibody (Invitrogen, MHCD1406) was used in flow cytometry on human samples (fig 1d). J Exp Med (2018) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; 1:20; loading ...; fig 4a
Invitrogen CD14 antibody (eBioscience, 17-0149) was used in flow cytometry on human samples at 1:20 (fig 4a). Stem Cell Res Ther (2018) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; loading ...; fig s3a
Invitrogen CD14 antibody (eBioscience, 61D3) was used in flow cytometry on human samples (fig s3a). J Leukoc Biol (2018) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; loading ...; fig s6m
Invitrogen CD14 antibody (eBioscience, 17-0149-42) was used in flow cytometry on human samples (fig s6m). Cancer Cell (2018) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; fig 1a
In order to study the involvement of Notch signaling in NK cell lineage determination, Invitrogen CD14 antibody (Invitrogen, TÜK4) was used in flow cytometry on human samples (fig 1a). J Immunol (2017) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; fig 1a
In order to study the involvement of Notch signaling in NK cell lineage determination, Invitrogen CD14 antibody (ebioscience, 61D3) was used in flow cytometry on human samples (fig 1a). J Immunol (2017) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; loading ...; fig 1c
In order to evaluate the role of IL-32alpha in NK cell inhibition, Invitrogen CD14 antibody (Thermo Fisher, Tuk4) was used in flow cytometry on human samples (fig 1c). J Immunol (2017) ncbi
mouse monoclonal (TUK4)
  • mass cytometry; human; loading ...; fig 2a
In order to investigate the immune composition of tumor microenvironment in hepatocellular carcinoma, Invitrogen CD14 antibody (Life Technologies, TuK4) was used in mass cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; loading ...; fig 1e
Invitrogen CD14 antibody (eBiosciences, 12-0149-42) was used in flow cytometry on human samples (fig 1e). J Clin Invest (2017) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; loading ...; fig 6c
In order to investigate origin of tumor-infiltrating T regulatory cells in breast cancer samples, Invitrogen CD14 antibody (Thermo Fischer Scientific, 12-0149) was used in flow cytometry on human samples (fig 6c). Cell Res (2017) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; loading ...; fig s1a
In order to determine the localization of FcgammaRI, FcgammaRII, and SIRPalpha in macrophages, Invitrogen CD14 antibody (eBiosciences, 61D3) was used in flow cytometry on human samples (fig s1a). J Cell Biol (2017) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; 1:100; fig 1a
In order to study the interactions among different monocyte populations and vascular endothelial cells, Invitrogen CD14 antibody (eBiosciences, 61D3) was used in flow cytometry on human samples at 1:100 (fig 1a). J Immunol (2017) ncbi
mouse monoclonal (61D3)
  • immunocytochemistry; human; fig 1b
In order to study the role to toll-like receptors and microglia on HIV disease, Invitrogen CD14 antibody (eBioscience, 12-0149) was used in immunocytochemistry on human samples (fig 1b). Retrovirology (2017) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; fig 3a
In order to elucidate how DR3/TL1A signaling controls bone loss, Invitrogen CD14 antibody (eBioscience, 61D3) was used in flow cytometry on human samples (fig 3a). Bone (2017) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; loading ...; fig s1b
Invitrogen CD14 antibody (eBiosciences, 61D3) was used in flow cytometry on human samples (fig s1b). Sci Rep (2016) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; 1:25; loading ...; fig 1b
In order to explore the role of thrombopoietin signaling in the human primitive hematopoietic stem cell compartment, Invitrogen CD14 antibody (eBiosciences, 61D3) was used in flow cytometry on human samples at 1:25 (fig 1b). Cell Transplant (2017) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; rhesus macaque; loading ...; fig 7a
In order to study the efficacy of nanoparticle adjuvants for inducing protective immunity against simian immunodeficiency virus, Invitrogen CD14 antibody (Invitrogen, TuK4) was used in flow cytometry on rhesus macaque samples (fig 7a). J Virol (2017) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; loading ...; fig 1d
  • immunocytochemistry; human; loading ...; fig 1c
In order to assess the effects of thrombomodulin on monocyte differentiation, Invitrogen CD14 antibody (eBioscience, 25-0149) was used in flow cytometry on human samples (fig 1d) and in immunocytochemistry on human samples (fig 1c). Sci Rep (2016) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; loading ...; fig 1a
In order to measure CD80 and CD86 expression on CD14+HLA-DR+ monocytes from patients with Chagas disease, Invitrogen CD14 antibody (Invitrogen, MA 1-82074) was used in flow cytometry on human samples (fig 1a). Rev Soc Bras Med Trop (2016) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; loading ...; tbl 1
In order to demonstrate that freezing already-stained samples suspended in 10% DMSO in FBS is practical and efficient way to preserve already-stained samples for mass cytometry assessment, Invitrogen CD14 antibody (Invitrogen, TuK4) was used in flow cytometry on human samples (tbl 1). Cytometry A (2017) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; loading ...
In order to screen to find antibodies that block HIV-1 acquisition and replication, Invitrogen CD14 antibody (Invitrogen, T[u]K4) was used in flow cytometry on human samples . J Virol (2017) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; loading ...; fig 3b
In order to determine the contribution of CD16 positive monocytes to antibody-dependent cellular cytotoxicity, Invitrogen CD14 antibody (eBiosciences, 61D3) was used in flow cytometry on human samples (fig 3b). Sci Rep (2016) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; loading ...
In order to determine the S. Typhi, S. Paratyphi A, and S. Paratyphi B cross-reactive CD4 positive T cell responses elicited by immunization with Ty21a, Invitrogen CD14 antibody (Thermo Scientific, TuK4) was used in flow cytometry on human samples . Clin Immunol (2016) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; loading ...; fig 3e
In order to assess dextran-based nanoparticles as a drug delivery system to target myeloid cells of the liver, Invitrogen CD14 antibody (eBioscience, 48014942) was used in flow cytometry on human samples (fig 3e). Nanomedicine (Lond) (2016) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; 1:5; loading ...
In order to find that leukocyte cell-derived chemotaxin 2 promotes expansion and mobilization of hematopoietic stem cells, Invitrogen CD14 antibody (eBioscience, 61D3) was used in flow cytometry on human samples at 1:5. Nat Commun (2016) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; fig 2
Invitrogen CD14 antibody (eBioscience, 11-0149-41) was used in flow cytometry on human samples (fig 2). Stem Cell Reports (2016) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; fig 3
In order to identify ABCA1 as a mycobacterial host-restriction factor, Invitrogen CD14 antibody (eBiosciences, 61D3) was used in flow cytometry on human samples (fig 3). Front Microbiol (2016) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; fig 1
Invitrogen CD14 antibody (eBiosciencs, 11-0149) was used in flow cytometry on human samples (fig 1). Nat Commun (2016) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; fig 1a
In order to assess the effects of platelet-derived ectosomes on natural killer cells, Invitrogen CD14 antibody (eBiosciences, 61D3) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; loading ...; fig s2b
Invitrogen CD14 antibody (eBioscience, 61D3) was used in flow cytometry on human samples (fig s2b). Sci Rep (2016) ncbi
mouse monoclonal (61D3)
  • flow cytometry; dogs; loading ...; tbl 1
In order to explore the outcome of canine diagnosed with acute leukemia, Invitrogen CD14 antibody (eBioscience, 61D3) was used in flow cytometry on dogs samples (tbl 1). Vet Comp Oncol (2017) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; loading ...; fig s2
In order to report the effects of PD-L1 modulation of T cell function in graft-versus-host disease, Invitrogen CD14 antibody (eBioscience, 61D3) was used in flow cytometry on human samples (fig s2). J Clin Invest (2016) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; fig 1b
In order to assess the use of human adipose-derived stem cells to treat cancer, Invitrogen CD14 antibody (Invitrogen, MHCD1404) was used in flow cytometry on human samples (fig 1b). Cytotherapy (2016) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; tbl 1
In order to research adipose tissue-derived mesenchymal stem cell proliferation and death with oxysterols, Invitrogen CD14 antibody (Invitrogen, MHCD1404- RPE) was used in flow cytometry on human samples (tbl 1). J Steroid Biochem Mol Biol (2017) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; loading ...; fig s1
In order to characterize the immune responses of children immunized with Plasmodium falciparum apical membrane antigen 1, Invitrogen CD14 antibody (Invitrogen, Tuk4) was used in flow cytometry on human samples (fig s1). Vaccine (2016) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; loading ...; fig 1b
In order to measure DR3 expression on peripheral blood mononuclear cells of patients with inflammatory bowel disease, Invitrogen CD14 antibody (eBiosciences, 61D3) was used in flow cytometry on human samples (fig 1b). Cytometry B Clin Cytom (2017) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; 1:200; fig 5
Invitrogen CD14 antibody (ebioscience, 61D3) was used in flow cytometry on human samples at 1:200 (fig 5). PLoS ONE (2016) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; loading ...; tbl 2
In order to assess the protective immunological events induced by vaccination with Leishmune in dogs, Invitrogen CD14 antibody (Invitrogen, MHCD1431) was used in flow cytometry on human samples (tbl 2). Vet Parasitol (2016) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; tbl 2
In order to determine the contribution of Leukocyte Ig Like Receptors to Mycobacterium tuberculosis infection, Invitrogen CD14 antibody (Invitrogen, MHCD1417) was used in flow cytometry on human samples (tbl 2). Sci Rep (2016) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; loading ...; tbl s1
In order to explore how junctional adhesion molecule family members differentially regulate CXCR4 function and CXCL12 secretion in the bone marrow niche, Invitrogen CD14 antibody (eBioscience, 15-0149-42) was used in flow cytometry on human samples (tbl s1). Stem Cells (2016) ncbi
mouse monoclonal (MEM-15)
  • flow cytometry; human; loading ...; fig 1a
In order to investigate the influence of peripheral blood monocytes on human cardiac myofibroblast activity, Invitrogen CD14 antibody (Thermo Scientific, MEM-15) was used in flow cytometry on human samples (fig 1a). Am J Physiol Heart Circ Physiol (2016) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human
In order to determine how HIV-1 Vpr protein induces proteasomal degradation of chromatin-associated class 1 HDACs to fight macrophage infection, Invitrogen CD14 antibody (Life Technologies, MHCD1417) was used in flow cytometry on human samples . J Biol Chem (2016) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; fig 5
Invitrogen CD14 antibody (eBioscience, 61D3) was used in flow cytometry on human samples (fig 5). PLoS Pathog (2015) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; 1:160; fig 1
In order to utilize mass cytometry for multiplexed peptide-MHC tetramer staining, Invitrogen CD14 antibody (Invitrogen, TuK4) was used in flow cytometry on human samples at 1:160 (fig 1). Methods Mol Biol (2015) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; loading ...; fig s2b
Invitrogen CD14 antibody (eBioscience, 61D3) was used in flow cytometry on human samples (fig s2b). Nat Commun (2015) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; fig 7
Invitrogen CD14 antibody (eBioscience, 61D3) was used in flow cytometry on human samples (fig 7). Eur J Immunol (2016) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; fig 1
Invitrogen CD14 antibody (eBioscience, 25-0149-41) was used in flow cytometry on human samples (fig 1). Clin Exp Immunol (2016) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human
In order to study the relationship between HIV infection and the innate immune system, Invitrogen CD14 antibody (Life Technologie, MHCD1417) was used in flow cytometry on human samples . J Vis Exp (2015) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; tbl 2
Invitrogen CD14 antibody (eBioscience, 12-0149-42) was used in flow cytometry on human samples (tbl 2). Exp Cell Res (2015) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; rhesus macaque; loading ...; fig 2a
In order to investigate the effects of microbial products on the liver, Invitrogen CD14 antibody (Invitrogen, Tuk4) was used in flow cytometry on rhesus macaque samples (fig 2a). J Infect Dis (2016) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human
Invitrogen CD14 antibody (eBioscience, 61D3) was used in flow cytometry on human samples . Science (2015) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human
In order to study the dynamics of Ag-specific CD4(+) T cells during antiretroviral therapy, Invitrogen CD14 antibody (Invitrogen, T??k4) was used in flow cytometry on human samples . J Immunol (2015) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; 1:800
In order to develop a system to determine human DC development and differentiation, Invitrogen CD14 antibody (Invitrogen, Tuk4) was used in flow cytometry on human samples at 1:800. J Immunol Methods (2015) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human
In order to elucidate regulation of gamma-globin expression in F-cells, Invitrogen CD14 antibody (Life Technologies, TUK4) was used in flow cytometry on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human
Invitrogen CD14 antibody (eBioscience, 25- 0149) was used in flow cytometry on human samples . Blood Cancer J (2015) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; fig 1
In order to examine the antibody repertoire of patients with acute systemic lupus erythematosus, Invitrogen CD14 antibody (Invitrogen, TK4) was used in flow cytometry on human samples (fig 1). Nat Immunol (2015) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human
In order to investigate the primary inflammatory and regulatory T cell responses induced by BCG vaccination in adults, Invitrogen CD14 antibody (Invitrogen, clone TuK4) was used in flow cytometry on human samples . Clin Vaccine Immunol (2015) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human
In order to describe an Fc engineering approach that specifically affects antibody-dependent cytokine release, Invitrogen CD14 antibody (Invitrogen, Q10013) was used in flow cytometry on human samples . MAbs (2015) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human
In order to optimize detection of IL-2 from live cells, Invitrogen CD14 antibody (Life Sciences/Invitrogen, Q10064) was used in flow cytometry on human samples . Cytometry A (2015) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; fig 4
In order to report the phase I trial results of CDX-301, Invitrogen CD14 antibody (Invitrogen, TuK4) was used in flow cytometry on human samples (fig 4). Bone Marrow Transplant (2015) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human
In order to determine if HIV elite controllers have exhausted T cells, Invitrogen CD14 antibody (Invitrogen, TuK4) was used in flow cytometry on human samples . J Infect Dis (2015) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; fig 4
Invitrogen CD14 antibody (eBioscience, 61D3) was used in flow cytometry on human samples (fig 4). J Rheumatol (2015) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; tbl 2
In order to learn how peritoneal macrophages enhance antibacterial responses by vitamin D supplementation, Invitrogen CD14 antibody (Invitrogen, MHCD-1404) was used in flow cytometry on human samples (tbl 2). PLoS ONE (2014) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human
In order to test if mesenchymal stromal cells support the growth and survival of leukemic stem cells in vitro, Invitrogen CD14 antibody (Invitrogen, tuk4) was used in flow cytometry on human samples . Stem Cell Res (2015) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; fig 3
Invitrogen CD14 antibody (eBioscience, 61D3) was used in flow cytometry on human samples (fig 3). J Lipid Res (2015) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human
In order to compared leukocyte proportions and absolute counts using reference real-time methods with a novel assay that allows long-term cryopreservation of fixed leukocytes for later counting, Invitrogen CD14 antibody (Invitrogen, Q10013) was used in flow cytometry on human samples . Cytometry A (2015) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human
Invitrogen CD14 antibody (eBioscience, 12-0149) was used in flow cytometry on human samples . J Pediatr Surg (2014) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human
Invitrogen CD14 antibody (eBioscience, 61D3) was used in flow cytometry on human samples . J Allergy Clin Immunol (2015) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; 5 ul
In order to study the incidence of coronary heart disease in cytomegalovirus-seropositive individuals, Invitrogen CD14 antibody (Invitrogen, MHCD1428) was used in flow cytometry on human samples at 5 ul. Circ Res (2015) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human
In order to evaluate immune responses by monocyte isolated from young and old adults before and after influenza vaccination, Invitrogen CD14 antibody (Life Technologies, TuK4) was used in flow cytometry on human samples . J Infect Dis (2015) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; fig 1
Invitrogen CD14 antibody (eBioscience, 61D3) was used in flow cytometry on human samples (fig 1). J Infect Dis (2015) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; 1:200; fig 4
In order to study juxtacrine signaling from macrophages and monocytes and a breast cancer stem cell niche, Invitrogen CD14 antibody (eBioscience, 25-0149) was used in flow cytometry on human samples at 1:200 (fig 4). Nat Cell Biol (2014) ncbi
mouse monoclonal (TUK4)
  • immunocytochemistry; human
In order to study the role of dendritic cells in relation to T cells, Invitrogen CD14 antibody (Life Technologies, Tuk4) was used in immunocytochemistry on human samples . J Immunol (2014) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human
In order to report the immune responses elicited in an outpatient Phase 2 clinical trial in which subjects were vaccinated with CVD 1208S (DeltaguaBA, Deltaset, Deltasen S. flexneri 2a), Invitrogen CD14 antibody (Caltag, TuK4) was used in flow cytometry on human samples . Front Immunol (2014) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human
Invitrogen CD14 antibody (eBioscience, 61D3) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human
  • immunocytochemistry; human
In order to study the effect of atorvastatin on telomerase activity in peripheral blood mononuclear cells and T-lymphocytes, Invitrogen CD14 antibody (Invitrogen, MHCD1428) was used in flow cytometry on human samples and in immunocytochemistry on human samples . Atherosclerosis (2014) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human
Invitrogen CD14 antibody (eBioscience, 61D3) was used in flow cytometry on human samples . Clin Cancer Res (2014) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human
Invitrogen CD14 antibody (eBioscience, 61D3) was used in flow cytometry on human samples . J Exp Med (2014) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human
In order to examine various DC after flu vaccination, Invitrogen CD14 antibody (Invitrogen, TuK4) was used in flow cytometry on human samples . Immunol Invest (2014) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; rhesus macaque; fig 3
In order to determine if vaccination with a rhesus macaque-derived adenoviral vector simian adenovirus 7 enhances mucosal T cell activation, Invitrogen CD14 antibody (Invitrogen, noca) was used in flow cytometry on rhesus macaque samples (fig 3). J Virol (2014) ncbi
mouse monoclonal (TUK4)
  • immunocytochemistry; human
In order to investigate the effect of TNF and IL-10 on synovial fibroblasts, Invitrogen CD14 antibody (Life Technologies, MHCD1401) was used in immunocytochemistry on human samples . Cell Tissue Res (2014) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human
Invitrogen CD14 antibody (eBiosciences, 61D3) was used in flow cytometry on human samples . J Clin Immunol (2014) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human
In order to investigate the progression of innate responses to mycobacteria in infants, Invitrogen CD14 antibody (Invitrogen, Tuk4) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human
In order to study NK function in solid tumors, Invitrogen CD14 antibody (Invitrogen, TuK4) was used in flow cytometry on human samples . Int J Cancer (2014) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human
Invitrogen CD14 antibody (eBioscience, 61D3) was used in flow cytometry on human samples . J Leukoc Biol (2014) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human
In order to quantify coexpression of different killer Ig-like molecules in patient natural killer cells with mutant TAP genes mediating deficient HLA class I expression, Invitrogen CD14 antibody (eBioscience, 61D3) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human
In order to examine the function of NK- and T-cells in order to understand how chronic myeloid leukemia patients maintain the treatment response after IFN-alpha discontinuation, Invitrogen CD14 antibody (Invitrogen, tuk4) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; fig 1
In order to study mucosal associated invariant T cells and B cell interactions, Invitrogen CD14 antibody (Invitrogen, clone TuK4) was used in flow cytometry on human samples (fig 1). Front Immunol (2014) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; 1:10; fig 4
In order to investigate the cytotoxicity of acyl glucuronide, Invitrogen CD14 antibody (Invitrogen, TuK4) was used in flow cytometry on human samples at 1:10 (fig 4). Drug Metab Dispos (2014) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; fig 3
In order to determine the role of conventional and regulatory T cells in protection from HIV-1 infection, Invitrogen CD14 antibody (Invitrogen, TuK4) was used in flow cytometry on human samples (fig 3). AIDS Res Hum Retroviruses (2013) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; fig 9
In order to characterize T cell responses of HIV-exposed, yet persistently uninfected individuals, Invitrogen CD14 antibody (Invitrogen, MHCD1428) was used in flow cytometry on human samples (fig 9). J Virol (2013) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; fig 1
In order to measure and characterize T/NK precursors among CD34(+)Lin(-) cell populations circulating in normal human adult peripheral blood, Invitrogen CD14 antibody (Invitrogen, TuK4) was used in flow cytometry on human samples (fig 1). J Immunol (2013) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human
In order to study early abdominal aortic aneurysm formation by CD14 directing adventitial macrophage precursor recruitment, Invitrogen CD14 antibody (Invitrogen, noca) was used in flow cytometry on human samples . J Am Heart Assoc (2013) ncbi
mouse monoclonal (TUK4)
  • immunocytochemistry; human; fig 1
In order to assess the effect of immunosuppression used for organ transplantation on immune responses to adeno-associated virus capsid antigens, Invitrogen CD14 antibody (Invitrogen, clone TuK4) was used in immunocytochemistry on human samples (fig 1). Hum Gene Ther (2013) ncbi
mouse monoclonal (TUK4)
In order to investigate mucosal dysfunction in relation to HIV/SIV pathogenesis, Invitrogen CD14 antibody (Invitrogen, T?uK4) was used . J Immunol (2013) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human
In order to examine the role of IL-17A-producing multifunctional T cells in the pathogenesis of toxic shock syndrome, Invitrogen CD14 antibody (Invitrogen, TuK4) was used in flow cytometry on human samples . Clin Immunol (2013) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; fig 2
In order to assess the functionality of virus-specific CD8+ T cells in older individuals acutely infected with West Nile virus and chronically infected with Epstein Barr virus and Cytomegalovirus, Invitrogen CD14 antibody (noca, T K4) was used in flow cytometry on human samples (fig 2). PLoS Pathog (2012) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; fig 1
In order to identify integrin alpha2 as a novel stem cell marker, Invitrogen CD14 antibody (Invitrogen, TuK4) was used in flow cytometry on human samples (fig 1). Stem Cells (2013) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; fig 1
In order to study B cell populations in patients with N-methyl-D-aspartate receptor encephalitis, Invitrogen CD14 antibody (Invitrogen, TUK4) was used in flow cytometry on human samples (fig 1). Dev Med Child Neurol (2013) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; rhesus macaque; loading ...; fig 2a
In order to test if vaccination alters the activation state of T cells within the gastrointestinal mucosa, inguinal lymph nodes, and peripheral blood, Invitrogen CD14 antibody (Invitrogen, Tuk4) was used in flow cytometry on rhesus macaque samples (fig 2a). Hum Vaccin Immunother (2012) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; fig 3
In order to study of the age-related changes in human dendritic cells from subjects infected with Schistosoma haematobium, Invitrogen CD14 antibody (Invitrogen, TUK4) was used in flow cytometry on human samples (fig 3). PLoS Negl Trop Dis (2012) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; fig s3
Invitrogen CD14 antibody (eBioscience, 61D3) was used in flow cytometry on human samples (fig s3). PLoS Pathog (2012) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; fig 1
In order to characterize therapy-induced T cell reactivity using a panel of 145 melanoma-associated CD8(+) T cell epitopes, Invitrogen CD14 antibody (Invitrogen, MHCD1429) was used in flow cytometry on human samples (fig 1). Oncoimmunology (2012) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human
In order to analyze the regulation of Amphiregulin expression in human T cell subsets, Invitrogen CD14 antibody (Invitrogen, tuk4) was used in flow cytometry on human samples . PLoS ONE (2012) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human
In order to explore the multifunctional IL-17A responses against S. Typhi antigens in T memory subsets, Invitrogen CD14 antibody (Invitrogen, clone TuK4) was used in flow cytometry on human samples . PLoS ONE (2012) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; fig 2
In order to examine the effects of eltrombopag on leukemia cell proliferation and the mechanism of its antiproliferative effects, Invitrogen CD14 antibody (Invitrogen, MHCD1406) was used in flow cytometry on human samples (fig 2). Blood (2012) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; fig 1
In order to study influenza-specific CD4 T cells respond to vaccination using Ki67 as a marker, Invitrogen CD14 antibody (Invitrogen, clone TUK4) was used in flow cytometry on human samples (fig 1). Vaccine (2012) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human
Invitrogen CD14 antibody (eBioscience, 61D3) was used in flow cytometry on human samples . Arthritis Res Ther (2012) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; fig 3
In order to discuss how co-infections and secondary parasite infections may disrupt the immunologic responses induced by a pre-existing parasitic infection, Invitrogen CD14 antibody (InVitrogen, TuK4) was used in flow cytometry on human samples (fig 3). PLoS ONE (2012) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human
In order to develop and validate a novel system for high throughput quantitation of autophagy in primary human leukocytes, Invitrogen CD14 antibody (Invitrogen, MHCD1428) was used in flow cytometry on human samples . Autophagy (2012) ncbi
mouse monoclonal (TUK4)
  • immunocytochemistry; human
In order to discuss the use of umbilical cord blood as a source of transplantable hematopoietic stem cells, Invitrogen CD14 antibody (Invitrogen, TuK4) was used in immunocytochemistry on human samples . Transfusion (2011) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; rhesus macaque; fig 1
In order to characterize different macaque NK cell subpopulations, Invitrogen CD14 antibody (Invitrogen, TuK4) was used in flow cytometry on rhesus macaque samples (fig 1). Immunology (2011) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; fig 2
In order to discuss the live attenuated yellow fever vaccines, Invitrogen CD14 antibody (Caltag, TuK4) was used in flow cytometry on human samples (fig 2). J Infect Dis (2011) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; fig S1
In order to examine tumor and nonadjacent normal breast tissue from women with breast cancer, who either had or had not received neoadjuvant chemotherapy before surgery, Invitrogen CD14 antibody (Invitrogen, Q10056) was used in flow cytometry on human samples (fig S1). Proc Natl Acad Sci U S A (2012) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; fig 2
In order to describe a 15-year-old male with longitudinally extensive transverse myelitis with magnetic resonance imaging findings of oedema, cavitation, and gadolinium enhancement, Invitrogen CD14 antibody (Invitrogen, TUK4) was used in flow cytometry on human samples (fig 2). Dev Med Child Neurol (2011) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; fig 4
In order to test if anti-CD8 Abs induce effector function, Invitrogen CD14 antibody (Caltag, clone Tuk4) was used in flow cytometry on human samples (fig 4). J Immunol (2011) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; fig 1
In order to test if rejection of AAV-transduced hepatocytes is due to AAV capsid-specific CD8 positive T cells that become reactivated upon gene transfer, Invitrogen CD14 antibody (Invitrogen, clone TuK4) was used in flow cytometry on human samples (fig 1). Mol Ther (2011) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; fig 1
In order to examine human cross-reactive T cells against a pandemic virus, Invitrogen CD14 antibody (Invitrogen, clone TUK4) was used in flow cytometry on human samples (fig 1). Vaccine (2011) ncbi
mouse monoclonal (TUK4)
  • immunocytochemistry; human
In order to discuss the use of internal antigens to provide better protection against multiple influenza subtypes, Invitrogen CD14 antibody (Invitrogen, TuK4) was used in immunocytochemistry on human samples . Clin Infect Dis (2011) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; 1:20; tbl 1
In order to isolate and characterize human Sertoli cells, Invitrogen CD14 antibody (Invitrogen, MHCD1401) was used in flow cytometry on human samples at 1:20 (tbl 1). Cell Transplant (2011) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; fig 1
In order to discuss the benefits of studying primary immunodeficiencies, Invitrogen CD14 antibody (Caltag, TUK4) was used in flow cytometry on human samples (fig 1). Int Arch Allergy Immunol (2010) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human
In order to describe protocols for immunostaining and multiparameter flow cytometric analysis of major human antigen-presenting cells in peripheral blood, Invitrogen CD14 antibody (Invitrogen, MHCD1430) was used in flow cytometry on human samples . Nat Protoc (2010) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; fig 1
In order to study IL-7 receptor expression and IL-7 signaling in human thymocytes, Invitrogen CD14 antibody (eBioscience, 61D3) was used in flow cytometry on human samples (fig 1). Hum Immunol (2010) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; 1:40; fig 3
In order to investigate targeting CEACAM6 for treatment of pancreatic adenocarcinomas, Invitrogen CD14 antibody (CalTag, clone TUK 4) was used in flow cytometry on human samples at 1:40 (fig 3). J Pathol (2009) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human
In order to study the improvement of simultaneous phenotype-specific telomere length measurement by FISH-flow cytometry by quantum dots thermal stability, Invitrogen CD14 antibody (Invitrogen, noca) was used in flow cytometry on human samples . J Immunol Methods (2009) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; fig 1
In order to discuss the molecular mechanisms that prevent apoptosis induced by damaged DNA in myeloproliferative disorders, Invitrogen CD14 antibody (Caltag, MHCD1405) was used in flow cytometry on human samples (fig 1). N Engl J Med (2008) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; fig 1
In order to assess the immunological status after Bz-treatment during early indeterminate Chagas disease, Invitrogen CD14 antibody (Caltag, TuK4) was used in flow cytometry on human samples (fig 1). Microbes Infect (2008) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; fig 4
In order to test if leukocyte Ig-like receptor A2 regulates DC differentiation using a leprosy model, Invitrogen CD14 antibody (Caltag, TUK4) was used in flow cytometry on human samples (fig 4). J Immunol (2007) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; fig 1
In order to investigate the impact of HSP-27 treatment on monocyte differentiation into dendritic cells, Invitrogen CD14 antibody (eBioscience, 61D3) was used in flow cytometry on human samples (fig 1). Eur J Immunol (2007) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human
In order to test if the normally discarded bone marrow collection kits are a convenient source of large numbers of mesenchymal stem cells, Invitrogen CD14 antibody (Caltag, TuK4) was used in flow cytometry on human samples . Transplantation (2007) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human
In order to compare on-line hemofiltration to high-flux hemodialysis, Invitrogen CD14 antibody (Caltag, MHCD1406) was used in flow cytometry on human samples . Kidney Int (2007) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human
In order to develop an assay to quantitate the number of latently infected cells carrying replication competent HIV-1, Invitrogen CD14 antibody (Caltag, T K4) was used in flow cytometry on human samples . Methods Mol Biol (2005) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; African green monkey; fig 1
In order to discuss available reagents for studying the neotropical primate squirrel monkey, Invitrogen CD14 antibody (Caltag Laboratories, TuK4) was used in flow cytometry on African green monkey samples (fig 1). J Immunol Methods (2005) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; fig 2
In order to assess the effects of a TransFix-based stabilization technique on leukocyte scatter characteristics, immunophenotyping, membrane permeability, absolute cell counting and morphology, Invitrogen CD14 antibody (Caltag Laboratories, TUK4) was used in flow cytometry on human samples (fig 2). J Immunol Methods (2004) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human
In order to study the life-cycle events of HIV-1 in primary cultures of human uterine epithelial cells and stromal fibroblasts, Invitrogen CD14 antibody (Caltag, MHCD1401) was used in flow cytometry on human samples . J Infect Dis (2004) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human
In order to ask if flow cytometry can be used for the detection of bone marrow involvement in the different types of B-cell malignant neoplasms, Invitrogen CD14 antibody (Zymed, TUK4) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2003) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; fig 4
In order to report that CD34(+) progenitor cell-derived Langerhans cells-type DCs exhibit a differentiation state-dependent susceptibility to CMV infection, Invitrogen CD14 antibody (Caltag, TUK4) was used in flow cytometry on human samples (fig 4). J Virol (2003) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human
In order to describe a protocol for the isolation HSC from human fetal liver, Invitrogen CD14 antibody (Caltag, T??K4) was used in flow cytometry on human samples . Biol Proced Online (2002) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human
In order to report how to isolate highly purified hematopoietic intermediates, Invitrogen CD14 antibody (Caltag, TUK4) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (2002) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human
In order to determine of proinflammatory cytokine responses induced by certain bacterial protein adhesins are dependent on TLRs, Invitrogen CD14 antibody (Caltag, Tuk4) was used in flow cytometry on human samples . Clin Diagn Lab Immunol (2002) ncbi
mouse monoclonal (B-A8)
  • flow cytometry; human
In order to assess the effect of microfilariae antigen on dendritic cells, Invitrogen CD14 antibody (Biosource, B-A8) was used in flow cytometry on human samples . Infect Immun (2001) ncbi
mouse monoclonal (B-A8)
  • flow cytometry; human; fig 2
In order to examine the effects of sulfasalazine and its metabolites on human dendritic cells, Invitrogen CD14 antibody (Biosource, clone B-A8) was used in flow cytometry on human samples (fig 2). Croat Med J (2001) ncbi
mouse monoclonal (B-A8)
  • flow cytometry; human
In order to elucidate how aspirin inhibits dendritic cell function, Invitrogen CD14 antibody (Biosource, B-A8) was used in flow cytometry on human samples . Immunology (2000) ncbi
mouse monoclonal (B-A8)
  • flow cytometry; human
In order to test if type-I interferons influence dendritic cell differentiation and function, Invitrogen CD14 antibody (Biosource, B-A8) was used in flow cytometry on human samples . Blood (2000) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human
In order to characterize a chemically synthesized fragment of IL-2, Invitrogen CD14 antibody (Caltag, MHCD1406) was used in flow cytometry on human samples . J Exp Med (2000) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; rhesus macaque
In order to examine the innate and adaptive immune responses of rhesus macaques infected with SIVmac251, Invitrogen CD14 antibody (BioSource, Tuk4) was used in flow cytometry on rhesus macaque samples . J Virol (2000) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human
In order to characterize the cells present in the cutaneous blister fluid patients with toxic epidermal necrolysis, Invitrogen CD14 antibody (Caltag, TuK4) was used in flow cytometry on human samples . Clin Exp Immunol (2000) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human
In order to determine the number of CD4, CCR5, and CXCR4 antibody-binding sites on various T cells and macrophages, Invitrogen CD14 antibody (Caltag, Tuk4) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (1999) ncbi
mouse monoclonal (MEM-15)
  • flow cytometry; human; fig 3
In order to test if recombinant human interferon-gamma enhancing clearance of microbes in patients with chronic granulomatous disease, Invitrogen CD14 antibody (Caltag, MEM-15) was used in flow cytometry on human samples (fig 3). Blood (1997) ncbi
mouse monoclonal (TUK4)
  • immunocytochemistry; human; fig 2
In order to describe the cellular composition and organization of lymphoid aggregates in the stratum basalis of uterine endometrium, Invitrogen CD14 antibody (Caltag, TUK 4) was used in immunocytochemistry on human samples (fig 2). J Leukoc Biol (1997) ncbi
Abcam
domestic goat polyclonal
  • western blot; human; 1:1000; fig 6e
Abcam CD14 antibody (Abcam, ab45870) was used in western blot on human samples at 1:1000 (fig 6e). Cell Mol Life Sci (2022) ncbi
domestic rabbit monoclonal (EPR3653)
  • immunohistochemistry; human; loading ...; fig 1a
Abcam CD14 antibody (Abcam, ab133335) was used in immunohistochemistry on human samples (fig 1a). iScience (2021) ncbi
mouse monoclonal (4B4F12)
  • western blot; mouse; loading ...; fig s2b
Abcam CD14 antibody (Abcam, ab182032) was used in western blot on mouse samples (fig s2b). EMBO J (2019) ncbi
mouse monoclonal (4B4F12)
  • immunocytochemistry; mouse; 1:100; loading ...; fig 1a
Abcam CD14 antibody (Abcam, ab182032) was used in immunocytochemistry on mouse samples at 1:100 (fig 1a). BMC Nephrol (2017) ncbi
mouse monoclonal (4B4F12)
  • flow cytometry; human; loading ...; fig 3
Abcam CD14 antibody (Abcam, ab182032) was used in flow cytometry on human samples (fig 3). J Cell Mol Med (2017) ncbi
mouse monoclonal (4B4F12)
  • immunohistochemistry - paraffin section; pigs ; 1:200; fig 6
Abcam CD14 antibody (abcam, ab182032) was used in immunohistochemistry - paraffin section on pigs samples at 1:200 (fig 6). Arthritis Res Ther (2016) ncbi
domestic rabbit monoclonal (EPR3652)
  • immunohistochemistry - paraffin section; human; 1:100; fig s2
In order to gain insight into biomarkers of response and mechanisms of resistance to immune checkpoint blockade by analysis of immune signatures in longitudinal tumor samples, Abcam CD14 antibody (Abcam, Ab133503) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig s2). Cancer Discov (2016) ncbi
mouse monoclonal (4B4F12)
  • immunohistochemistry; mouse; 1:1000; loading ...; fig 3e
Abcam CD14 antibody (AbCam, ab182032) was used in immunohistochemistry on mouse samples at 1:1000 (fig 3e). PLoS Pathog (2016) ncbi
domestic rabbit monoclonal (SP192)
  • immunohistochemistry; human; loading ...; fig 6b
In order to study the effect of insulin on tumor necrosis factor-dependent early osteoarthritic in obesity and type 2 diabetes mellitus, Abcam CD14 antibody (Abcam, ab183322) was used in immunohistochemistry on human samples (fig 6b). Arthritis Rheumatol (2016) ncbi
mouse monoclonal (1H5D8)
  • immunocytochemistry; human; 1:100; fig 1
Abcam CD14 antibody (Abcam, ab181470) was used in immunocytochemistry on human samples at 1:100 (fig 1). BMC Cancer (2015) ncbi
mouse monoclonal (MEM-18)
  • immunocytochemistry; domestic sheep; fig 4
Abcam CD14 antibody (abcam, ab6083) was used in immunocytochemistry on domestic sheep samples (fig 4). Cell Tissue Bank (2016) ncbi
monoclonal
  • flow cytometry; human
Abcam CD14 antibody (Abcam, ab28061) was used in flow cytometry on human samples . J Biomed Mater Res A (2015) ncbi
Bio-Rad
mouse monoclonal (TUK4)
  • flow cytometry; bovine; fig s1
Bio-Rad CD14 antibody (AbD Serotec, MCA1568A647T) was used in flow cytometry on bovine samples (fig s1). Vet Res (2016) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; tbl 1
Bio-Rad CD14 antibody (AbD Serotec, MCA1568F) was used in flow cytometry on human samples (tbl 1). PLoS ONE (2016) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; loading ...
Bio-Rad CD14 antibody (AbD Serotec, MCA1568F) was used in flow cytometry on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; cat; 1:50; tbl 3
Bio-Rad CD14 antibody (AbD Serotec, MCA1568T) was used in flow cytometry on cat samples at 1:50 (tbl 3). Cell Reprogram (2015) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; domestic rabbit; fig 8
Bio-Rad CD14 antibody (AbD Serotec, MCA1568PB) was used in flow cytometry on domestic rabbit samples (fig 8). PLoS ONE (2015) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human
Bio-Rad CD14 antibody (AbD Serotec, MCA1568PE) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human
Bio-Rad CD14 antibody (Serotec, MCA1568PE) was used in flow cytometry on human samples . Nanomedicine (2015) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; bovine; loading ...; fig 3c
Bio-Rad CD14 antibody (Serotec, MCA1568) was used in flow cytometry on bovine samples (fig 3c). Theriogenology (2014) ncbi
mouse monoclonal (MEM-18)
  • flow cytometry; human; fig 1
In order to discuss methods to detect fetomaternal hemorrhage, Bio-Rad CD14 antibody (Serotec, Clone MEM-18) was used in flow cytometry on human samples (fig 1). Transfusion (2014) ncbi
Santa Cruz Biotechnology
mouse monoclonal (UCH-M1)
  • flow cytometry; human; loading ...; fig 3b
In order to examine the effect of GM-CSF on TLR1, TLR2, and TLR4 using human monocytes, Santa Cruz Biotechnology CD14 antibody (CD14-FITC, UCH-M1) was used in flow cytometry on human samples (fig 3b). PLoS ONE (2016) ncbi
mouse monoclonal (61D3)
  • flow cytometry; human; 1:10; fig 3
Santa Cruz Biotechnology CD14 antibody (Santa Cruz, sc-52457) was used in flow cytometry on human samples at 1:10 (fig 3). Mol Med Rep (2016) ncbi
mouse monoclonal (UCH-M1)
  • western blot; mouse; fig 8
Santa Cruz Biotechnology CD14 antibody (Santa Cruz, sc-1182) was used in western blot on mouse samples (fig 8). J Biol Chem (2016) ncbi
mouse monoclonal (UCH-M1)
  • immunocytochemistry; domestic rabbit; 5 ug/ml
In order to create an in vitro primary lung co-culture platform derived from New Zealand white rabbits, Santa Cruz Biotechnology CD14 antibody (Santa Cruz Biotechnology, sc-1182) was used in immunocytochemistry on domestic rabbit samples at 5 ug/ml. In Vitro Cell Dev Biol Anim (2015) ncbi
mouse monoclonal (5A3B11B5)
  • western blot; human
Santa Cruz Biotechnology CD14 antibody (Santa Cruz Biotechnology, sc-58951) was used in western blot on human samples . J Leukoc Biol (2014) ncbi
mouse monoclonal (BA-8)
  • flow cytometry; human; fig 1c
Santa Cruz Biotechnology CD14 antibody (Santa Cruz, sc-7328) was used in flow cytometry on human samples (fig 1c). Cell Biol Int (2015) ncbi
mouse monoclonal (5A3B11B5)
  • western blot; human
Santa Cruz Biotechnology CD14 antibody (Santa Cruz, sc-58951) was used in western blot on human samples . J Biomed Mater Res A (2015) ncbi
mouse monoclonal (BA-8)
  • western blot; human
In order to identify a novel anticancer mechanism that functions through autophagy-mediated necroptosis, Santa Cruz Biotechnology CD14 antibody (Santa Cruz Biotechnology, sc-7328) was used in western blot on human samples . Oncogene (2014) ncbi
Miltenyi Biotec
human monoclonal (REA599)
  • flow cytometry; human; 1:100; fig 2f
Miltenyi Biotec CD14 antibody (Miltenyi, 130-110-520) was used in flow cytometry on human samples at 1:100 (fig 2f). Nat Med (2021) ncbi
human monoclonal (REA599)
  • flow cytometry; human; loading ...; fig s2
Miltenyi Biotec CD14 antibody (Miltenyi Biotech, 130-110-524) was used in flow cytometry on human samples (fig s2). J Biol Chem (2019) ncbi
Novus Biologicals
mouse monoclonal (M5E2)
  • immunohistochemistry - frozen section; human; 1:100; loading ...; fig 2a
Novus Biologicals CD14 antibody (Novus Biological, M5E2) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig 2a). PLoS ONE (2020) ncbi
mouse monoclonal (4B4F12)
  • western blot; mouse; loading ...; fig s1
Novus Biologicals CD14 antibody (Novus Biologicals, NBP2-37291) was used in western blot on mouse samples (fig s1). Sci Rep (2018) ncbi
Sino Biological
domestic rabbit monoclonal (001)
  • immunohistochemistry - paraffin section; human; loading ...; fig s5b
  • immunohistochemistry; human
  • immunohistochemistry - paraffin section; domestic rabbit
Sino Biological CD14 antibody (Sino Biological, 10073-R001) was used in immunohistochemistry - paraffin section on human samples (fig s5b), in immunohistochemistry on human samples and in immunohistochemistry - paraffin section on domestic rabbit samples . J Clin Invest (2019) ncbi
Beckman Coulter
mouse monoclonal (RMO52)
  • flow cytometry; human; loading ...; fig s2
Beckman Coulter CD14 antibody (Beckman Coulter, RMO52) was used in flow cytometry on human samples (fig s2). EBioMedicine (2020) ncbi
mouse monoclonal (RM052)
  • flow cytometry; human; loading ...; fig s2
Beckman Coulter CD14 antibody (Beckman Coulter, RMO52) was used in flow cytometry on human samples (fig s2). EBioMedicine (2020) ncbi
mouse monoclonal (RM052)
  • flow cytometry; human; loading ...; fig s4a
Beckman Coulter CD14 antibody (Beckman Coulter, RMO52) was used in flow cytometry on human samples (fig s4a). Nat Commun (2020) ncbi
mouse monoclonal (RMO52)
  • flow cytometry; human; loading ...; fig s4a
Beckman Coulter CD14 antibody (Beckman Coulter, RMO52) was used in flow cytometry on human samples (fig s4a). Nat Commun (2020) ncbi
mouse monoclonal (RMO52)
  • flow cytometry; human; loading ...; fig 1a
Beckman Coulter CD14 antibody (Beckman, IM2707U) was used in flow cytometry on human samples (fig 1a). BMC Infect Dis (2019) ncbi
mouse monoclonal (RM052)
  • flow cytometry; human; loading ...; fig 3b
Beckman Coulter CD14 antibody (Beckman Coulter, RMO52) was used in flow cytometry on human samples (fig 3b). Front Immunol (2019) ncbi
mouse monoclonal (RMO52)
  • flow cytometry; human; loading ...; fig 3b
Beckman Coulter CD14 antibody (Beckman Coulter, RMO52) was used in flow cytometry on human samples (fig 3b). Front Immunol (2019) ncbi
mouse monoclonal (RMO52)
  • flow cytometry; human; loading ...; fig 4b
Beckman Coulter CD14 antibody (Beckman Coulter, RMO52) was used in flow cytometry on human samples (fig 4b). J Virol (2019) ncbi
mouse monoclonal (RM052)
  • flow cytometry; human; loading ...; fig 4b
Beckman Coulter CD14 antibody (Beckman Coulter, RMO52) was used in flow cytometry on human samples (fig 4b). J Virol (2019) ncbi
mouse monoclonal (RMO52)
  • mass cytometry; human; loading ...; fig 2j
Beckman Coulter CD14 antibody (Beckman Coulter, A22331) was used in mass cytometry on human samples (fig 2j). Cell (2019) ncbi
mouse monoclonal (RMO52)
  • flow cytometry; human; loading ...; fig s7c
Beckman Coulter CD14 antibody (Beckman Coulter, PNIM2707U) was used in flow cytometry on human samples (fig s7c). Cell (2017) ncbi
mouse monoclonal (RM052)
  • flow cytometry; human; loading ...; fig 1
Beckman Coulter CD14 antibody (Beckman Coulter, IM0650U) was used in flow cytometry on human samples (fig 1). Exp Ther Med (2017) ncbi
mouse monoclonal (RMO52)
  • flow cytometry; human; tbl 3
In order to document and describe lymphocyte predominant cells from lymph nodes involved in nodular lymphocyte predominant Hodgkin lymphoma, Beckman Coulter CD14 antibody (Beckman Coulter, RM052) was used in flow cytometry on human samples (tbl 3). Am J Pathol (2017) ncbi
mouse monoclonal (RM052)
  • flow cytometry; human; 1:25; loading ...; fig 1b
In order to explore the role of thrombopoietin signaling in the human primitive hematopoietic stem cell compartment, Beckman Coulter CD14 antibody (Beckman Coulter, RMO2) was used in flow cytometry on human samples at 1:25 (fig 1b). Cell Transplant (2017) ncbi
mouse monoclonal (RM052)
  • flow cytometry; human; loading ...; fig 3a
Beckman Coulter CD14 antibody (Beckman Coulter Immunotech, RMO52) was used in flow cytometry on human samples (fig 3a). PLoS ONE (2016) ncbi
mouse monoclonal (RMO52)
  • flow cytometry; human; loading ...; fig 3a
Beckman Coulter CD14 antibody (Beckman Coulter Immunotech, RMO52) was used in flow cytometry on human samples (fig 3a). PLoS ONE (2016) ncbi
mouse monoclonal (RMO52)
  • flow cytometry; human; loading ...; fig 4b
In order to assess dextran-based nanoparticles as a drug delivery system to target myeloid cells of the liver, Beckman Coulter CD14 antibody (Beckman Coulter, IM0643) was used in flow cytometry on human samples (fig 4b). Nanomedicine (Lond) (2016) ncbi
mouse monoclonal (RMO52)
  • flow cytometry; human; loading ...; fig 2a
Beckman Coulter CD14 antibody (Beckman Coulter, IM0645) was used in flow cytometry on human samples (fig 2a). Eur J Immunol (2016) ncbi
mouse monoclonal (RMO52)
  • flow cytometry; human; loading ...; fig 1a
Beckman Coulter CD14 antibody (Beckman Coulter, RM052) was used in flow cytometry on human samples (fig 1a). J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (RMO52)
  • flow cytometry; human; loading ...; fig 1d
Beckman Coulter CD14 antibody (Beckman, IM0645U) was used in flow cytometry on human samples (fig 1d). PLoS ONE (2016) ncbi
mouse monoclonal (RMO52)
  • flow cytometry; human; loading ...; fig 3b
Beckman Coulter CD14 antibody (Beckman Coulter, RMO52) was used in flow cytometry on human samples (fig 3b). J Immunol (2016) ncbi
mouse monoclonal (RM052)
  • flow cytometry; human; loading ...; fig 3b
Beckman Coulter CD14 antibody (Beckman Coulter, RMO52) was used in flow cytometry on human samples (fig 3b). J Immunol (2016) ncbi
mouse monoclonal (RMO52)
  • flow cytometry; human
In order to study disruption of the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicity due to immunomodulatory drugs, Beckman Coulter CD14 antibody (Beckman Coulter, RM052) was used in flow cytometry on human samples . Nat Med (2016) ncbi
mouse monoclonal (RMO52)
  • flow cytometry; African green monkey; loading ...; fig 2a
In order to discuss the use of flow cytometry to examine common marmosets, Beckman Coulter CD14 antibody (Beckman Coulter, RMO52) was used in flow cytometry on African green monkey samples (fig 2a). J Med Primatol (2016) ncbi
mouse monoclonal (RMO52)
  • flow cytometry; mouse; loading ...; fig 6a
In order to optimize myeloid engraftment for humanized mice, Beckman Coulter CD14 antibody (Beckman Coulter, RMO52) was used in flow cytometry on mouse samples (fig 6a). Stem Cells Dev (2016) ncbi
mouse monoclonal (RMO52)
  • flow cytometry; mouse; loading ...; fig 6a
In order to develop the first bioreactor system that allows the integrated three dimensional biomechanical stimulation of a whole-heart construct while allowing for simultaneous controlled perfusion of the coronary system, Beckman Coulter CD14 antibody (Beckman Coulter, RMO52) was used in flow cytometry on mouse samples (fig 6a). Methods Mol Biol (2016) ncbi
mouse monoclonal (RMO52)
  • flow cytometry; human; loading ...; tbl 3
Beckman Coulter CD14 antibody (Beckman Coulter, IM2640U) was used in flow cytometry on human samples (tbl 3). PLoS ONE (2016) ncbi
mouse monoclonal (RMO52)
  • flow cytometry; human; loading ...; fig s6b
In order to characterize oligopotent progenitors from the fetal liver, Beckman Coulter CD14 antibody (Coulter, A22331) was used in flow cytometry on human samples (fig s6b). Science (2016) ncbi
mouse monoclonal (RMO52)
  • flow cytometry; rhesus macaque
In order to describe a selective CD28 antagonist for treatment of rheumatoid arthritis, Beckman Coulter CD14 antibody (Beckman Coulter, RMO52) was used in flow cytometry on rhesus macaque samples . Clin Exp Immunol (2016) ncbi
mouse monoclonal (RMO52)
  • flow cytometry; human; fig 1
In order to identify the response to anti-MPO antibodies in the form of increased surface expression of ANCA autoantigens and IL-1beta secretion acting as intermediate monocytes in ANCA vasculitis, Beckman Coulter CD14 antibody (Beckman Coulter, RMO52) was used in flow cytometry on human samples (fig 1). Sci Rep (2015) ncbi
mouse monoclonal (RMO52)
  • flow cytometry; human
Beckman Coulter CD14 antibody (Beckman Coulter, IM0645U) was used in flow cytometry on human samples . Bone (2015) ncbi
mouse monoclonal (RMO52)
  • immunocytochemistry; Burton's mouthbrooder; 1:100
In order to discuss how to diagnosis hematolymphoid neoplasms using flow cytometry, Beckman Coulter CD14 antibody (Beckman Coulter, RM052) was used in immunocytochemistry on Burton's mouthbrooder samples at 1:100. Cytometry B Clin Cytom (2015) ncbi
mouse monoclonal (RMO52)
  • flow cytometry; human
Beckman Coulter CD14 antibody (Beckman Coulte, A70204) was used in flow cytometry on human samples . Arthritis Res Ther (2015) ncbi
mouse monoclonal (RMO52)
  • flow cytometry; human
Beckman Coulter CD14 antibody (Beckman Coulter, PN A22331) was used in flow cytometry on human samples . Curr Protoc Cytom (2015) ncbi
mouse monoclonal (RMO52)
  • flow cytometry; human
Beckman Coulter CD14 antibody (Beckman Coulter, IM2580U) was used in flow cytometry on human samples . Xenotransplantation (2015) ncbi
mouse monoclonal (RMO52)
  • flow cytometry; rhesus macaque
Beckman Coulter CD14 antibody (Beckman Coulter, IM2580U) was used in flow cytometry on rhesus macaque samples . J Virol (2014) ncbi
mouse monoclonal (RMO52)
  • flow cytometry; human
Beckman Coulter CD14 antibody (Beckman Coulte, IM0645U) was used in flow cytometry on human samples . Stem Cells Dev (2015) ncbi
mouse monoclonal (RMO52)
  • flow cytometry; human
Beckman Coulter CD14 antibody (Beckman Coulter, PN IM2707U) was used in flow cytometry on human samples . Arthritis Res Ther (2014) ncbi
mouse monoclonal (RMO52)
  • flow cytometry; human
In order to identify the mesenchymal markers on human adipose stem/progenitor cells, Beckman Coulter CD14 antibody (Beckman, IM2640U) was used in flow cytometry on human samples . Cytometry A (2013) ncbi
mouse monoclonal (RMO52)
  • flow cytometry; South American squirrel monkey
In order to discuss available reagents for studying the neotropical primate squirrel monkey, Beckman Coulter CD14 antibody (Beckman, RMO52) was used in flow cytometry on South American squirrel monkey samples . J Immunol Methods (2005) ncbi
mouse monoclonal (322A-1)
  • flow cytometry; South American squirrel monkey
In order to discuss available reagents for studying the neotropical primate squirrel monkey, Beckman Coulter CD14 antibody (Beckman, 322A-1(MY4)) was used in flow cytometry on South American squirrel monkey samples . J Immunol Methods (2005) ncbi
mouse monoclonal (322A-1)
  • flow cytometry; human
Beckman Coulter CD14 antibody (Beckman Coulter, 6603262) was used in flow cytometry on human samples . J Immunol (2002) ncbi
Dako
mouse monoclonal (TUK4)
  • flow cytometry; human; loading ...; fig s4a
Dako CD14 antibody (Dako, TUK4) was used in flow cytometry on human samples (fig s4a). Int J Mol Sci (2021) ncbi
mouse monoclonal (TUK4)
  • flow cytometry; human; loading ...; tbl 2
In order to investigate the role of cell surface 90 kDa heat shock protein in cytokine response, Dako CD14 antibody (Dako, TUK4) was used in flow cytometry on human samples (tbl 2). J Leukoc Biol (2017) ncbi
mouse monoclonal (TUK4)
  • immunohistochemistry - paraffin section; mouse
Dako CD14 antibody (Dako, M0825) was used in immunohistochemistry - paraffin section on mouse samples . Arthritis Rheumatol (2015) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D7A2T)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 8a
Cell Signaling Technology CD14 antibody (Cell Signaling, 75181) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 8a). J Exp Med (2020) ncbi
Tonbo Biosciences
mouse monoclonal (61D3)
  • flow cytometry; human; 1:200; loading ...; fig 1e
Tonbo Biosciences CD14 antibody (Tonbo biosciences, 20-0149-T100) was used in flow cytometry on human samples at 1:200 (fig 1e). elife (2019) ncbi
BD Biosciences
mouse monoclonal (M5E2)
  • other; human; 1:100; loading ...; fig 5g
  • flow cytometry; human; 1:100; fig s1b
BD Biosciences CD14 antibody (BD Pharmingen, 555398) was used in other on human samples at 1:100 (fig 5g) and in flow cytometry on human samples at 1:100 (fig s1b). Nat Commun (2022) ncbi
mouse monoclonal (M?P9)
  • flow cytometry; human; loading ...; fig s1
BD Biosciences CD14 antibody (BD Bioscience, 347493) was used in flow cytometry on human samples (fig s1). Front Med (Lausanne) (2022) ncbi
mouse monoclonal (MφP9)
  • flow cytometry; human
BD Biosciences CD14 antibody (BD Bioscience, 345784) was used in flow cytometry on human samples . Front Immunol (2022) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 2e
BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on human samples (fig 2e). Med Oncol (2022) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; 1:50; fig s4c
BD Biosciences CD14 antibody (BD Biosciences, 555397) was used in flow cytometry on human samples at 1:50 (fig s4c). Cells (2022) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; 1:300; loading ...; fig 6a
BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on human samples at 1:300 (fig 6a). Nat Commun (2021) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 3b
BD Biosciences CD14 antibody (BD, M5E2) was used in flow cytometry on human samples (fig 3b). Acta Neuropathol (2021) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; 1:500; loading ...
BD Biosciences CD14 antibody (BD, 555397) was used in flow cytometry on human samples at 1:500. Cell (2021) ncbi
mouse monoclonal (M?P9)
  • flow cytometry; human; loading ...; fig 5a
BD Biosciences CD14 antibody (BD Bioscience, M??P9) was used in flow cytometry on human samples (fig 5a). Arthritis Res Ther (2021) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; 1:1000; loading ...; fig s1d
BD Biosciences CD14 antibody (BD Bioscience, 555398) was used in flow cytometry on human samples at 1:1000 (fig s1d). Cell (2021) ncbi
mouse monoclonal (M?P9)
  • flow cytometry; human; loading ...; fig 8i
BD Biosciences CD14 antibody (BD Horizon, 563561) was used in flow cytometry on human samples (fig 8i). Sci Rep (2021) ncbi
monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig s2a
BD Biosciences CD14 antibody (BD, 740773) was used in flow cytometry on human samples (fig s2a). Cell (2021) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig s1
BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on human samples (fig s1). elife (2020) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig s2
BD Biosciences CD14 antibody (Becton Dickinson, 561391) was used in flow cytometry on human samples (fig s2). Cell (2020) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 7a
BD Biosciences CD14 antibody (BD, M5E2) was used in flow cytometry on human samples (fig 7a). J Exp Med (2020) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; African green monkey; loading ...; fig s3c
BD Biosciences CD14 antibody (BD Pharmingen, 555398) was used in flow cytometry on African green monkey samples (fig s3c). PLoS Pathog (2020) ncbi
mouse monoclonal (MfiP9)
  • flow cytometry; human; 3:50; loading ...; fig 1c
BD Biosciences CD14 antibody (BD Biosciences, MfP9) was used in flow cytometry on human samples at 3:50 (fig 1c). Science (2020) ncbi
mouse monoclonal (M?P9)
  • flow cytometry; human; loading ...; fig s1
BD Biosciences CD14 antibody (BD Biosciences, 562692) was used in flow cytometry on human samples (fig s1). Int J Mol Sci (2020) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 5a
BD Biosciences CD14 antibody (BD, 561116) was used in flow cytometry on human samples (fig 5a). Front Immunol (2019) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig s1b
BD Biosciences CD14 antibody (BD, 557153) was used in flow cytometry on human samples (fig s1b). J Clin Invest (2020) ncbi
mouse monoclonal (M?P9)
  • flow cytometry; human; fig 1
BD Biosciences CD14 antibody (BD, 347493) was used in flow cytometry on human samples (fig 1). J Cancer (2020) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig s6a
BD Biosciences CD14 antibody (BD Biosciences, 561385) was used in flow cytometry on human samples (fig s6a). Cell (2019) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig s6c
BD Biosciences CD14 antibody (BD, M5E2) was used in flow cytometry on human samples (fig s6c). Science (2019) ncbi
mouse monoclonal (MfiP9)
  • flow cytometry; human; loading ...; fig s6c
BD Biosciences CD14 antibody (BD, MfiP9) was used in flow cytometry on human samples (fig s6c). Science (2019) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; rhesus macaque; loading ...; fig s5
BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on rhesus macaque samples (fig s5). Science (2019) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig s1
BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on human samples (fig s1). Eur J Immunol (2019) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig s6d
BD Biosciences CD14 antibody (BD Pharmingen, 555398) was used in flow cytometry on human samples (fig s6d). Nat Commun (2019) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; 1:100; loading ...; fig s7c
BD Biosciences CD14 antibody (BD Bioscience, 555397) was used in flow cytometry on human samples at 1:100 (fig s7c). Nat Commun (2019) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; 1:20; loading ...; fig s1b
BD Biosciences CD14 antibody (BD Biosciences, 557742) was used in flow cytometry on human samples at 1:20 (fig s1b). Sci Adv (2019) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; mouse; loading ...
BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on mouse samples . Nature (2019) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 2k
BD Biosciences CD14 antibody (BD Biosciences, 561116) was used in flow cytometry on human samples (fig 2k). elife (2019) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 3b
BD Biosciences CD14 antibody (BD, 557154) was used in flow cytometry on human samples (fig 3b). Front Immunol (2019) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig s5a
BD Biosciences CD14 antibody (BD, 561391) was used in flow cytometry on human samples (fig s5a). Nat Commun (2019) ncbi
mouse monoclonal (M?P9)
  • flow cytometry; human; 1:100; loading ...; fig s9b
BD Biosciences CD14 antibody (BD Bioscience, 560180) was used in flow cytometry on human samples at 1:100 (fig s9b). Nat Commun (2019) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences CD14 antibody (BD, 555399) was used in flow cytometry on human samples (fig 3a). J Clin Invest (2019) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig s1
BD Biosciences CD14 antibody (BD, M5E2) was used in flow cytometry on human samples (fig s1). Nat Immunol (2019) ncbi
mouse monoclonal (M5E2)
  • immunohistochemistry - frozen section; human; 1:10; loading ...; fig s6a
BD Biosciences CD14 antibody (BD Biosciences, 555397) was used in immunohistochemistry - frozen section on human samples at 1:10 (fig s6a). Cell (2019) ncbi
monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences CD14 antibody (BD, 740773) was used in flow cytometry on human samples (fig 3a). Cell Rep (2018) ncbi
mouse monoclonal (MPhiP9)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD14 antibody (BD Biosciences, MPhiP-9) was used in flow cytometry on human samples (fig 1a). J Virol (2019) ncbi
mouse monoclonal (M?P9)
  • flow cytometry; human; loading ...; fig 3b
BD Biosciences CD14 antibody (BD, 562690) was used in flow cytometry on human samples (fig 3b). J Exp Med (2018) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 1b
BD Biosciences CD14 antibody (BD Biosciences, 563698) was used in flow cytometry on human samples (fig 1b). J Clin Invest (2018) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on human samples (fig 1a). J Immunol (2018) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig s7b
BD Biosciences CD14 antibody (BD, 555397) was used in flow cytometry on human samples (fig s7b). Eur J Immunol (2018) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 1c
BD Biosciences CD14 antibody (BD Bioscience, 555397) was used in flow cytometry on human samples (fig 1c). J Clin Invest (2018) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig s4a
BD Biosciences CD14 antibody (BD, M5E2) was used in flow cytometry on human samples (fig s4a). J Clin Invest (2018) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; African green monkey; loading ...; fig 6a
BD Biosciences CD14 antibody (BD Biosciences, 561385) was used in flow cytometry on African green monkey samples (fig 6a). J Clin Invest (2018) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on human samples (fig 2a). Cancer Immunol Res (2018) ncbi
mouse monoclonal (M?P9)
  • flow cytometry; human; fig 1a
BD Biosciences CD14 antibody (BD Biosciences, M??P9) was used in flow cytometry on human samples (fig 1a). Front Immunol (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig s1d, s5d
BD Biosciences CD14 antibody (BD Pharmingen, 555398) was used in flow cytometry on human samples (fig s1d, s5d). Nat Med (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 5c
BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on human samples (fig 5c). J Immunol (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; camel ; loading ...; fig 5c
  • flow cytometry; human; loading ...; fig 5c
BD Biosciences CD14 antibody (BD, M5E2) was used in flow cytometry on camel samples (fig 5c) and in flow cytometry on human samples (fig 5c). Open Vet J (2017) ncbi
mouse monoclonal (M?P9)
  • flow cytometry; human; loading ...; tbl 2
In order to investigate the role of cell surface 90 kDa heat shock protein in cytokine response, BD Biosciences CD14 antibody (BD Bioscience, MP9) was used in flow cytometry on human samples (tbl 2). J Leukoc Biol (2017) ncbi
mouse monoclonal (M?P9)
  • flow cytometry; human; loading ...; fig 6a
In order to study the the activation of T lymphocyte death by Ebola virus glycoprotein, BD Biosciences CD14 antibody (BD Biosciences, 563561) was used in flow cytometry on human samples (fig 6a). PLoS Pathog (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig 1a
In order to investigate the expression of Toll-like receptors in satellite glial cells, BD Biosciences CD14 antibody (BD Bioscience, M5E2) was used in flow cytometry on human samples (fig 1a). Eur J Immunol (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig st12
In order to identify new types of human blood dendritic cells, monocytes, and progenitors through single-cell RNA-seq, BD Biosciences CD14 antibody (BD, M5E2) was used in flow cytometry on human samples (fig st12). Science (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 1d
In order to report that autosomal recessive, partial Go-Ichi-Ni-San 1 deficiency impairs DNA replication and underlies intra-uterine and postnatal growth retardation, chronic neutropenia, and natural killer cell deficiency, BD Biosciences CD14 antibody (BD Pharmingen, M5E2) was used in flow cytometry on human samples (fig 1d). J Clin Invest (2017) ncbi
mouse monoclonal (MφP9)
  • flow cytometry; human; loading ...; fig 5d
In order to find a role for IL-4 in promoting breast cancer aggressiveness, BD Biosciences CD14 antibody (BD Biosciences, MfaiP9) was used in flow cytometry on human samples (fig 5d). Cancer Res (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; rhesus macaque; loading ...; fig s16b
BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on rhesus macaque samples (fig s16b). JCI Insight (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; 1:50; loading ...; tbl 1
BD Biosciences CD14 antibody (Becton, 555397) was used in flow cytometry on human samples at 1:50 (tbl 1). Sci Rep (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 3b
In order to compare methods of isolating skin mononuclear phagocytes, BD Biosciences CD14 antibody (Becton Dickinson, M5E2) was used in flow cytometry on human samples (fig 3b). J Leukoc Biol (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig 1a
In order to elucidate the effects of pathogen recognition receptors on dendritic cell maturation, HIV infection, and on the quality of HIV-specific cytotoxic T-cell activation, BD Biosciences CD14 antibody (BD Pharmingen, M5E2) was used in flow cytometry on human samples (fig 1a). Eur J Immunol (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig s1a
In order to elucidate the impact of plasma membrane integrity on bacterial replication in different functional populations of human primary macrophages, BD Biosciences CD14 antibody (BD, M5E2) was used in flow cytometry on human samples (fig s1a). J Cell Biol (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 3e
BD Biosciences CD14 antibody (BD, 555397) was used in flow cytometry on human samples (fig 3e). Cell (2017) ncbi
mouse monoclonal (M?P9)
  • flow cytometry; human; loading ...; fig S1a
BD Biosciences CD14 antibody (BD, 641394) was used in flow cytometry on human samples (fig S1a). Sci Rep (2017) ncbi
mouse monoclonal (M5E2)
  • blocking or activating experiments; human; loading ...
In order to implicate myeloid differentiation factor-2 as the high-affinity soluble CD83 binding partner, BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in blocking or activating experiments on human samples . J Immunol (2017) ncbi
mouse monoclonal (M?P9)
  • flow cytometry; human; loading ...; fig 4b
BD Biosciences CD14 antibody (BD, M??P9) was used in flow cytometry on human samples (fig 4b). Front Immunol (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 5
In order to analyze B-cell responses to meningococcal polysaccharide and conjugate vaccines against Neisseria meningitidis, BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on human samples (fig 5). Genome Med (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...
BD Biosciences CD14 antibody (BD Pharmingen, 555399) was used in flow cytometry on human samples . PLoS Pathog (2017) ncbi
mouse monoclonal (M?P9)
  • flow cytometry; human; loading ...
BD Biosciences CD14 antibody (Pharmingen, M/P9) was used in flow cytometry on human samples . Oncol Lett (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 1
BD Biosciences CD14 antibody (BD Biosciences, 555399) was used in flow cytometry on human samples (fig 1). PLoS ONE (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...
In order to show T cell immunoglobulin and ITIM domain expression increases over time despite early initiation of antiretroviral treatment, BD Biosciences CD14 antibody (BD Bioscience, M5E2) was used in flow cytometry on human samples . Sci Rep (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; crab eating macaque; loading ...; fig 3a
In order to ask if small particle aerosols of virus would penetrate the lower respiratory tract and blanket alveoli where target cells reside, BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on crab eating macaque samples (fig 3a). J Immunol (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...
BD Biosciences CD14 antibody (BD, M5E2) was used in flow cytometry on human samples . Nature (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; African green monkey; loading ...; fig 7
BD Biosciences CD14 antibody (BD Biosciences, 557742) was used in flow cytometry on African green monkey samples (fig 7). J Biol Chem (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; rhesus macaque; loading ...; fig 1a
In order to examine frequency and function of myeloid-derived suppressor cells in SIV-infected rhesus macaques, BD Biosciences CD14 antibody (Becton Dickinson, m5e2) was used in flow cytometry on rhesus macaque samples (fig 1a). J Immunol (2017) ncbi
mouse monoclonal (MφP9)
  • flow cytometry; human; loading ...; fig 3d
In order to discuss the contribution of epigenetic changes to the development of type 1 diabetes, BD Biosciences CD14 antibody (BD Biosciences, 345784) was used in flow cytometry on human samples (fig 3d). Nat Commun (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; tbl s2
BD Biosciences CD14 antibody (BD Biosciences, 558121) was used in flow cytometry on human samples (tbl s2). Science (2016) ncbi
mouse monoclonal (M5E2)
  • immunocytochemistry; human; loading ...; fig 5a,5b
In order to generate cell line to examine the molecular events controlling HIV expression in the microglia, BD Biosciences CD14 antibody (BD, 555397) was used in immunocytochemistry on human samples (fig 5a,5b). J Neurovirol (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 1d
In order to determine which cells express CD83, BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on human samples (fig 1d). J Immunol (2016) ncbi
mouse monoclonal (M?P9)
  • flow cytometry; human; loading ...
In order to measure cell size and cell surface markers of human MSCs after intravenous injection in immune competent mice, BD Biosciences CD14 antibody (Becton, Dickinson, and Company, M??P9) was used in flow cytometry on human samples . Cytotherapy (2017) ncbi
mouse monoclonal (MφP9)
  • flow cytometry; human
In order to evaluate combinations of TLR and C-type lectin receptor agonists on the Th1 responses of newborn dendritic cells, BD Biosciences CD14 antibody (BD Biosciences, MfaiP9) was used in flow cytometry on human samples . J Immunol (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; 1:20; loading ...; fig 1c
BD Biosciences CD14 antibody (BD Biosciences, 555399) was used in flow cytometry on human samples at 1:20 (fig 1c). Nat Commun (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...
In order to assess the role of C1q in downregulating allergic inflammation, BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on human samples . Mucosal Immunol (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 1a, s2d
In order to discuss targeting CD123 to treat systemic lupus erythematosus, BD Biosciences CD14 antibody (BD Biosciences, 555399) was used in flow cytometry on human samples (fig 1a, s2d). JCI Insight (2016) ncbi
mouse monoclonal (MφP9)
  • flow cytometry; human; loading ...
In order to assess receptor for hyaluronic acid-mediated motility specific dendritic cell responses, BD Biosciences CD14 antibody (BD Biosciences, 345784) was used in flow cytometry on human samples . Oncotarget (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...
In order to identify RLTPR in patients and determine the effects of these mutations on CD4 positive T cells, BD Biosciences CD14 antibody (BD, M5E2) was used in flow cytometry on human samples . J Exp Med (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences CD14 antibody (BD, 555399) was used in flow cytometry on human samples (fig 3a). Eur J Immunol (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 4c
BD Biosciences CD14 antibody (BD Biosciences, M5-E2) was used in flow cytometry on human samples (fig 4c). Immunology (2017) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; 1:1000
BD Biosciences CD14 antibody (BD Biosciences, 550787) was used in flow cytometry on human samples at 1:1000. Oncol Lett (2016) ncbi
mouse monoclonal (M5E2)
  • immunohistochemistry - paraffin section; rhesus macaque; 1:100; fig 5
BD Biosciences CD14 antibody (BD Biosciences, 557742) was used in immunohistochemistry - paraffin section on rhesus macaque samples at 1:100 (fig 5). J Neuroinflammation (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; 1:100; fig 1a
In order to investigate the impact of a cancer-specific MUC1 glycoform, BD Biosciences CD14 antibody (BD, M5E2) was used in flow cytometry on human samples at 1:100 (fig 1a). Nat Immunol (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig 1
BD Biosciences CD14 antibody (BD Biosciences, 558121) was used in flow cytometry on human samples (fig 1). Mol Med Rep (2016) ncbi
mouse monoclonal (MφP9)
  • flow cytometry; human; 1:32; loading ...; fig s1c
In order to use flow cytometry and barcoded peptide-major histocompatibility complex multimers to screen for T cell specificities, BD Biosciences CD14 antibody (BD, 345784) was used in flow cytometry on human samples at 1:32 (fig s1c). Nat Biotechnol (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig s6
BD Biosciences CD14 antibody (BD Biosciences, 555398) was used in flow cytometry on human samples (fig s6). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences CD14 antibody (BD, 555399) was used in flow cytometry on human samples (fig 3a). Invest Ophthalmol Vis Sci (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
In order to optimize the generation of therapeutic extracellular vesicles and identify molecules involved in their clearance, BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on human samples . Biomaterials (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD14 antibody (Becton Dickinson, M5E2) was used in flow cytometry on human samples (fig 1a). J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 1c
In order to determine the frequency and function of intermediate monocytes and TIE2-expressing monocytes during chemotherapy and anti-angiogenic cancer treatment, BD Biosciences CD14 antibody (Becton-Dickinson, 555397) was used in flow cytometry on human samples (fig 1c). Oncoimmunology (2016) ncbi
mouse monoclonal (M?P9)
  • flow cytometry; human; loading ...
In order to utilize humanized major histocompatibility class I- and class II-deficient NOG mice to assess the antitumor effect of an anti-programmed death-1 antibody, BD Biosciences CD14 antibody (BD Pharmingen, MP9) was used in flow cytometry on human samples . Clin Cancer Res (2017) ncbi
mouse monoclonal (MφP9)
  • flow cytometry; human; loading ...; fig 4a
In order to report that IgA-producing plasma cells are a major source of inducible NO synthase in Helicobacter pylori-infected patients, BD Biosciences CD14 antibody (BD, MfaiP9) was used in flow cytometry on human samples (fig 4a). J Immunol (2016) ncbi
mouse monoclonal (M?P9)
  • flow cytometry; human; loading ...; fig s8a
BD Biosciences CD14 antibody (BD Biosciences, MP9) was used in flow cytometry on human samples (fig s8a). Int J Cancer (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig 3
In order to test if CD4 positive T cells expressing immune checkpoint molecules are enriched in HIV-infected cells in patients receiving antiretroviral therapy, BD Biosciences CD14 antibody (BD, 561391) was used in flow cytometry on human samples (fig 3). PLoS Pathog (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig 2a
In order to assess the inflammatory responses in the rectal mucosa of patients with well-defined non-celiac wheat sensitivity, BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on human samples (fig 2a). Clin Transl Gastroenterol (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 1a
In order to characterize B cells and antibody repertoires from injection drug users, BD Biosciences CD14 antibody (BD, M5E2) was used in flow cytometry on human samples (fig 1a). PLoS ONE (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
In order to study the promotion of the development of self-reactive T cells by hydrophobic CDR3 residues, BD Biosciences CD14 antibody (BD Biosciences, 561391) was used in flow cytometry on human samples . Nat Immunol (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 3b
In order to study the function of desmoglein-2 and generate knockout mice, BD Biosciences CD14 antibody (BD, M5E2) was used in flow cytometry on human samples (fig 3b). Angiogenesis (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 1
In order to report the exercise-induced changes on the blood cell composition of patients with metabolic syndrome, BD Biosciences CD14 antibody (Becton Dickinson, 557742) was used in flow cytometry on human samples (fig 1). Cytometry B Clin Cytom (2018) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on human samples . PLoS ONE (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; rhesus macaque; 1:50
In order to optimize vaccination with Aventis Pasteur's canarypox vector-HIV, BD Biosciences CD14 antibody (BD Biosciences, 557923) was used in flow cytometry on rhesus macaque samples at 1:50. Nat Med (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; African green monkey; loading ...; fig 2a
In order to discuss the use of flow cytometry to examine common marmosets, BD Biosciences CD14 antibody (BD, M5E2) was used in flow cytometry on African green monkey samples (fig 2a). J Med Primatol (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig s3b
In order to assess the ability of human cystatin C to alter pathogenic activated monocytes and modulate Crohn's disease, BD Biosciences CD14 antibody (BD Pharmingen, M5E2) was used in flow cytometry on human samples (fig s3b). J Leukoc Biol (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; 1:200; fig 1
BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on human samples at 1:200 (fig 1). Oncoimmunology (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; 1:80; fig 3
BD Biosciences CD14 antibody (BD PharMingen, 561391) was used in flow cytometry on human samples at 1:80 (fig 3). Oncoimmunology (2016) ncbi
mouse monoclonal (M5E2)
  • western blot; human; loading ...; fig 3b
BD Biosciences CD14 antibody (BD Biosciences, 555398) was used in western blot on human samples (fig 3b). J Biol Chem (2016) ncbi
mouse monoclonal (M?P9)
  • flow cytometry; mouse; loading ...
In order to explore the contribution of Musashi-2 in determining hematopoietic stem cell fate, BD Biosciences CD14 antibody (BD Biosciences, M??P9) was used in flow cytometry on mouse samples . Nature (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; rhesus macaque
In order to investigate the mechanisms by which methamphetamine contributes to the pro-inflammatory central nervous system environment in macaques infected with the simian immunodeficiency virus, BD Biosciences CD14 antibody (BD Pharmingen, M5E2) was used in flow cytometry on rhesus macaque samples . BMC Immunol (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig 1
In order to assess if statins modulate the monocyte phenotype and function associated with HIV-1 neuropathogenesis, BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on human samples (fig 1). J Neurovirol (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig 6
BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on human samples (fig 6). Nat Immunol (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences CD14 antibody (BD, 555398) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig 1
BD Biosciences CD14 antibody (BD, 557923) was used in flow cytometry on human samples (fig 1). Oncoimmunology (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 1
BD Biosciences CD14 antibody (Becton Dickinson-Pharmingen, M5E2) was used in flow cytometry on human samples (fig 1). Cell Immunol (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; 1:200; loading ...; fig 1a
In order to find that central nervous system infiltration of peripheral monocytes correlates with improved motor neuron survival in a genetic amyotrophic lateral sclerosis mouse model, BD Biosciences CD14 antibody (BD, 550787) was used in flow cytometry on human samples at 1:200 (fig 1a). Acta Neuropathol (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 1a
In order to optimize myeloid engraftment for humanized mice, BD Biosciences CD14 antibody (Becton Dickinson, M5E2) was used in flow cytometry on human samples (fig 1a). Stem Cells Dev (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 1a
In order to develop the first bioreactor system that allows the integrated three dimensional biomechanical stimulation of a whole-heart construct while allowing for simultaneous controlled perfusion of the coronary system, BD Biosciences CD14 antibody (Becton Dickinson, M5E2) was used in flow cytometry on human samples (fig 1a). Methods Mol Biol (2016) ncbi
mouse monoclonal (MφP9)
  • flow cytometry; human; loading ...; tbl 1
In order to discuss cell- and tissue-specific changes in DNA methylation in type 1 diabetes, BD Biosciences CD14 antibody (BD Biosciences, MfaiP9) was used in flow cytometry on human samples (tbl 1). Methods Mol Biol (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; 1:1000; loading ...; fig 2b
BD Biosciences CD14 antibody (BD Biosciences, 557742) was used in flow cytometry on human samples at 1:1000 (fig 2b). Mol Med Rep (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig 6
In order to study cessation of colorectal cancer colonization of the liver by acting on the hepatic microenvironment by IFN-alpha gene/cell therapy, BD Biosciences CD14 antibody (BD Pharmingen, M5E2) was used in flow cytometry on human samples (fig 6). EMBO Mol Med (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig s1a
In order to study the role of distinct RNA transcriptome patterns in angiogenesis in Tie2-expressing monocytes, BD Biosciences CD14 antibody (BD Biosciences, 555397) was used in flow cytometry on human samples (fig s1a). Gene (2016) ncbi
mouse monoclonal (M?P9)
  • flow cytometry; human; loading ...; fig S1A; 4C
In order to analyze the frequency and phenotype of monocyte subpopulations in peripheral blood, cerebrospinal fluid, and brain biopsy material derived from multiple sclerosis patients, BD Biosciences CD14 antibody (BD, M??P9) was used in flow cytometry on human samples (fig S1A; 4C). J Immunol (2016) ncbi
mouse monoclonal (MfiP9)
  • flow cytometry; human; loading ...; fig S1A; 4C
In order to analyze the frequency and phenotype of monocyte subpopulations in peripheral blood, cerebrospinal fluid, and brain biopsy material derived from multiple sclerosis patients, BD Biosciences CD14 antibody (BD, M??P9) was used in flow cytometry on human samples (fig S1A; 4C). J Immunol (2016) ncbi
mouse monoclonal (M?P9)
  • flow cytometry; human; fig 7.45.3
In order to validate a single-cell measurement, simultaneously, for cell surface proteins, messenger RNA, and intracellular proteins, BD Biosciences CD14 antibody (BD Biosciences, 340683) was used in flow cytometry on human samples (fig 7.45.3). Curr Protoc Cytom (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; tbl 2
In order to study human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue, BD Biosciences CD14 antibody (BD Pharmingen, 555397) was used in flow cytometry on human samples (tbl 2). Int J Mol Med (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig 1
BD Biosciences CD14 antibody (BD Biosciences, 557153) was used in flow cytometry on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; rhesus macaque
In order to characterize functional and phenotypic properties of monoclonal antibodies specific for Rhesus Macaque CD200, Mincle, and CD200R, BD Biosciences CD14 antibody (BD, 557153) was used in flow cytometry on rhesus macaque samples . PLoS ONE (2015) ncbi
mouse monoclonal (M?P9)
  • flow cytometry; human; loading ...; fig s2a
In order to study age-related changes in human immunity during a primary virus infection experimentally induced by immunization with live-attenuated yellow fever vaccine, BD Biosciences CD14 antibody (BD Biosciences, M P9) was used in flow cytometry on human samples (fig s2a). J Immunol (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig s1f
In order to study age-related changes in human immunity during a primary virus infection experimentally induced by immunization with live-attenuated yellow fever vaccine, BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on human samples (fig s1f). J Immunol (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig 3
BD Biosciences CD14 antibody (BD Biosciences, 561712) was used in flow cytometry on human samples (fig 3). Stem Cell Reports (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BD Biosciences CD14 antibody (BD Pharmingen, 558121) was used in flow cytometry on human samples . Am J Reprod Immunol (2015) ncbi
mouse monoclonal (M?P9)
  • flow cytometry; human; fig 2
BD Biosciences CD14 antibody (BD Biosciences, 560350) was used in flow cytometry on human samples (fig 2). Stem Cell Res Ther (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 5b
In order to explore the roles of ATG2B and GSKIP in the development of familial myeloproliferative neoplasms, BD Biosciences CD14 antibody (Pharmingen, M5E2) was used in flow cytometry on human samples (fig 5b). Nat Genet (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig 1
BD Biosciences CD14 antibody (BD Biosciences, 558121) was used in flow cytometry on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (M?P9)
  • flow cytometry; domestic sheep; 20 ug/ml; fig 3
BD Biosciences CD14 antibody (BD PharMigen, 340660) was used in flow cytometry on domestic sheep samples at 20 ug/ml (fig 3). Cell Tissue Bank (2016) ncbi
mouse monoclonal (M?P9)
  • flow cytometry; human; fig 2
BD Biosciences CD14 antibody (BD Biosciences, 560180) was used in flow cytometry on human samples (fig 2). J Endod (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; 1:100
BD Biosciences CD14 antibody (BD Bioscience, 557742) was used in flow cytometry on human samples at 1:100. Stem Cells Int (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BD Biosciences CD14 antibody (BD Pharmingen, 555399) was used in flow cytometry on human samples . Biochim Biophys Acta (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig 1e
BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on human samples (fig 1e). Cytotherapy (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig S1
BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on human samples (fig S1). J Neuroinflammation (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
In order to investigate how xenogeneic-free conditions affect the therapeutic capacity of peripheral blood-derived endothelial-colony cells, BD Biosciences CD14 antibody (BD Bioscience, 555397) was used in flow cytometry on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig 2
BD Biosciences CD14 antibody (Becton-Dickinson, 561707) was used in flow cytometry on human samples (fig 2). Oncotarget (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on human samples (fig 2a). Ann Rheum Dis (2016) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BD Biosciences CD14 antibody (BD, 557742) was used in flow cytometry on human samples . J Exp Med (2015) ncbi
mouse monoclonal (M?P9)
  • flow cytometry; human; 1:100; fig s3
BD Biosciences CD14 antibody (BD, 560180) was used in flow cytometry on human samples at 1:100 (fig s3). Nat Commun (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BD Biosciences CD14 antibody (BD, 555397) was used in flow cytometry on human samples . Scand J Immunol (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BD Biosciences CD14 antibody (Pharmingen, 555398) was used in flow cytometry on human samples . Springerplus (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; African green monkey
BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on African green monkey samples . J Infect Dis (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; 2.5:100; fig 2a
In order to show that hepatitis B virus exposure in utero enhances immunity to bacterial infections, BD Biosciences CD14 antibody (Becton Dickinson, M5E2) was used in flow cytometry on human samples at 2.5:100 (fig 2a). Nat Commun (2015) ncbi
mouse monoclonal (M5E2)
  • immunocytochemistry; human
BD Biosciences CD14 antibody (BD PharMingen, 555396) was used in immunocytochemistry on human samples . Cancer Biol Ther (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig 1e
BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on human samples (fig 1e). J Immunol (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; crab eating macaque; fig 1
  • flow cytometry; human; fig 1
BD Biosciences CD14 antibody (BD Biosciences, 558121) was used in flow cytometry on crab eating macaque samples (fig 1) and in flow cytometry on human samples (fig 1). MAbs (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig 1
BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on human samples (fig 1). J Immunol (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BD Biosciences CD14 antibody (BD Pharmingen, M5E2) was used in flow cytometry on human samples . Clin Cancer Res (2015) ncbi
mouse monoclonal (M5E2)
  • immunohistochemistry - paraffin section; rat; fig s2
BD Biosciences CD14 antibody (BD Biosciences, 555397) was used in immunohistochemistry - paraffin section on rat samples (fig s2). J Control Release (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BD Biosciences CD14 antibody (BD Pharmingen, 555397) was used in flow cytometry on human samples . Alcohol (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BD Biosciences CD14 antibody (Becton Dickinson, M5E2) was used in flow cytometry on human samples . J Leukoc Biol (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on human samples . Arthritis Rheumatol (2015) ncbi
mouse monoclonal (M?P9)
  • flow cytometry; human
BD Biosciences CD14 antibody (BD Biosciences, MphiP9) was used in flow cytometry on human samples . Immun Inflamm Dis (2014) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; rhesus macaque
In order to examine the mechanism of anti-alpha4 antibody treatment in monkeys, BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on rhesus macaque samples . PLoS Pathog (2014) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BD Biosciences CD14 antibody (BD, M5E2) was used in flow cytometry on human samples . Eur J Cancer (2015) ncbi
mouse monoclonal (M?P9)
  • flow cytometry; human; fig 5
  • immunocytochemistry; human; fig 6
In order to use of a myoblasts from a symptomatic female carrier of X-linnked Emery-Dreifuss muscular dystrophy to study abnormal proliferation and spontaneous differentiation, BD Biosciences CD14 antibody (Becton Dickinson, 560349) was used in flow cytometry on human samples (fig 5) and in immunocytochemistry on human samples (fig 6). Neuromuscul Disord (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig 1
BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on human samples (fig 1). J Leukoc Biol (2015) ncbi
mouse monoclonal (M?P9)
  • flow cytometry; human
BD Biosciences CD14 antibody (BD PharMingen, MphiP9) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (M?P9)
  • flow cytometry; human; 1:100
BD Biosciences CD14 antibody (BD Biosciences, M(phi)P9) was used in flow cytometry on human samples at 1:100. Nat Commun (2014) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BD Biosciences CD14 antibody (BD Pharmingen, M5E2) was used in flow cytometry on human samples . J Infect Dis (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig 4
BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on human samples (fig 4). Cancer Discov (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on human samples . Rheumatology (Oxford) (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
In order to study l immune markers in H1N1pdm2009 virus-infected pregnant women, pregnant women with an influenza-like illness, healthy pregnant women, and healthy non-pregnant women, BD Biosciences CD14 antibody (BD, 557742) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (M?P9)
  • flow cytometry; human
BD Biosciences CD14 antibody (BD, MphiP9) was used in flow cytometry on human samples . J Exp Med (2014) ncbi
mouse monoclonal (M5E2)
  • immunocytochemistry; mouse
BD Biosciences CD14 antibody (PharMingen, M5E2) was used in immunocytochemistry on mouse samples . Hum Pathol (2014) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BD Biosciences CD14 antibody (BD Biosciences, 557154) was used in flow cytometry on human samples . Xenotransplantation (2015) ncbi
mouse monoclonal (M?P9)
  • flow cytometry; mouse
  • flow cytometry; human
BD Biosciences CD14 antibody (Becton Dickenson, MphiP9) was used in flow cytometry on mouse samples and in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (2014) ncbi
mouse monoclonal (M?P9)
  • flow cytometry; human; loading ...; tbl 1
BD Biosciences CD14 antibody (BD Biosciences, 557831) was used in flow cytometry on human samples (tbl 1). Chronobiol Int (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; 1:500
BD Biosciences CD14 antibody (BD Biosciences, 555398) was used in flow cytometry on human samples at 1:500. PLoS ONE (2014) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BD Biosciences CD14 antibody (BD PharMingen, M5E2) was used in flow cytometry on human samples . J Leukoc Biol (2014) ncbi
mouse monoclonal (M?P9)
  • flow cytometry; human
BD Biosciences CD14 antibody (BD Biosciences, MOP9) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 1a
In order to isolate and characterize mesenchymal stromal cells from head and neck squamous cell carcinoma and study their interaction with tumor cells, BD Biosciences CD14 antibody (BD Bioscience, M5E2) was used in flow cytometry on human samples (fig 1a). Stem Cell Res Ther (2014) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig s1
In order to investigate the impact of CCR6(+)CXCR3(+)CCR4(-) cells in latent tuberculosis infection, BD Biosciences CD14 antibody (BD Bioscience, M5E2) was used in flow cytometry on human samples (fig s1). J Immunol (2014) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BD Biosciences CD14 antibody (BD Bioscience, M5E2) was used in flow cytometry on human samples . PLoS Pathog (2014) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
In order to examine various DC after flu vaccination, BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on human samples . Immunol Invest (2014) ncbi
mouse monoclonal (M5E2)
  • immunocytochemistry; human
In order to analyze HIV-specific naive and memory CD4(+) T cells through two methods, BD Biosciences CD14 antibody (BD, M5E2) was used in immunocytochemistry on human samples . J Exp Med (2014) ncbi
mouse monoclonal (M?P9)
  • flow cytometry; human; 1:40
BD Biosciences CD14 antibody (BD Biosciences, MphiP9) was used in flow cytometry on human samples at 1:40. Nat Commun (2014) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 3d
In order to elucidate the relationship between female genital schistosomiasis and HIV infection, BD Biosciences CD14 antibody (BD, M5E2) was used in flow cytometry on human samples (fig 3d). PLoS ONE (2014) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on human samples . J Infect Dis (2014) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
In order to investigate the progression of innate responses to mycobacteria in infants, BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; rhesus macaque
BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on rhesus macaque samples . J Immunol (2014) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BD Biosciences CD14 antibody (Becton Dickinson, M5E2) was used in flow cytometry on human samples . Biomed Res Int (2014) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on human samples . PLoS Pathog (2014) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig 5
BD Biosciences CD14 antibody (BD Biosciences, 561708) was used in flow cytometry on human samples (fig 5). PLoS Pathog (2014) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; African green monkey; loading ...; fig 9
  • flow cytometry; human; loading ...; fig 9
BD Biosciences CD14 antibody (BD, m5E2) was used in flow cytometry on African green monkey samples (fig 9) and in flow cytometry on human samples (fig 9). J Immunol (2014) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on human samples . Clin Exp Immunol (2014) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; loading ...; fig 2
In order to correlate biomarkers associated with coagulation, monocyte activation, and inflammation in elite controllers of HIV infection, BD Biosciences CD14 antibody (BD Bioscience, M5E2) was used in flow cytometry on human samples (fig 2). J Infect Dis (2014) ncbi
mouse monoclonal (M5E2)
  • immunohistochemistry - frozen section; rhesus macaque; loading ...
BD Biosciences CD14 antibody (BD Pharmingen, 557153) was used in immunohistochemistry - frozen section on rhesus macaque samples . Mol Ther (2014) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human; fig 1
BD Biosciences CD14 antibody (BD, M5E2) was used in flow cytometry on human samples (fig 1). J Tissue Eng Regen Med (2015) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BD Biosciences CD14 antibody (BD Biosciences, M5E2) was used in flow cytometry on human samples . PLoS ONE (2013) ncbi
mouse monoclonal (M?P9)
  • flow cytometry; human
In order to discuss the use of PPR ligands as adjuvants and the use of interferon-gamma release assays as a diagnostic tool, BD Biosciences CD14 antibody (BD, 560180) was used in flow cytometry on human samples . PLoS ONE (2012) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BD Biosciences CD14 antibody (BD Biosciences, 555397) was used in flow cytometry on human samples . Invest Ophthalmol Vis Sci (2012) ncbi
mouse monoclonal (M5E2)
  • flow cytometry; human
BD Biosciences CD14 antibody (BD, clone M5E2) was used in flow cytometry on human samples . J Immunol Methods (2009) ncbi
Leica Biosystems
(7)
  • immunohistochemistry; human; 1:100; fig 1h
Leica Biosystems CD14 antibody (Leica Biosystems, 7) was used in immunohistochemistry on human samples at 1:100 (fig 1h). Front Immunol (2017) ncbi
(7)
  • immunohistochemistry - paraffin section; human; 1:5000; loading ...; fig 7A
In order to analyze the frequency and phenotype of monocyte subpopulations in peripheral blood, cerebrospinal fluid, and brain biopsy material derived from multiple sclerosis patients, Leica Biosystems CD14 antibody (Novocastra, 7) was used in immunohistochemistry - paraffin section on human samples at 1:5000 (fig 7A). J Immunol (2016) ncbi
Articles Reviewed
  1. Beider K, Voevoda Dimenshtein V, Zoabi A, Rosenberg E, Magen H, Ostrovsky O, et al. CXCL13 chemokine is a novel player in multiple myeloma osteolytic microenvironment, M2 macrophage polarization, and tumor progression. J Hematol Oncol. 2022;15:144 pubmed publisher
  2. Wakao S, Oguma Y, Kushida Y, Kuroda Y, Tatsumi K, Dezawa M. Phagocytosing differentiated cell-fragments is a novel mechanism for controlling somatic stem cell differentiation within a short time frame. Cell Mol Life Sci. 2022;79:542 pubmed publisher
  3. Ye Y, Zhang X, Su D, Ren Y, Cheng F, Yao Y, et al. Therapeutic efficacy of human adipose mesenchymal stem cells in Crohn's colon fibrosis is improved by IFN-γ and kynurenic acid priming through indoleamine 2,3-dioxygenase-1 signaling. Stem Cell Res Ther. 2022;13:465 pubmed publisher
  4. Amaral E, Foreman T, Namasivayam S, Hilligan K, Kauffman K, Barbosa Bomfim C, et al. GPX4 regulates cellular necrosis and host resistance in Mycobacterium tuberculosis infection. J Exp Med. 2022;219: pubmed publisher
  5. Sinha S, Castillo V, Espinoza C, Tindle C, Fonseca A, Dan J, et al. COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis. EBioMedicine. 2022;82:104185 pubmed publisher
  6. Yong L, Yu Y, Li B, Ge H, Zhen Q, Mao Y, et al. Calcium/calmodulin-dependent protein kinase IV promotes imiquimod-induced psoriatic inflammation via macrophages and keratinocytes in mice. Nat Commun. 2022;13:4255 pubmed publisher
  7. Rosa T, Mendes M, Linhares N, Rodrigues T, Dias A, Leal Calvo T, et al. The Type I Interferon Pathway Is Upregulated in the Cutaneous Lesions and Blood of Multibacillary Leprosy Patients With Erythema Nodosum Leprosum. Front Med (Lausanne). 2022;9:899998 pubmed publisher
  8. Eikmans M, van der Keur C, Anholts J, Drabbels J, van Beelen E, de Sousa Lopes S, et al. Primary Trophoblast Cultures: Characterization of HLA Profiles and Immune Cell Interactions. Front Immunol. 2022;13:814019 pubmed publisher
  9. Poletto E, Colella P, Pimentel Vera L, Khan S, Tomatsu S, Baldo G, et al. Improved engraftment and therapeutic efficacy by human genome-edited hematopoietic stem cells with Busulfan-based myeloablation. Mol Ther Methods Clin Dev. 2022;25:392-409 pubmed publisher
  10. Omari S, Geraghty D, Khalafallah A, Venkat P, Shegog Y, Ragg S, et al. Optimized flow cytometric detection of transient receptor potential vanilloid-1 (TRPV1) in human hematological malignancies. Med Oncol. 2022;39:81 pubmed publisher
  11. Wu X, Xia T, Shin W, Yu K, Jung W, Herrmann A, et al. Viral Mimicry of Interleukin-17A by SARS-CoV-2 ORF8. MBio. 2022;13:e0040222 pubmed publisher
  12. R xfc tsche D, Michalak Mićka K, Zielinska D, Moll H, Moehrlen U, Biedermann T, et al. The Role of CD200-CD200 Receptor in Human Blood and Lymphatic Endothelial Cells in the Regulation of Skin Tissue Inflammation. Cells. 2022;11: pubmed publisher
  13. Pinkert J, Boehm H, Trautwein M, Doecke W, Wessel F, Ge Y, et al. T cell-mediated elimination of cancer cells by blocking CEACAM6-CEACAM1 interaction. Oncoimmunology. 2022;11:2008110 pubmed publisher
  14. Chen Y, Feng R, He B, Wang J, Xian N, Huang G, et al. PD-1H Expression Associated With CD68 Macrophage Marker Confers an Immune-Activated Microenvironment and Favorable Overall Survival in Human Esophageal Squamous Cell Carcinoma. Front Mol Biosci. 2021;8:777370 pubmed publisher
  15. Liu Y, Wang L, Song Q, Ali M, Crowe W, Kucera G, et al. Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion. Nat Nanotechnol. 2022;17:206-216 pubmed publisher
  16. Fu H, Gui Y, Liu S, Wang Y, Bastacky S, Qiao Y, et al. The hepatocyte growth factor/c-met pathway is a key determinant of the fibrotic kidney local microenvironment. iScience. 2021;24:103112 pubmed publisher
  17. Moreira T, Mangani D, Cox L, Leibowitz J, Lobo E, Oliveira M, et al. PD-L1+ and XCR1+ dendritic cells are region-specific regulators of gut homeostasis. Nat Commun. 2021;12:4907 pubmed publisher
  18. Yamagishi M, Kubokawa M, Kuze Y, Suzuki A, Yokomizo A, Kobayashi S, et al. Chronological genome and single-cell transcriptome integration characterizes the evolutionary process of adult T cell leukemia-lymphoma. Nat Commun. 2021;12:4821 pubmed publisher
  19. Spiegel J, Patel S, Muffly L, Hossain N, Oak J, Baird J, et al. CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial. Nat Med. 2021;27:1419-1431 pubmed publisher
  20. Li D, Edwards R, Manne K, Martinez D, Schäfer A, Alam S, et al. In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies. Cell. 2021;184:4203-4219.e32 pubmed publisher
  21. Bohannon C, Ende Z, Cao W, Mboko W, Ranjan P, Kumar A, et al. Influenza Virus Infects and Depletes Activated Adaptive Immune Responders. Adv Sci (Weinh). 2021;8:e2100693 pubmed publisher
  22. Motozono C, Toyoda M, Zahradník J, Saito A, Nasser H, Tan T, et al. SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity. Cell Host Microbe. 2021;29:1124-1136.e11 pubmed publisher
  23. Wang Z, Muecksch F, Schaefer Babajew D, Finkin S, Viant C, Gaebler C, et al. Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection. Nature. 2021;595:426-431 pubmed publisher
  24. Hibl B, Dailey Garnes N, Kneubehl A, Vogt M, Spencer Clinton J, Rico Hesse R. Mosquito-bite infection of humanized mice with chikungunya virus produces systemic disease with long-term effects. PLoS Negl Trop Dis. 2021;15:e0009427 pubmed publisher
  25. Lu Q, Liu J, Zhao S, Gomez Castro M, Laurent Rolle M, Dong J, et al. SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2. Immunity. 2021;54:1304-1319.e9 pubmed publisher
  26. Williams W, Meyerhoff R, Edwards R, Li H, Manne K, Nicely N, et al. Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies. Cell. 2021;184:2955-2972.e25 pubmed publisher
  27. Reis M, Willis G, Fernandez Gonzalez A, Yeung V, Taglauer E, Magaletta M, et al. Mesenchymal Stromal Cell-Derived Extracellular Vesicles Restore Thymic Architecture and T Cell Function Disrupted by Neonatal Hyperoxia. Front Immunol. 2021;12:640595 pubmed publisher
  28. Jang S, Economides K, Moniz R, Sia C, Lewis N, McCoy C, et al. ExoSTING, an extracellular vesicle loaded with STING agonists, promotes tumor immune surveillance. Commun Biol. 2021;4:497 pubmed publisher
  29. Zong D, Huang B, LI Y, Lu Y, Xiang N, Guo C, et al. Chromatin accessibility landscapes of immune cells in rheumatoid arthritis nominate monocytes in disease pathogenesis. BMC Biol. 2021;19:79 pubmed publisher
  30. Laurent E, Sieber A, Salzer B, Wachernig A, Seigner J, Lehner M, et al. Directed Evolution of Stabilized Monomeric CD19 for Monovalent CAR Interaction Studies and Monitoring of CAR-T Cell Patients. ACS Synth Biol. 2021;10:1184-1198 pubmed publisher
  31. Gómez Ferrer M, Villanueva Badenas E, Sánchez Sánchez R, Sánchez López C, Baquero M, Sepulveda P, et al. HIF-1α and Pro-Inflammatory Signaling Improves the Immunomodulatory Activity of MSC-Derived Extracellular Vesicles. Int J Mol Sci. 2021;22: pubmed publisher
  32. Ingelfinger F, Krishnarajah S, Kramer M, Utz S, Galli E, Lutz M, et al. Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signature. Acta Neuropathol. 2021;141:901-915 pubmed publisher
  33. Szabo P, Dogra P, Gray J, Wells S, Connors T, Weisberg S, et al. Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19. Immunity. 2021;54:797-814.e6 pubmed publisher
  34. Dejnirattisai W, Zhou D, Ginn H, Duyvesteyn H, Supasa P, Case J, et al. The antigenic anatomy of SARS-CoV-2 receptor binding domain. Cell. 2021;184:2183-2200.e22 pubmed publisher
  35. Jeong J, Choi S, Ahn S, Oh J, Kim Y, Lee C, et al. Neutrophil extracellular trap clearance by synovial macrophages in gout. Arthritis Res Ther. 2021;23:88 pubmed publisher
  36. Chiou S, Tseng D, Reuben A, Mallajosyula V, Molina I, Conley S, et al. Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery. Immunity. 2021;54:586-602.e8 pubmed publisher
  37. Andreano E, Nicastri E, Paciello I, Pileri P, Manganaro N, Piccini G, et al. Extremely potent human monoclonal antibodies from COVID-19 convalescent patients. Cell. 2021;184:1821-1835.e16 pubmed publisher
  38. Khosravi Maharlooei M, Li H, Hoelzl M, Zhao G, Ruiz A, Misra A, et al. Role of the thymus in spontaneous development of a multi-organ autoimmune disease in human immune system mice. J Autoimmun. 2021;119:102612 pubmed publisher
  39. Chen J, Cao X, Li B, Zhao Z, Chen S, Lai S, et al. Warburg Effect Is a Cancer Immune Evasion Mechanism Against Macrophage Immunosurveillance. Front Immunol. 2020;11:621757 pubmed publisher
  40. Fletcher R, Tong J, Risnik D, Leibowitz B, Wang Y, Concha Benavente F, et al. Non-steroidal anti-inflammatory drugs induce immunogenic cell death in suppressing colorectal tumorigenesis. Oncogene. 2021;40:2035-2050 pubmed publisher
  41. Sokal A, Chappert P, Barba Spaeth G, Roeser A, Fourati S, Azzaoui I, et al. Maturation and persistence of the anti-SARS-CoV-2 memory B cell response. Cell. 2021;184:1201-1213.e14 pubmed publisher
  42. Wang Z, Schmidt F, Weisblum Y, Muecksch F, Barnes C, Finkin S, et al. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature. 2021;592:616-622 pubmed publisher
  43. Combes A, Courau T, Kuhn N, Hu K, Ray A, Chen W, et al. Global absence and targeting of protective immune states in severe COVID-19. Nature. 2021;591:124-130 pubmed publisher
  44. Wang Y, Mohseni M, Grauel A, Diez J, Guan W, Liang S, et al. SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms. Sci Rep. 2021;11:1399 pubmed publisher
  45. Gregorova M, Morse D, Brignoli T, Steventon J, Hamilton F, Albur M, et al. Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumonia. elife. 2020;9: pubmed publisher
  46. Snyder M, Sembrat J, Noda K, MYERBURG M, Craig A, Mitash N, et al. Human Lung-Resident Macrophages Colocalize with and Provide Costimulation to PD1hi Tissue-Resident Memory T Cells. Am J Respir Crit Care Med. 2021;203:1230-1244 pubmed publisher
  47. Rodda L, Netland J, Shehata L, Pruner K, Morawski P, Thouvenel C, et al. Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19. Cell. 2021;184:169-183.e17 pubmed publisher
  48. Kasatskaya S, Ladell K, Egorov E, Miners K, Davydov A, Metsger M, et al. Functionally specialized human CD4+ T-cell subsets express physicochemically distinct TCRs. elife. 2020;9: pubmed publisher
  49. Noz M, Bekkering S, Groh L, Nielen T, Lamfers E, Schlitzer A, et al. Reprogramming of bone marrow myeloid progenitor cells in patients with severe coronary artery disease. elife. 2020;9: pubmed publisher
  50. Neidleman J, Luo X, Frouard J, Xie G, Hsiao F, Ma T, et al. Phenotypic analysis of the unstimulated in vivo HIV CD4 T cell reservoir. elife. 2020;9: pubmed publisher
  51. Stary V, Wolf B, Unterleuthner D, List J, Talic M, Laengle J, et al. Short-course radiotherapy promotes pro-inflammatory macrophages via extracellular vesicles in human rectal cancer. J Immunother Cancer. 2020;8: pubmed publisher
  52. Tan E, Hopkins R, Lim C, Jamuar S, Ong C, Thoon K, et al. Dominant-negative NFKBIA mutation promotes IL-1β production causing hepatic disease with severe immunodeficiency. J Clin Invest. 2020;130:5817-5832 pubmed publisher
  53. Pasciuto E, Burton O, Roca C, Lagou V, Rajan W, Theys T, et al. Microglia Require CD4 T Cells to Complete the Fetal-to-Adult Transition. Cell. 2020;182:625-640.e24 pubmed publisher
  54. Camu W, Mickunas M, Veyrune J, Payan C, Garlanda C, Locati M, et al. Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trial. EBioMedicine. 2020;59:102844 pubmed publisher
  55. Grifoni A, Weiskopf D, Ramirez S, Mateus J, Dan J, Moderbacher C, et al. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell. 2020;181:1489-1501.e15 pubmed publisher
  56. Halder L, Jo E, Hasan M, Ferreira Gomes M, Krüger T, Westermann M, et al. Immune modulation by complement receptor 3-dependent human monocyte TGF-β1-transporting vesicles. Nat Commun. 2020;11:2331 pubmed publisher
  57. Wong S, Lenzini S, Cooper M, Mooney D, Shin J. Soft extracellular matrix enhances inflammatory activation of mesenchymal stromal cells to induce monocyte production and trafficking. Sci Adv. 2020;6:eaaw0158 pubmed publisher
  58. Beziat V, Tavernier S, Chen Y, Ma C, Materna M, Laurence A, et al. Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome. J Exp Med. 2020;217: pubmed publisher
  59. Stebegg M, Bignon A, Hill D, Silva Cayetano A, Krueger C, Vanderleyden I, et al. Rejuvenating conventional dendritic cells and T follicular helper cell formation after vaccination. elife. 2020;9: pubmed publisher
  60. Martin E, Minet N, Boschat A, Sanquer S, Sobrino S, Lenoir C, et al. Impaired lymphocyte function and differentiation in CTPS1-deficient patients result from a hypomorphic homozygous mutation. JCI Insight. 2020;5: pubmed publisher
  61. Beltran Camacho L, Jimenez Palomares M, Rojas Torres M, Sánchez Gomar I, Rosal Vela A, Eslava Alcon S, et al. Identification of the initial molecular changes in response to circulating angiogenic cells-mediated therapy in critical limb ischemia. Stem Cell Res Ther. 2020;11:106 pubmed publisher
  62. Raehtz K, Barrenas F, Xu C, Busman Sahay K, Valentine A, Law L, et al. African green monkeys avoid SIV disease progression by preventing intestinal dysfunction and maintaining mucosal barrier integrity. PLoS Pathog. 2020;16:e1008333 pubmed publisher
  63. Lubow J, Virgilio M, Merlino M, Collins D, Mashiba M, Peterson B, et al. Mannose receptor is an HIV restriction factor counteracted by Vpr in macrophages. elife. 2020;9: pubmed publisher
  64. Tezera L, Bielecka M, Ogongo P, Walker N, Ellis M, Garay Baquero D, et al. Anti-PD-1 immunotherapy leads to tuberculosis reactivation via dysregulation of TNF-α. elife. 2020;9: pubmed publisher
  65. Park J, Botting R, Domínguez Conde C, Popescu D, Lavaert M, Kunz D, et al. A cell atlas of human thymic development defines T cell repertoire formation. Science. 2020;367: pubmed publisher
  66. Adams C, Ercolano E, Ferluga S, Sofela A, Dave F, Negroni C, et al. A Rapid Robust Method for Subgrouping Non-NF2 Meningiomas According to Genotype and Detection of Lower Levels of M2 Macrophages in AKT1 E17K Mutated Tumours. Int J Mol Sci. 2020;21: pubmed publisher
  67. Trus I, Udenze D, Bérubé N, Wheler C, Martel M, Gerdts V, et al. CpG-Recoding in Zika Virus Genome Causes Host-Age-Dependent Attenuation of Infection With Protection Against Lethal Heterologous Challenge in Mice. Front Immunol. 2019;10:3077 pubmed publisher
  68. Theivanthiran B, Evans K, Devito N, Plebanek M, Sturdivant M, Wachsmuth L, et al. A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti-PD-1 immunotherapy. J Clin Invest. 2020;130:2570-2586 pubmed publisher
  69. Gherardini J, Uchida Y, Hardman J, Chéret J, Mace K, Bertolini M, et al. Tissue-resident macrophages can be generated de novo in adult human skin from resident progenitor cells during substance P-mediated neurogenic inflammation ex vivo. PLoS ONE. 2020;15:e0227817 pubmed publisher
  70. Schafflick D, Xu C, Hartlehnert M, Cole M, Schulte Mecklenbeck A, Lautwein T, et al. Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis. Nat Commun. 2020;11:247 pubmed publisher
  71. Gate D, Saligrama N, Leventhal O, Yang A, Unger M, Middeldorp J, et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer's disease. Nature. 2020;577:399-404 pubmed publisher
  72. Song S, Li Y, Zhang K, Zhang X, Huang Y, Xu M, et al. Cancer Stem Cells of Diffuse Large B Cell Lymphoma Are Not Enriched in the CD45+CD19- cells but in the ALDHhigh Cells. J Cancer. 2020;11:142-152 pubmed publisher
  73. Jimeno R, Lebrusant Fernandez M, Margreitter C, LUCAS B, Veerapen N, Kelly G, et al. Tissue-specific shaping of the TCR repertoire and antigen specificity of iNKT cells. elife. 2019;8: pubmed publisher
  74. Leylek R, Alcántara Hernández M, Lanzar Z, Lüdtke A, Perez O, Reizis B, et al. Integrated Cross-Species Analysis Identifies a Conserved Transitional Dendritic Cell Population. Cell Rep. 2019;29:3736-3750.e8 pubmed publisher
  75. Park C, Kehrl J. An integrin/MFG-E8 shuttle loads HIV-1 viral-like particles onto follicular dendritic cells in mouse lymph node. elife. 2019;8: pubmed publisher
  76. Liu Q, Ou Q, Chen H, Gao Y, Liu Y, Xu Y, et al. Differential expression and predictive value of monocyte scavenger receptor CD163 in populations with different tuberculosis infection statuses. BMC Infect Dis. 2019;19:1006 pubmed publisher
  77. Muhammad F, Wang D, Montieth A, Lee S, Preble J, Foster C, et al. PD-1+ melanocortin receptor dependent-Treg cells prevent autoimmune disease. Sci Rep. 2019;9:16941 pubmed publisher
  78. Guo P, Li L, Li W, Zhao J, Hu F, Zhang F, et al. The clinical significance of myeloid-derived suppressor cells in dengue fever patients. BMC Infect Dis. 2019;19:926 pubmed publisher
  79. Zhang Q, He Y, Luo N, Patel S, Han Y, Gao R, et al. Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma. Cell. 2019;179:829-845.e20 pubmed publisher
  80. Yan D, Wang J, Sun H, Zamani A, Zhang H, Chen W, et al. TIPE2 specifies the functional polarization of myeloid-derived suppressor cells during tumorigenesis. J Exp Med. 2020;217: pubmed publisher
  81. Stewart B, Ferdinand J, Young M, Mitchell T, Loudon K, Riding A, et al. Spatiotemporal immune zonation of the human kidney. Science. 2019;365:1461-1466 pubmed publisher
  82. Di Mascio M, Lifson J, Srinivasula S, Kim I, Degrange P, Keele B, et al. Evaluation of an antibody to α4β7 in the control of SIVmac239-nef-stop infection. Science. 2019;365:1025-1029 pubmed publisher
  83. Findlay E, Currie A, Zhang A, Ovciarikova J, Young L, Stevens H, et al. Exposure to the antimicrobial peptide LL-37 produces dendritic cells optimized for immunotherapy. Oncoimmunology. 2019;8:1608106 pubmed publisher
  84. Culemann S, Grüneboom A, Nicolás Ávila J, Weidner D, Lämmle K, Rothe T, et al. Locally renewing resident synovial macrophages provide a protective barrier for the joint. Nature. 2019;572:670-675 pubmed publisher
  85. Barkal A, Brewer R, Markovic M, Kowarsky M, Barkal S, Zaro B, et al. CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy. Nature. 2019;572:392-396 pubmed publisher
  86. Brook A, Jenkins R, Clayton A, Kift Morgan A, Raby A, Shephard A, et al. Neutrophil-derived miR-223 as local biomarker of bacterial peritonitis. Sci Rep. 2019;9:10136 pubmed publisher
  87. Wirsching H, Zhang H, Szulzewsky F, Arora S, Grandi P, Cimino P, et al. Arming oHSV with ULBP3 drives abscopal immunity in lymphocyte-depleted glioblastoma. JCI Insight. 2019;4: pubmed publisher
  88. Inagaki Katashiba N, Ito T, Inaba M, Azuma Y, Tanaka A, Phan V, et al. Statins can suppress DC-mediated Th2 responses through the repression of OX40-ligand and CCL17 expression. Eur J Immunol. 2019;49:2051-2062 pubmed publisher
  89. Burel J, Pomaznoy M, Lindestam Arlehamn C, Weiskopf D, da Silva Antunes R, Jung Y, et al. Circulating T cell-monocyte complexes are markers of immune perturbations. elife. 2019;8: pubmed publisher
  90. Minuesa G, Albanese S, Xie W, Kazansky Y, Worroll D, Chow A, et al. Small-molecule targeting of MUSASHI RNA-binding activity in acute myeloid leukemia. Nat Commun. 2019;10:2691 pubmed publisher
  91. Xia Y, Gao Y, Wang B, Zhang H, Zhang Q. Optimizing the Method of Cell Separation from Bile of Patients with Cholangiocarcinoma for Flow Cytometry. Gastroenterol Res Pract. 2019;2019:5436961 pubmed publisher
  92. Pascual García M, Bonfill Teixidor E, Planas Rigol E, Rubio Perez C, Iurlaro R, Arias A, et al. LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy. Nat Commun. 2019;10:2416 pubmed publisher
  93. Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck W, et al. Comprehensive Integration of Single-Cell Data. Cell. 2019;: pubmed publisher
  94. Pellin D, Loperfido M, Baricordi C, Wolock S, Montepeloso A, Weinberg O, et al. A comprehensive single cell transcriptional landscape of human hematopoietic progenitors. Nat Commun. 2019;10:2395 pubmed publisher
  95. Escolano A, Gristick H, Abernathy M, Merkenschlager J, Gautam R, Oliveira T, et al. Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques. Nature. 2019;: pubmed publisher
  96. Yuan Y, Zhao Q, Zhao S, Zhang P, Zhao H, Li Z, et al. Characterization of transcriptome profile and clinical features of a novel immunotherapy target CD204 in diffuse glioma. Cancer Med. 2019;8:3811-3821 pubmed publisher
  97. Ingegnere T, Mariotti F, Pelosi A, Quintarelli C, De Angelis B, Tumino N, et al. Human CAR NK Cells: A New Non-viral Method Allowing High Efficient Transfection and Strong Tumor Cell Killing. Front Immunol. 2019;10:957 pubmed publisher
  98. Ling C, Nishimoto K, Rolfs Z, Smith L, Frey B, Welham N. Differentiated fibrocytes assume a functional mesenchymal phenotype with regenerative potential. Sci Adv. 2019;5:eaav7384 pubmed publisher
  99. Allden S, Ogger P, Ghai P, McErlean P, Hewitt R, Toshner R, et al. The Transferrin Receptor CD71 Delineates Functionally Distinct Airway Macrophage Subsets during Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2019;: pubmed publisher
  100. Ho V, Yong H, Chevrier M, Narang V, Lum J, Toh Y, et al. RIG-I activation by a designer short RNA ligand protects human immune cells against dengue virus infection without causing cytotoxicity. J Virol. 2019;: pubmed publisher
  101. Fernandez I, Baxter R, Garcia Perez J, Vendrame E, Ranganath T, Kong D, et al. A novel human IL2RB mutation results in T and NK cell-driven immune dysregulation. J Exp Med. 2019;216:1255-1267 pubmed publisher
  102. Zhang J, Supakorndej T, Krambs J, Rao M, Abou Ezzi G, Ye R, et al. Bone marrow dendritic cells regulate hematopoietic stem/progenitor cell trafficking. J Clin Invest. 2019;129:2920-2931 pubmed publisher
  103. Kuriakose J, Redecke V, Guy C, Zhou J, Wu R, Ippagunta S, et al. Patrolling monocytes promote the pathogenesis of early lupus-like glomerulonephritis. J Clin Invest. 2019;129:2251-2265 pubmed publisher
  104. Guo M, Hartlova A, Gierlinski M, Prescott A, Castellvi J, Losa J, et al. Triggering MSR1 promotes JNK-mediated inflammation in IL-4-activated macrophages. EMBO J. 2019;38: pubmed publisher
  105. Veglia F, Tyurin V, Blasi M, De Leo A, Kossenkov A, Donthireddy L, et al. Fatty acid transport protein 2 reprograms neutrophils in cancer. Nature. 2019;569:73-78 pubmed publisher
  106. Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed publisher
  107. Talreja J, Talwar H, Bauerfeld C, Grossman L, Zhang K, Tranchida P, et al. HIF-1α regulates IL-1β and IL-17 in sarcoidosis. elife. 2019;8: pubmed publisher
  108. Oda H, Beck D, Kuehn H, Sampaio Moura N, Hoffmann P, Ibarra M, et al. Second Case of HOIP Deficiency Expands Clinical Features and Defines Inflammatory Transcriptome Regulated by LUBAC. Front Immunol. 2019;10:479 pubmed publisher
  109. Cassetta L, Fragkogianni S, Sims A, Swierczak A, Forrester L, Zhang H, et al. Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets. Cancer Cell. 2019;35:588-602.e10 pubmed publisher
  110. Janela B, Patel A, Lau M, Goh C, Msallam R, Kong W, et al. A Subset of Type I Conventional Dendritic Cells Controls Cutaneous Bacterial Infections through VEGFα-Mediated Recruitment of Neutrophils. Immunity. 2019;50:1069-1083.e8 pubmed publisher
  111. Sweere J, Van Belleghem J, Ishak H, Bach M, Popescu M, Sunkari V, et al. Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection. Science. 2019;363: pubmed publisher
  112. Perdomo J, Leung H, Ahmadi Z, Yan F, Chong J, Passam F, et al. Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia. Nat Commun. 2019;10:1322 pubmed publisher
  113. Chakarov S, Lim H, Tan L, Lim S, See P, Lum J, et al. Two distinct interstitial macrophage populations coexist across tissues in specific subtissular niches. Science. 2019;363: pubmed publisher
  114. Frank A, Ebersberger S, Fink A, Lampe S, Weigert A, Schmid T, et al. Apoptotic tumor cell-derived microRNA-375 uses CD36 to alter the tumor-associated macrophage phenotype. Nat Commun. 2019;10:1135 pubmed publisher
  115. Crippa S, Rossella V, Aprile A, Silvestri L, Rivis S, Scaramuzza S, et al. Bone marrow stromal cells from β-thalassemia patients have impaired hematopoietic supportive capacity. J Clin Invest. 2019;129:1566-1580 pubmed publisher
  116. Sachdeva M, Duchateau P, Depil S, Poirot L, Valton J. Granulocyte-macrophage colony-stimulating factor inactivation in CAR T-cells prevents monocyte-dependent release of key cytokine release syndrome mediators. J Biol Chem. 2019;294:5430-5437 pubmed publisher
  117. Boscheinen J, Thomann S, Knipe D, Deluca N, Schuler Thurner B, Gross S, et al. Generation of an Oncolytic Herpes Simplex Virus 1 Expressing Human MelanA. Front Immunol. 2019;10:2 pubmed publisher
  118. Wen Z, Jin K, Shen Y, Yang Z, Li Y, Wu B, et al. N-myristoyltransferase deficiency impairs activation of kinase AMPK and promotes synovial tissue inflammation. Nat Immunol. 2019;20:313-325 pubmed publisher
  119. Banki Z, Krabbendam L, Klaver D, Leng T, Kruis S, Mehta H, et al. Antibody opsonization enhances MAIT cell responsiveness to bacteria via a TNF-dependent mechanism. Immunol Cell Biol. 2019;97:538-551 pubmed publisher
  120. Jin Y, Roberts G, Ferrara T, Ben S, van Geel N, Wolkerstorfer A, et al. Early-onset autoimmune vitiligo associated with an enhancer variant haplotype that upregulates class II HLA expression. Nat Commun. 2019;10:391 pubmed publisher
  121. Taura M, Song E, Ho Y, Iwasaki A. Apobec3A maintains HIV-1 latency through recruitment of epigenetic silencing machinery to the long terminal repeat. Proc Natl Acad Sci U S A. 2019;116:2282-2289 pubmed publisher
  122. Wheeler M, Jaronen M, Covacu R, Zandee S, Scalisi G, Rothhammer V, et al. Environmental Control of Astrocyte Pathogenic Activities in CNS Inflammation. Cell. 2019;176:581-596.e18 pubmed publisher
  123. Herten M, Zilkens C, Thorey F, Tassemeier T, Lensing Höhn S, Fischer J, et al. Biomechanical Stability and Osteogenesis in a Tibial Bone Defect Treated by Autologous Ovine Cord Blood Cells-A Pilot Study. Molecules. 2019;24: pubmed publisher
  124. Jones G, Bain C, Fenton T, Kelly A, Brown S, Ivens A, et al. Dynamics of Colon Monocyte and Macrophage Activation During Colitis. Front Immunol. 2018;9:2764 pubmed publisher
  125. Chea L, Wyatt L, Gangadhara S, Moss B, Amara R. Novel Modified Vaccinia Virus Ankara Vector Expressing Anti-apoptotic Gene B13R Delays Apoptosis and Enhances Humoral Responses. J Virol. 2019;93: pubmed publisher
  126. Wiedemann G, Aithal C, Kraechan A, Heise C, Cadilha B, Zhang J, et al. Microphthalmia-Associated Transcription Factor (MITF) Regulates Immune Cell Migration into Melanoma. Transl Oncol. 2019;12:350-360 pubmed publisher
  127. Mouhadeb O, Ben Shlomo S, Cohen K, Farkash I, Gruber S, Maharshak N, et al. Impaired COMMD10-Mediated Regulation of Ly6Chi Monocyte-Driven Inflammation Disrupts Gut Barrier Function. Front Immunol. 2018;9:2623 pubmed publisher
  128. Chinta K, Rahman M, Saini V, Glasgow J, Reddy V, Lever J, et al. Microanatomic Distribution of Myeloid Heme Oxygenase-1 Protects against Free Radical-Mediated Immunopathology in Human Tuberculosis. Cell Rep. 2018;25:1938-1952.e5 pubmed publisher
  129. Kennedy J, Steain M, Slobedman B, Abendroth A. Infection and Functional Modulation of Human Monocytes and Macrophages by Varicella-Zoster Virus. J Virol. 2019;93: pubmed publisher
  130. Kelly A, Günaltay S, McEntee C, Shuttleworth E, Smedley C, Houston S, et al. Human monocytes and macrophages regulate immune tolerance via integrin αvβ8-mediated TGFβ activation. J Exp Med. 2018;215:2725-2736 pubmed publisher
  131. Kuranda K, Jean Alphonse P, Leborgne C, Hardet R, Collaud F, Marmier S, et al. Exposure to wild-type AAV drives distinct capsid immunity profiles in humans. J Clin Invest. 2018;128:5267-5279 pubmed publisher
  132. Otsuka Y, Watanabe E, Shinya E, Okura S, Saeki H, Geijtenbeek T, et al. Differentiation of Langerhans Cells from Monocytes and Their Specific Function in Inducing IL-22-Specific Th Cells. J Immunol. 2018;201:3006-3016 pubmed publisher
  133. Fauster A, Rebsamen M, Willmann K, César Razquin A, Girardi E, Bigenzahn J, et al. Systematic genetic mapping of necroptosis identifies SLC39A7 as modulator of death receptor trafficking. Cell Death Differ. 2019;26:1138-1155 pubmed publisher
  134. Olin A, Henckel E, Chen Y, Lakshmikanth T, Pou C, Mikes J, et al. Stereotypic Immune System Development in Newborn Children. Cell. 2018;174:1277-1292.e14 pubmed publisher
  135. Voigt J, Malone D, Dias J, Leeansyah E, Björkström N, Ljunggren H, et al. Proteome analysis of human CD56neg NK cells reveals a homogeneous phenotype surprisingly similar to CD56dim NK cells. Eur J Immunol. 2018;48:1456-1469 pubmed publisher
  136. Alissafi T, Hatzioannou A, Mintzas K, Barouni R, Banos A, Sormendi S, et al. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells. J Clin Invest. 2018;128:3840-3852 pubmed publisher
  137. Honeycutt J, Liao B, Nixon C, Cleary R, Thayer W, Birath S, et al. T cells establish and maintain CNS viral infection in HIV-infected humanized mice. J Clin Invest. 2018;128:2862-2876 pubmed publisher
  138. Yeo L, Woodwyk A, Sood S, Lorenc A, Eichmann M, Pujol Autonell I, et al. Autoreactive T effector memory differentiation mirrors β cell function in type 1 diabetes. J Clin Invest. 2018;128:3460-3474 pubmed publisher
  139. Mitchell K, Barreyro L, Todorova T, Taylor S, Antony Debré I, Narayanagari S, et al. IL1RAP potentiates multiple oncogenic signaling pathways in AML. J Exp Med. 2018;215:1709-1727 pubmed publisher
  140. Risnes L, Christophersen A, Dahal Koirala S, Neumann R, Sandve G, Sarna V, et al. Disease-driving CD4+ T cell clonotypes persist for decades in celiac disease. J Clin Invest. 2018;128:2642-2650 pubmed publisher
  141. Bhattacharjee P, Keyel P. Cholesterol-dependent cytolysins impair pro-inflammatory macrophage responses. Sci Rep. 2018;8:6458 pubmed publisher
  142. Clayton K, Collins D, Lengieza J, Ghebremichael M, Dotiwala F, Lieberman J, et al. Resistance of HIV-infected macrophages to CD8+ T lymphocyte-mediated killing drives activation of the immune system. Nat Immunol. 2018;19:475-486 pubmed publisher
  143. Ferrando Martinez S, Moysi E, Pegu A, Andrews S, Nganou Makamdop K, Ambrozak D, et al. Accumulation of follicular CD8+ T cells in pathogenic SIV infection. J Clin Invest. 2018;128:2089-2103 pubmed publisher
  144. Melo Gonzalez F, Fenton T, Forss C, Smedley C, Goenka A, MacDonald A, et al. Intestinal mucin activates human dendritic cells and IL-8 production in a glycan-specific manner. J Biol Chem. 2018;293:8543-8553 pubmed publisher
  145. Hong D, Ding J, Li O, He Q, Ke M, Zhu M, et al. Human-induced pluripotent stem cell-derived macrophages and their immunological function in response to tuberculosis infection. Stem Cell Res Ther. 2018;9:49 pubmed publisher
  146. Trifonova R, Barteneva N. Quantitation of IRF3 Nuclear Translocation in Heterogeneous Cellular Populations from Cervical Tissue Using Imaging Flow Cytometry. Methods Mol Biol. 2018;1745:125-153 pubmed publisher
  147. Oei V, Siernicka M, Graczyk Jarzynka A, Hoel H, Yang W, Palacios D, et al. Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen Receptors. Cancer Immunol Res. 2018;6:467-480 pubmed publisher
  148. Taylor J, Cash M, Santostefano K, Nakanishi M, Terada N, Wallet M. CRISPR/Cas9 knockout of USP18 enhances type I IFN responsiveness and restricts HIV-1 infection in macrophages. J Leukoc Biol. 2018;: pubmed publisher
  149. Nieto C, Bragado R, Municio C, Sierra Filardi E, Alonso B, Escribese M, et al. The Activin A-Peroxisome Proliferator-Activated Receptor Gamma Axis Contributes to the Transcriptome of GM-CSF-Conditioned Human Macrophages. Front Immunol. 2018;9:31 pubmed publisher
  150. Fujisaka Y, Iwata T, Tamai K, Nakamura M, Mochizuki M, Shibuya R, et al. Long non-coding RNA HOTAIR up-regulates chemokine (C-C motif) ligand 2 and promotes proliferation of macrophages and myeloid-derived suppressor cells in hepatocellular carcinoma cell lines. Oncol Lett. 2018;15:509-514 pubmed publisher
  151. Cribbs A, Hookway E, Wells G, Lindow M, Obad S, Oerum H, et al. Inhibition of histone H3K27 demethylases selectively modulates inflammatory phenotypes of natural killer cells. J Biol Chem. 2018;293:2422-2437 pubmed publisher
  152. Kunimoto H, Meydan C, Nazir A, Whitfield J, Shank K, Rapaport F, et al. Cooperative Epigenetic Remodeling by TET2 Loss and NRAS Mutation Drives Myeloid Transformation and MEK Inhibitor Sensitivity. Cancer Cell. 2018;33:44-59.e8 pubmed publisher
  153. Bujko A, Atlasy N, Landsverk O, Richter L, Yaqub S, Horneland R, et al. Transcriptional and functional profiling defines human small intestinal macrophage subsets. J Exp Med. 2018;215:441-458 pubmed publisher
  154. Jeong J, Hong S, Kwon O, Ghang B, Hwang I, Kim Y, et al. CD14+ Cells with the Phenotype of Infiltrated Monocytes Consist of Distinct Populations Characterized by Anti-inflammatory as well as Pro-inflammatory Activity in Gouty Arthritis. Front Immunol. 2017;8:1260 pubmed publisher
  155. Gaidt M, Ebert T, Chauhan D, Ramshorn K, Pinci F, Zuber S, et al. The DNA Inflammasome in Human Myeloid Cells Is Initiated by a STING-Cell Death Program Upstream of NLRP3. Cell. 2017;171:1110-1124.e18 pubmed publisher
  156. Meng Y, Zhou W, Jin L, Liu L, Chang K, Mei J, et al. RANKL-mediated harmonious dialogue between fetus and mother guarantees smooth gestation by inducing decidual M2 macrophage polarization. Cell Death Dis. 2017;8:e3105 pubmed publisher
  157. Holbrook B, Aycock S, Machiele E, Clemens E, Gries D, Jorgensen M, et al. An R848 adjuvanted influenza vaccine promotes early activation of B cells in the draining lymph nodes of non-human primate neonates. Immunology. 2018;153:357-367 pubmed publisher
  158. Vu L, Pickering B, Cheng Y, Zaccara S, Nguyen D, Minuesa G, et al. The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells. Nat Med. 2017;23:1369-1376 pubmed publisher
  159. Kyoizumi S, Kubo Y, Kajimura J, Yoshida K, Hayashi T, Nakachi K, et al. Fate Decision Between Group 3 Innate Lymphoid and Conventional NK Cell Lineages by Notch Signaling in Human Circulating Hematopoietic Progenitors. J Immunol. 2017;199:2777-2793 pubmed publisher
  160. Salio M, Gasser O, González López C, Martens A, Veerapen N, Gileadi U, et al. Activation of Human Mucosal-Associated Invariant T Cells Induces CD40L-Dependent Maturation of Monocyte-Derived and Primary Dendritic Cells. J Immunol. 2017;199:2631-2638 pubmed publisher
  161. Lee J, Tam H, Adler L, Ilstad Minnihan A, Macaubas C, Mellins E. The MHC class II antigen presentation pathway in human monocytes differs by subset and is regulated by cytokines. PLoS ONE. 2017;12:e0183594 pubmed publisher
  162. Lunemann S, Martrus G, Goebels H, Kautz T, Langeneckert A, Salzberger W, et al. Hobit expression by a subset of human liver-resident CD56bright Natural Killer cells. Sci Rep. 2017;7:6676 pubmed publisher
  163. Resheq Y, Menzner A, Bosch J, Tickle J, Li K, Wilhelm A, et al. Impaired Transmigration of Myeloid-Derived Suppressor Cells across Human Sinusoidal Endothelium Is Associated with Decreased Expression of CD13. J Immunol. 2017;199:1672-1681 pubmed publisher
  164. Ichii M, Oritani K, Murase M, Komatsu K, Yamazaki M, Kyoden R, et al. Molecular targeting of inosine-5'-monophosphate dehydrogenase by FF-10501 promotes erythropoiesis via ROS/MAPK pathway. Leuk Lymphoma. 2018;59:448-459 pubmed publisher
  165. Gorvel L, Korenfeld D, Tung T, Klechevsky E. Dendritic Cell-Derived IL-32?: A Novel Inhibitory Cytokine of NK Cell Function. J Immunol. 2017;199:1290-1300 pubmed publisher
  166. Ott P, Hu Z, Keskin D, Shukla S, Sun J, Bozym D, et al. An immunogenic personal neoantigen vaccine for patients with melanoma. Nature. 2017;547:217-221 pubmed publisher
  167. Chew V, Lai L, Pan L, Lim C, Li J, Ong R, et al. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses. Proc Natl Acad Sci U S A. 2017;114:E5900-E5909 pubmed publisher
  168. Hussen J, Shawaf T, Al Herz A, Alturaifi H, Alluwaimi A. Reactivity of commercially available monoclonal antibodies to human CD antigens with peripheral blood leucocytes of dromedary camels (Camelus dromedarius). Open Vet J. 2017;7:150-153 pubmed publisher
  169. Dulberger C, McMurtrey C, Hölzemer A, Neu K, Liu V, Steinbach A, et al. Human Leukocyte Antigen F Presents Peptides and Regulates Immunity through Interactions with NK Cell Receptors. Immunity. 2017;46:1018-1029.e7 pubmed publisher
  170. Chang A, Dao T, Gejman R, Jarvis C, Scott A, Dubrovsky L, et al. A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens. J Clin Invest. 2017;127:2705-2718 pubmed publisher
  171. Bzowska M, Nogieć A, Bania K, Zygmunt M, Zarebski M, Dobrucki J, et al. Involvement of cell surface 90 kDa heat shock protein (HSP90) in pattern recognition by human monocyte-derived macrophages. J Leukoc Biol. 2017;102:763-774 pubmed publisher
  172. Gosselin D, Skola D, Coufal N, Holtman I, Schlachetzki J, Sajti E, et al. An environment-dependent transcriptional network specifies human microglia identity. Science. 2017;356: pubmed publisher
  173. Iampietro M, Younan P, Nishida A, Dutta M, Lubaki N, Santos R, et al. Ebola virus glycoprotein directly triggers T lymphocyte death despite of the lack of infection. PLoS Pathog. 2017;13:e1006397 pubmed publisher
  174. Mitterreiter J, Ouwendijk W, van Velzen M, van Nierop G, Osterhaus A, Verjans G. Satellite glial cells in human trigeminal ganglia have a broad expression of functional Toll-like receptors. Eur J Immunol. 2017;47:1181-1187 pubmed publisher
  175. See P, Dutertre C, Chen J, Günther P, McGovern N, Irac S, et al. Mapping the human DC lineage through the integration of high-dimensional techniques. Science. 2017;356: pubmed publisher
  176. Djaoud Z, Guethlein L, Horowitz A, Azzi T, Nemat Gorgani N, Olive D, et al. Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and ?? T cells. J Exp Med. 2017;214:1827-1841 pubmed publisher
  177. Villani A, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science. 2017;356: pubmed publisher
  178. Cottineau J, Kottemann M, Lach F, Kang Y, Vély F, Deenick E, et al. Inherited GINS1 deficiency underlies growth retardation along with neutropenia and NK cell deficiency. J Clin Invest. 2017;127:1991-2006 pubmed publisher
  179. Chen C, Sun W, Chen J, Huang J. Dynamic variations of the peripheral blood immune cell subpopulation in patients with critical H7N9 swine-origin influenza A virus infection: A retrospective small-scale study. Exp Ther Med. 2017;13:1490-1494 pubmed publisher
  180. Gaggianesi M, Turdo A, Chinnici A, Lipari E, Apuzzo T, Benfante A, et al. IL4 Primes the Dynamics of Breast Cancer Progression via DUSP4 Inhibition. Cancer Res. 2017;77:3268-3279 pubmed publisher
  181. Daley D, Mani V, Mohan N, Akkad N, Ochi A, Heindel D, et al. Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance. Nat Med. 2017;23:556-567 pubmed publisher
  182. van den Bosch T, Caliskan K, Kraaij M, Constantinescu A, Manintveld O, Leenen P, et al. CD16+ Monocytes and Skewed Macrophage Polarization toward M2 Type Hallmark Heart Transplant Acute Cellular Rejection. Front Immunol. 2017;8:346 pubmed publisher
  183. Dowling D, van Haren S, Scheid A, Bergelson I, Kim D, Mancuso C, et al. TLR7/8 adjuvant overcomes newborn hyporesponsiveness to pneumococcal conjugate vaccine at birth. JCI Insight. 2017;2:e91020 pubmed publisher
  184. Zhang J, Xu X, Shi M, Chen Y, Yu D, Zhao C, et al. CD13hi Neutrophil-like myeloid-derived suppressor cells exert immune suppression through Arginase 1 expression in pancreatic ductal adenocarcinoma. Oncoimmunology. 2017;6:e1258504 pubmed publisher
  185. Bergström I, Lundberg A, Jonsson S, Särndahl E, Ernerudh J, Jonasson L. Annexin A1 in blood mononuclear cells from patients with coronary artery disease: Its association with inflammatory status and glucocorticoid sensitivity. PLoS ONE. 2017;12:e0174177 pubmed publisher
  186. Lu X, Horner J, Paul E, Shang X, Troncoso P, Deng P, et al. Effective combinatorial immunotherapy for castration-resistant prostate cancer. Nature. 2017;543:728-732 pubmed publisher
  187. Di Maggio N, Martella E, Frismantiene A, Resink T, Schreiner S, Lucarelli E, et al. Extracellular matrix and α5β1 integrin signaling control the maintenance of bone formation capacity by human adipose-derived stromal cells. Sci Rep. 2017;7:44398 pubmed publisher
  188. Su S, Liao J, Liu J, Huang D, He C, Chen F, et al. Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer. Cell Res. 2017;27:461-482 pubmed publisher
  189. Lopes F, Bálint Å, Valvo S, Felce J, Hessel E, Dustin M, et al. Membrane nanoclusters of FcγRI segregate from inhibitory SIRPα upon activation of human macrophages. J Cell Biol. 2017;216:1123-1141 pubmed publisher
  190. Botting R, Bertram K, Baharlou H, Sandgren K, Fletcher J, Rhodes J, et al. Phenotypic and functional consequences of different isolation protocols on skin mononuclear phagocytes. J Leukoc Biol. 2017;101:1393-1403 pubmed publisher
  191. Cardinaud S, Urrutia A, Rouers A, Coulon P, Kervevan J, Richetta C, et al. Triggering of TLR-3, -4, NOD2, and DC-SIGN reduces viral replication and increases T-cell activation capacity of HIV-infected human dendritic cells. Eur J Immunol. 2017;47:818-829 pubmed publisher
  192. Lerner T, Borel S, Greenwood D, Repnik U, Russell M, Herbst S, et al. Mycobacterium tuberculosis replicates within necrotic human macrophages. J Cell Biol. 2017;216:583-594 pubmed publisher
  193. Israel L, Wang Y, Bulek K, Della Mina E, Zhang Z, Pedergnana V, et al. Human Adaptive Immunity Rescues an Inborn Error of Innate Immunity. Cell. 2017;168:789-800.e10 pubmed publisher
  194. Mordmuller B, Surat G, Lagler H, Chakravarty S, Ishizuka A, Lalremruata A, et al. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature. 2017;542:445-449 pubmed publisher
  195. Wouters K, Gaens K, Bijnen M, Verboven K, Jocken J, Wetzels S, et al. Circulating classical monocytes are associated with CD11c+ macrophages in human visceral adipose tissue. Sci Rep. 2017;7:42665 pubmed publisher
  196. Horvatinovich J, Grogan E, Norris M, Steinkasserer A, Lemos H, Mellor A, et al. Soluble CD83 Inhibits T Cell Activation by Binding to the TLR4/MD-2 Complex on CD14+ Monocytes. J Immunol. 2017;198:2286-2301 pubmed publisher
  197. Chimen M, Yates C, McGettrick H, Ward L, Harrison M, Apta B, et al. Monocyte Subsets Coregulate Inflammatory Responses by Integrated Signaling through TNF and IL-6 at the Endothelial Cell Interface. J Immunol. 2017;198:2834-2843 pubmed publisher
  198. Alvarez Carbonell D, Garcia Mesa Y, Milne S, Das B, Dobrowolski C, Rojas R, et al. Toll-like receptor 3 activation selectively reverses HIV latency in microglial cells. Retrovirology. 2017;14:9 pubmed publisher
  199. Patschan D, Schwarze K, Tampe B, Zeisberg M, Patschan S, Muller G. Endothelial Colony Forming Cells (ECFCs) in murine AKI - implications for future cell-based therapies. BMC Nephrol. 2017;18:53 pubmed publisher
  200. Canté Barrett K, Mendes R, Li Y, Vroegindeweij E, Pike Overzet K, Wabeke T, et al. Loss of CD44dim Expression from Early Progenitor Cells Marks T-Cell Lineage Commitment in the Human Thymus. Front Immunol. 2017;8:32 pubmed publisher
  201. O CONNOR D, Clutterbuck E, Thompson A, Snape M, Ramasamy M, Kelly D, et al. High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine. Genome Med. 2017;9:11 pubmed publisher
  202. Hammonds J, Beeman N, Ding L, Takushi S, Francis A, Wang J, et al. Siglec-1 initiates formation of the virus-containing compartment and enhances macrophage-to-T cell transmission of HIV-1. PLoS Pathog. 2017;13:e1006181 pubmed publisher
  203. Salvatori G, Foligno S, Sirleto P, Genovese S, Russo S, Coletti V, et al. Sometimes it is better to wait: First Italian case of a newborn with transient abnormal myelopoiesis and a favorable prognosis. Oncol Lett. 2017;13:191-195 pubmed publisher
  204. Hurtado Guerrero I, Pinto Medel M, Urbaneja P, Rodriguez Bada J, Leon A, Guerrero M, et al. Activation of the JAK-STAT Signaling Pathway after In Vitro Stimulation with IFNß in Multiple Sclerosis Patients According to the Therapeutic Response to IFNß. PLoS ONE. 2017;12:e0170031 pubmed publisher
  205. Tauriainen J, Scharf L, Frederiksen J, Naji A, Ljunggren H, Sonnerborg A, et al. Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals. Sci Rep. 2017;7:40354 pubmed publisher
  206. Wonderlich E, Swan Z, Bissel S, Hartman A, Carney J, O Malley K, et al. Widespread Virus Replication in Alveoli Drives Acute Respiratory Distress Syndrome in Aerosolized H5N1 Influenza Infection of Macaques. J Immunol. 2017;198:1616-1626 pubmed publisher
  207. Collins F, Williams J, Bloom A, Singh R, Jordan L, Stone M, et al. CCL3 and MMP-9 are induced by TL1A during death receptor 3 (TNFRSF25)-dependent osteoclast function and systemic bone loss. Bone. 2017;97:94-104 pubmed publisher
  208. Roberts E, Carnathan D, Li H, Shaw G, Silvestri G, Betts M. Collapse of Cytolytic Potential in SIV-Specific CD8+ T Cells Following Acute SIV Infection in Rhesus Macaques. PLoS Pathog. 2016;12:e1006135 pubmed publisher
  209. Wahl S, Drong A, Lehne B, Loh M, Scott W, Kunze S, et al. Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity. Nature. 2017;541:81-86 pubmed publisher
  210. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed publisher
  211. Liu L, Jacobsen F, Everds N, Zhuang Y, Yu Y, Li N, et al. Biological Characterization of a Stable Effector Functionless (SEFL) Monoclonal Antibody Scaffold in Vitro. J Biol Chem. 2017;292:1876-1883 pubmed publisher
  212. Hadadi E, Zhang B, Baidžajevas K, Yusof N, Puan K, Ong S, et al. Differential IL-1? secretion by monocyte subsets is regulated by Hsp27 through modulating mRNA stability. Sci Rep. 2016;6:39035 pubmed publisher
  213. Dross S, Munson P, Kim S, Bratt D, Tunggal H, Gervassi A, et al. Kinetics of Myeloid-Derived Suppressor Cell Frequency and Function during Simian Immunodeficiency Virus Infection, Combination Antiretroviral Therapy, and Treatment Interruption. J Immunol. 2017;198:757-766 pubmed publisher
  214. Assadi G, Vesterlund L, Bonfiglio F, Mazzurana L, Cordeddu L, Schepis D, et al. Functional Analyses of the Crohn's Disease Risk Gene LACC1. PLoS ONE. 2016;11:e0168276 pubmed publisher
  215. Cheng L, Ma J, Li J, Li D, Li G, Li F, et al. Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs. J Clin Invest. 2017;127:269-279 pubmed publisher
  216. Matsuoka Y, Takahashi M, Sumide K, Kawamura H, Nakatsuka R, Fujioka T, et al. CD34 Antigen and the MPL Receptor Expression Defines a Novel Class of Human Cord Blood-Derived Primitive Hematopoietic Stem Cells. Cell Transplant. 2017;26:1043-1058 pubmed publisher
  217. Kasturi S, Kozlowski P, Nakaya H, Burger M, Russo P, Pham M, et al. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques. J Virol. 2017;91: pubmed publisher
  218. Tsai C, Lin Y, Huang C, Shih C, Tsai Y, Tsao N, et al. Thrombomodulin regulates monocye differentiation via PKC? and ERK1/2 pathway in vitro and in atherosclerotic artery. Sci Rep. 2016;6:38421 pubmed publisher
  219. Andresen V, Erikstein B, Mukherjee H, Sulen A, Popa M, S rnes S, et al. Anti-proliferative activity of the NPM1 interacting natural product avrainvillamide in acute myeloid leukemia. Cell Death Dis. 2016;7:e2497 pubmed publisher
  220. Paul D, Teschendorff A, Dang M, Lowe R, Hawa M, Ecker S, et al. Increased DNA methylation variability in type 1 diabetes across three immune effector cell types. Nat Commun. 2016;7:13555 pubmed publisher
  221. Faivre V, Lukaszewicz A, Payen D. Downregulation of Blood Monocyte HLA-DR in ICU Patients Is Also Present in Bone Marrow Cells. PLoS ONE. 2016;11:e0164489 pubmed publisher
  222. Snyder Mackler N, Sanz J, Kohn J, Brinkworth J, Morrow S, Shaver A, et al. Social status alters immune regulation and response to infection in macaques. Science. 2016;354:1041-1045 pubmed
  223. Garcia Mesa Y, Jay T, Checkley M, Luttge B, Dobrowolski C, Valadkhan S, et al. Immortalization of primary microglia: a new platform to study HIV regulation in the central nervous system. J Neurovirol. 2017;23:47-66 pubmed publisher
  224. Zhang G, Zhang J, Zhu C, Lin L, Wang J, Zhang H, et al. MicroRNA-98 regulates osteogenic differentiation of human bone mesenchymal stromal cells by targeting BMP2. J Cell Mol Med. 2017;21:254-264 pubmed publisher
  225. Ju X, Silveira P, Hsu W, Elgundi Z, Alingcastre R, Verma N, et al. The Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell Population. J Immunol. 2016;197:4613-4625 pubmed
  226. Leibacher J, Dauber K, Ehser S, Brixner V, Kollar K, Vogel A, et al. Human mesenchymal stromal cells undergo apoptosis and fragmentation after intravenous application in immune-competent mice. Cytotherapy. 2017;19:61-74 pubmed publisher
  227. Gouwy M, Ruytinx P, Radice E, Claudi F, Van Raemdonck K, Bonecchi R, et al. CXCL4 and CXCL4L1 Differentially Affect Monocyte Survival and Dendritic Cell Differentiation and Phagocytosis. PLoS ONE. 2016;11:e0166006 pubmed publisher
  228. Geng S, Chen K, Yuan R, Peng L, Maitra U, Diao N, et al. The persistence of low-grade inflammatory monocytes contributes to aggravated atherosclerosis. Nat Commun. 2016;7:13436 pubmed publisher
  229. Soares A, Neves P, Cavalcanti M, Marinho S, Oliveira W, Souza J, et al. Expression of co-stimulatory molecules CD80 and CD86 is altered in CD14 + HLA-DR + monocytes from patients with Chagas disease following induction by Trypanosoma cruzi recombinant antigens. Rev Soc Bras Med Trop. 2016;49:632-636 pubmed publisher
  230. Sumatoh H, Teng K, Cheng Y, Newell E. Optimization of mass cytometry sample cryopreservation after staining. Cytometry A. 2017;91:48-61 pubmed publisher
  231. Cheeseman H, Olejniczak N, Rogers P, Evans A, King D, Ziprin P, et al. Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies. J Virol. 2017;91: pubmed publisher
  232. van Haren S, Dowling D, Foppen W, Christensen D, Andersen P, Reed S, et al. Age-Specific Adjuvant Synergy: Dual TLR7/8 and Mincle Activation of Human Newborn Dendritic Cells Enables Th1 Polarization. J Immunol. 2016;197:4413-4424 pubmed
  233. Serr I, Fürst R, Ott V, Scherm M, Nikolaev A, Gökmen F, et al. miRNA92a targets KLF2 and the phosphatase PTEN signaling to promote human T follicular helper precursors in T1D islet autoimmunity. Proc Natl Acad Sci U S A. 2016;113:E6659-E6668 pubmed
  234. Adair J, Waters T, Haworth K, Kubek S, Trobridge G, Hocum J, et al. Semi-automated closed system manufacturing of lentivirus gene-modified haematopoietic stem cells for gene therapy. Nat Commun. 2016;7:13173 pubmed publisher
  235. Mascarell L, Airouche S, Berjont N, Gary C, Gueguen C, Fourcade G, et al. The regulatory dendritic cell marker C1q is a potent inhibitor of allergic inflammation. Mucosal Immunol. 2017;10:695-704 pubmed publisher
  236. Oon S, Huynh H, Tai T, Ng M, Monaghan K, Biondo M, et al. A cytotoxic anti-IL-3Rα antibody targets key cells and cytokines implicated in systemic lupus erythematosus. JCI Insight. 2016;1:e86131 pubmed publisher
  237. Sadeghi K, Wisgrill L, Wessely I, Diesner S, Schuller S, Dürr C, et al. GM-CSF Down-Regulates TLR Expression via the Transcription Factor PU.1 in Human Monocytes. PLoS ONE. 2016;11:e0162667 pubmed publisher
  238. Yeap W, Wong K, Shimasaki N, Teo E, Quek J, Yong H, et al. CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes. Sci Rep. 2016;6:34310 pubmed publisher
  239. Willemen Y, Van den Bergh J, Bonte S, Anguille S, Heirman C, Stein B, et al. The tumor-associated antigen RHAMM (HMMR/CD168) is expressed by monocyte-derived dendritic cells and presented to T cells. Oncotarget. 2016;7:73960-73970 pubmed publisher
  240. Wang Y, Ma C, Ling Y, Bousfiha A, Camcioglu Y, Jacquot S, et al. Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations. J Exp Med. 2016;213:2413-2435 pubmed
  241. Wahid R, Fresnay S, Levine M, Sztein M. Cross-reactive multifunctional CD4+ T cell responses against Salmonella enterica serovars Typhi, Paratyphi A and Paratyphi B in humans following immunization with live oral typhoid vaccine Ty21a. Clin Immunol. 2016;173:87-95 pubmed publisher
  242. Foerster F, Bamberger D, Schupp J, Weilbächer M, Kaps L, Strobl S, et al. Dextran-based therapeutic nanoparticles for hepatic drug delivery. Nanomedicine (Lond). 2016;11:2663-2677 pubmed
  243. Rai V, Dietz N, Dilisio M, Radwan M, Agrawal D. Vitamin D attenuates inflammation, fatty infiltration, and cartilage loss in the knee of hyperlipidemic microswine. Arthritis Res Ther. 2016;18:203 pubmed publisher
  244. An L, Gorman J, Stephens G, Swerdlow B, Warrener P, Bonnell J, et al. Complement C5a induces PD-L1 expression and acts in synergy with LPS through Erk1/2 and JNK signaling pathways. Sci Rep. 2016;6:33346 pubmed publisher
  245. Kelly A, Robinson M, Roche G, Biron C, O Farrelly C, Ryan E. Immune Cell Profiling of IFN-? Response Shows pDCs Express Highest Level of IFN-?R1 and Are Directly Responsive via the JAK-STAT Pathway. J Interferon Cytokine Res. 2016;36:671-680 pubmed
  246. Fuchs S, Kaiser Labusch P, Bank J, Ammann S, Kolb Kokocinski A, Edelbusch C, et al. Tyrosine kinase 2 is not limiting human antiviral type III interferon responses. Eur J Immunol. 2016;46:2639-2649 pubmed publisher
  247. Kundu R, Theodoraki A, Haas C, Zhang Y, Chain B, Kriston Vizi J, et al. Cell-type-specific modulation of innate immune signalling by vitamin D in human mononuclear phagocytes. Immunology. 2017;150:55-63 pubmed publisher
  248. Pachnio A, Ciáurriz M, Begum J, Lal N, Zuo J, Beggs A, et al. Cytomegalovirus Infection Leads to Development of High Frequencies of Cytotoxic Virus-Specific CD4+ T Cells Targeted to Vascular Endothelium. PLoS Pathog. 2016;12:e1005832 pubmed publisher
  249. Zahran A, Aly S, Altayeb H, Ali A. Circulating endothelial cells and their progenitors in acute myeloid leukemia. Oncol Lett. 2016;12:1965-1970 pubmed
  250. Schmidt A, Kannan P, Chougnet C, Danzer S, Miller L, Jobe A, et al. Intra-amniotic LPS causes acute neuroinflammation in preterm rhesus macaques. J Neuroinflammation. 2016;13:238 pubmed publisher
  251. Lu X, Chen Q, Rong Y, Yang G, Li C, Xu N, et al. LECT2 drives haematopoietic stem cell expansion and mobilization via regulating the macrophages and osteolineage cells. Nat Commun. 2016;7:12719 pubmed publisher
  252. Beatson R, Tajadura Ortega V, Achkova D, Picco G, Tsourouktsoglou T, Klausing S, et al. The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9. Nat Immunol. 2016;17:1273-1281 pubmed publisher
  253. Deng Y, Cheng J, Fu B, Liu W, Chen G, Zhang Q, et al. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells. Oncogene. 2017;36:1090-1101 pubmed publisher
  254. Ilkovitch D, Ferris L. Myeloid-derived suppressor cells are elevated in patients with psoriasis and produce various molecules. Mol Med Rep. 2016;14:3935-40 pubmed publisher
  255. Bentzen A, Marquard A, Lyngaa R, Saini S, Ramskov S, Donia M, et al. Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes. Nat Biotechnol. 2016;34:1037-1045 pubmed publisher
  256. Zhou Q, Yu X, Demirkaya E, Deuitch N, Stone D, Tsai W, et al. Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory disease. Proc Natl Acad Sci U S A. 2016;113:10127-32 pubmed publisher
  257. Huynh L, Kusnadi A, Park S, Murata K, Park Min K, Ivashkiv L. Opposing regulation of the late phase TNF response by mTORC1-IL-10 signaling and hypoxia in human macrophages. Sci Rep. 2016;6:31959 pubmed publisher
  258. Knickelbein J, Liu B, Arakelyan A, Zicari S, Hannes S, Chen P, et al. Modulation of Immune Responses by Extracellular Vesicles From Retinal Pigment Epithelium. Invest Ophthalmol Vis Sci. 2016;57:4101-7 pubmed publisher
  259. Watson D, Bayık D, Srivatsan A, Bergamaschi C, Valentin A, Niu G, et al. Efficient production and enhanced tumor delivery of engineered extracellular vesicles. Biomaterials. 2016;105:195-205 pubmed publisher
  260. Yao Y, Deng Q, Song W, Zhang H, Li Y, Yang Y, et al. MIF Plays a Key Role in Regulating Tissue-Specific Chondro-Osteogenic Differentiation Fate of Human Cartilage Endplate Stem Cells under Hypoxia. Stem Cell Reports. 2016;7:249-62 pubmed publisher
  261. Demers K, Makedonas G, Buggert M, Eller M, Ratcliffe S, Goonetilleke N, et al. Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection. PLoS Pathog. 2016;12:e1005805 pubmed publisher
  262. Cerny D, Thi Le D, The T, Zuest R, Kg S, Velumani S, et al. Complete human CD1a deficiency on Langerhans cells due to a rare point mutation in the coding sequence. J Allergy Clin Immunol. 2016;138:1709-1712.e11 pubmed publisher
  263. Schauer D, Starlinger P, Alidzanovic L, Zajc P, Maier T, Feldman A, et al. Chemotherapy of colorectal liver metastases induces a rapid rise in intermediate blood monocytes which predicts treatment response. Oncoimmunology. 2016;5:e1160185 pubmed publisher
  264. Long J, Basu Roy R, Zhang Y, Antrobus R, Du Y, Smith D, et al. Plasma Membrane Profiling Reveals Upregulation of ABCA1 by Infected Macrophages Leading to Restriction of Mycobacterial Growth. Front Microbiol. 2016;7:1086 pubmed publisher
  265. Jacoby E, Nguyen S, Fountaine T, Welp K, Gryder B, Qin H, et al. CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity. Nat Commun. 2016;7:12320 pubmed publisher
  266. Ashizawa T, Iizuka A, Nonomura C, Kondou R, Maeda C, Miyata H, et al. Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout Mouse. Clin Cancer Res. 2017;23:149-158 pubmed publisher
  267. Neumann L, Mueller M, Moos V, Heller F, Meyer T, Loddenkemper C, et al. Mucosal Inducible NO Synthase-Producing IgA+ Plasma Cells in Helicobacter pylori-Infected Patients. J Immunol. 2016;197:1801-8 pubmed publisher
  268. Sadallah S, Schmied L, Eken C, Charoudeh H, Amicarella F, Schifferli J. Platelet-Derived Ectosomes Reduce NK Cell Function. J Immunol. 2016;197:1663-71 pubmed publisher
  269. Pinilla Vera M, Xiong Z, Zhao Y, Zhao J, Donahoe M, Barge S, et al. Full Spectrum of LPS Activation in Alveolar Macrophages of Healthy Volunteers by Whole Transcriptomic Profiling. PLoS ONE. 2016;11:e0159329 pubmed publisher
  270. Harfuddin Z, Dharmadhikari B, Wong S, Duan K, Poidinger M, Kwajah S, et al. Transcriptional and functional characterization of CD137L-dendritic cells identifies a novel dendritic cell phenotype. Sci Rep. 2016;6:29712 pubmed publisher
  271. Saccomano M, Dullin C, Alves F, Napp J. Preclinical evaluation of near-infrared (NIR) fluorescently labeled cetuximab as a potential tool for fluorescence-guided surgery. Int J Cancer. 2016;139:2277-89 pubmed publisher
  272. Fromentin R, Bakeman W, Lawani M, Khoury G, Hartogensis W, DaFonseca S, et al. CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART. PLoS Pathog. 2016;12:e1005761 pubmed publisher
  273. Bennett A, Williams L, Ferguson M, Hauck M, Suter S, Lanier C, et al. Canine acute leukaemia: 50 cases (1989-2014). Vet Comp Oncol. 2017;15:1101-1114 pubmed publisher
  274. Di Liberto D, Mansueto P, D Alcamo A, Lo Pizzo M, Lo Presti E, Geraci G, et al. Predominance of Type 1 Innate Lymphoid Cells in the Rectal Mucosa of Patients With Non-Celiac Wheat Sensitivity: Reversal After a Wheat-Free Diet. Clin Transl Gastroenterol. 2016;7:e178 pubmed publisher
  275. Piepenbrink M, Samuel M, Zheng B, Carter B, Fucile C, Bunce C, et al. Humoral Dysregulation Associated with Increased Systemic Inflammation among Injection Heroin Users. PLoS ONE. 2016;11:e0158641 pubmed publisher
  276. Stadinski B, Shekhar K, Gomez Tourino I, Jung J, Sasaki K, Sewell A, et al. Hydrophobic CDR3 residues promote the development of self-reactive T cells. Nat Immunol. 2016;17:946-55 pubmed publisher
  277. Ebert L, Tan L, Johan M, Min K, Cockshell M, Parham K, et al. A non-canonical role for desmoglein-2 in endothelial cells: implications for neoangiogenesis. Angiogenesis. 2016;19:463-86 pubmed publisher
  278. Cheng W, van Asten S, Burns L, Evans H, Walter G, Hashim A, et al. Periodontitis-associated pathogens P. gingivalis and A. actinomycetemcomitans activate human CD14(+) monocytes leading to enhanced Th17/IL-17 responses. Eur J Immunol. 2016;46:2211-21 pubmed publisher
  279. Lo T, Silveira P, Fromm P, Verma N, Vu P, Kupresanin F, et al. Characterization of the Expression and Function of the C-Type Lectin Receptor CD302 in Mice and Humans Reveals a Role in Dendritic Cell Migration. J Immunol. 2016;197:885-98 pubmed publisher
  280. Gadd V, Patel P, Jose S, Horsfall L, Powell E, Irvine K. Altered Peripheral Blood Monocyte Phenotype and Function in Chronic Liver Disease: Implications for Hepatic Recruitment and Systemic Inflammation. PLoS ONE. 2016;11:e0157771 pubmed publisher
  281. Chen P, Roh W, Reuben A, Cooper Z, Spencer C, Prieto P, et al. Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade. Cancer Discov. 2016;6:827-37 pubmed publisher
  282. Eichner R, Heider M, Fernández Sáiz V, van Bebber F, Garz A, Lemeer S, et al. Immunomodulatory drugs disrupt the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicity. Nat Med. 2016;22:735-43 pubmed publisher
  283. Saha A, O Connor R, Thangavelu G, Lovitch S, Dandamudi D, Wilson C, et al. Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality. J Clin Invest. 2016;126:2642-60 pubmed publisher
  284. Wonner R, Wallner S, Orso E, Schmitz G. Effects of acute exercise on monocyte subpopulations in metabolic syndrome patients. Cytometry B Clin Cytom. 2018;94:596-605 pubmed publisher
  285. Pinkenburg O, Meyer T, Bannert N, Norley S, Bolte K, Czudai Matwich V, et al. The Human Antimicrobial Protein Bactericidal/Permeability-Increasing Protein (BPI) Inhibits the Infectivity of Influenza A Virus. PLoS ONE. 2016;11:e0156929 pubmed publisher
  286. Zhang G, Liu H, Huang J, Chen S, Pan X, Huang H, et al. TREM-1low is a novel characteristic for tumor-associated macrophages in lung cancer. Oncotarget. 2016;7:40508-40517 pubmed publisher
  287. Vaccari M, Gordon S, Fourati S, Schifanella L, Liyanage N, Cameron M, et al. Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition. Nat Med. 2016;22:762-70 pubmed publisher
  288. Neumann B, Shi T, Gan L, Klippert A, Daskalaki M, Stolte Leeb N, et al. Comprehensive panel of cross-reacting monoclonal antibodies for analysis of different immune cells and their distribution in the common marmoset (Callithrix jacchus). J Med Primatol. 2016;45:139-46 pubmed publisher
  289. Onzi G, Ledur P, Hainzenreder L, Bertoni A, Silva A, Lenz G, et al. Analysis of the safety of mesenchymal stromal cells secretome for glioblastoma treatment. Cytotherapy. 2016;18:828-37 pubmed publisher
  290. Gren S, Janciauskiene S, Sandeep S, Jonigk D, Kvist P, Gerwien J, et al. The protease inhibitor cystatin C down-regulates the release of IL-? and TNF-? in lipopolysaccharide activated monocytes. J Leukoc Biol. 2016;100:811-822 pubmed
  291. Kay A, Strauss Albee D, Blish C. Application of Mass Cytometry (CyTOF) for Functional and Phenotypic Analysis of Natural Killer Cells. Methods Mol Biol. 2016;1441:13-26 pubmed publisher
  292. Hollmen M, Karaman S, Schwager S, Lisibach A, Christiansen A, Maksimow M, et al. G-CSF regulates macrophage phenotype and associates with poor overall survival in human triple-negative breast cancer. Oncoimmunology. 2016;5:e1115177 pubmed
  293. Cook A, McDonnell A, Lake R, Nowak A. Dexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies. Oncoimmunology. 2016;5:e1066062 pubmed
  294. Silva S, Levy D, Ruiz J, de Melo T, Isaac C, Fidelis M, et al. Oxysterols in adipose tissue-derived mesenchymal stem cell proliferation and death. J Steroid Biochem Mol Biol. 2017;169:164-175 pubmed publisher
  295. Wu Y, Lan C, Ren D, Chen G. Induction of Siglec-1 by Endotoxin Tolerance Suppresses the Innate Immune Response by Promoting TGF-?1 Production. J Biol Chem. 2016;291:12370-82 pubmed publisher
  296. Rentas S, Holzapfel N, Belew M, Pratt G, Voisin V, Wilhelm B, et al. Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells. Nature. 2016;532:508-511 pubmed publisher
  297. Bal S, Bernink J, Nagasawa M, Groot J, Shikhagaie M, Golebski K, et al. IL-1?, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs. Nat Immunol. 2016;17:636-45 pubmed publisher
  298. Najera J, Bustamante E, Bortell N, Morsey B, Fox H, Ravasi T, et al. Methamphetamine abuse affects gene expression in brain-derived microglia of SIV-infected macaques to enhance inflammation and promote virus targets. BMC Immunol. 2016;17:7 pubmed publisher
  299. Graves S, Kouriba B, Diarra I, Daou M, Niangaly A, Coulibaly D, et al. Strain-specific Plasmodium falciparum multifunctional CD4(+) T cell cytokine expression in Malian children immunized with the FMP2.1/AS02A vaccine candidate. Vaccine. 2016;34:2546-55 pubmed publisher
  300. Malkiel S, Jeganathan V, Wolfson S, Manjarrez Orduno N, Marasco E, Aranow C, et al. Checkpoints for Autoreactive B Cells in the Peripheral Blood of Lupus Patients Assessed by Flow Cytometry. Arthritis Rheumatol. 2016;68:2210-20 pubmed publisher
  301. Del Bel Belluz L, Guidi R, Pateras I, Levi L, Mihaljevic B, Rouf S, et al. The Typhoid Toxin Promotes Host Survival and the Establishment of a Persistent Asymptomatic Infection. PLoS Pathog. 2016;12:e1005528 pubmed publisher
  302. Seifert L, Werba G, Tiwari S, Giao Ly N, Alothman S, Alqunaibit D, et al. The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression. Nature. 2016;532:245-9 pubmed publisher
  303. Yadav A, Betts M, Collman R. Statin modulation of monocyte phenotype and function: implications for HIV-1-associated neurocognitive disorders. J Neurovirol. 2016;22:584-596 pubmed
  304. Slebioda T, Bojarska Junak A, Cyman M, Landowski P, Kaminska B, Celinski K, et al. Expression of death receptor 3 on peripheral blood mononuclear cells differes in adult IBD patients and children with newly diagnosed IBD. Cytometry B Clin Cytom. 2017;92:165-169 pubmed publisher
  305. Jensen K, Gallagher I, Kaliszewska A, Zhang C, Abejide O, Gallagher M, et al. Live and inactivated Salmonella enterica serovar Typhimurium stimulate similar but distinct transcriptome profiles in bovine macrophages and dendritic cells. Vet Res. 2016;47:46 pubmed publisher
  306. Leone D, Kozakowski N, Kornauth C, Waidacher T, Neudert B, Loeffler A, et al. The Phenotypic Characterization of the Human Renal Mononuclear Phagocytes Reveal a Co-Ordinated Response to Injury. PLoS ONE. 2016;11:e0151674 pubmed publisher
  307. Chan Y, Gack M. A phosphomimetic-based mechanism of dengue virus to antagonize innate immunity. Nat Immunol. 2016;17:523-30 pubmed publisher
  308. Moreira M, Costa Pereira C, Alves M, Marteleto B, Ribeiro V, Peruhype Magalhães V, et al. Vaccination against canine leishmaniosis increases the phagocytic activity, nitric oxide production and expression of cell activation/migration molecules in neutrophils and monocytes. Vet Parasitol. 2016;220:33-45 pubmed publisher
  309. Lin R, Zhang J, Zhou L, Wang B. Altered function of monocytes/macrophages in patients with autoimmune hepatitis. Mol Med Rep. 2016;13:3874-80 pubmed publisher
  310. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  311. Gao J, Duan Z, Zhang L, Huang X, Long L, Tu J, et al. Failure recovery of circulating NKG2D+CD56dimNK cells in HBV-associated hepatocellular carcinoma after hepatectomy predicts early recurrence. Oncoimmunology. 2016;5:e1048061 pubmed
  312. Mosquera Restrepo S, Caro A, Peláez Jaramillo C, Rojas M. Mononuclear phagocyte accumulates a stearic acid derivative during differentiation into macrophages. Effects of stearic acid on macrophage differentiation and Mycobacterium tuberculosis control. Cell Immunol. 2016;303:24-33 pubmed publisher
  313. Zwolak A, Słabczyńska O, Semeniuk J, Daniluk J, Szuster Ciesielska A. Metformin Changes the Relationship between Blood Monocyte Toll-Like Receptor 4 Levels and Nonalcoholic Fatty Liver Disease-Ex Vivo Studies. PLoS ONE. 2016;11:e0150233 pubmed publisher
  314. Zondler L, Müller K, Khalaji S, Bliederhäuser C, Ruf W, Grozdanov V, et al. Peripheral monocytes are functionally altered and invade the CNS in ALS patients. Acta Neuropathol. 2016;132:391-411 pubmed publisher
  315. Hogan L, Jones D, Allen R. Expression of the innate immune receptor LILRB5 on monocytes is associated with mycobacteria exposure. Sci Rep. 2016;6:21780 pubmed publisher
  316. Offersen R, Nissen S, Rasmussen T, Østergaard L, Denton P, Søgaard O, et al. A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells. J Virol. 2016;90:4441-4453 pubmed publisher
  317. Coughlan A, Harmon C, Whelan S, O Brien E, O Reilly V, Crotty P, et al. Myeloid Engraftment in Humanized Mice: Impact of Granulocyte-Colony Stimulating Factor Treatment and Transgenic Mouse Strain. Stem Cells Dev. 2016;25:530-41 pubmed publisher
  318. Hülsmann J, Aubin H, Wehrmann A, Jenke A, Lichtenberg A, Akhyari P. Whole-Heart Construct Cultivation Under 3D Mechanical Stimulation of the Left Ventricle. Methods Mol Biol. 2016;1502:181-94 pubmed publisher
  319. Chang C, Hale S, Cox C, Blair A, Kronsteiner B, Grabowska R, et al. Junctional Adhesion Molecule-A Is Highly Expressed on Human Hematopoietic Repopulating Cells and Associates with the Key Hematopoietic Chemokine Receptor CXCR4. Stem Cells. 2016;34:1664-78 pubmed publisher
  320. Ludigs K, Jandus C, Utzschneider D, Staehli F, Bessoles S, Dang A, et al. NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions. Nat Commun. 2016;7:10554 pubmed publisher
  321. Jean Charles P, Zhang L, Wu J, Han S, Brian L, Freedman N, et al. Ubiquitin-specific Protease 20 Regulates the Reciprocal Functions of β-Arrestin2 in Toll-like Receptor 4-promoted Nuclear Factor κB (NFκB) Activation. J Biol Chem. 2016;291:7450-64 pubmed publisher
  322. Roan F, Stoklasek T, Whalen E, Molitor J, Bluestone J, Buckner J, et al. CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis. J Immunol. 2016;196:2051-2062 pubmed publisher
  323. Leite F, Lima M, Marino F, Cosentino M, Ribeiro L. Dopaminergic Receptors and Tyrosine Hydroxylase Expression in Peripheral Blood Mononuclear Cells: A Distinct Pattern in Central Obesity. PLoS ONE. 2016;11:e0147483 pubmed publisher
  324. Mewhort H, Lipon B, Svystonyuk D, Teng G, Guzzardi D, Silva C, et al. Monocytes increase human cardiac myofibroblast-mediated extracellular matrix remodeling through TGF-β1. Am J Physiol Heart Circ Physiol. 2016;310:H716-24 pubmed publisher
  325. Dang M, Bradford C, Pozzilli P, Leslie R. Methylation Analysis in Distinct Immune Cell Subsets in Type 1 Diabetes. Methods Mol Biol. 2016;1433:143-51 pubmed publisher
  326. Wei W, Liu C, Qin D, Song L, Xia L, Lei H, et al. Targeting peroxiredoxin I potentiates 1,25-dihydroxyvitamin D3-induced cell differentiation in leukemia cells. Mol Med Rep. 2016;13:2201-7 pubmed publisher
  327. Catarinella M, Monestiroli A, Escobar G, Fiocchi A, Tran N, Aiolfi R, et al. IFNα gene/cell therapy curbs colorectal cancer colonization of the liver by acting on the hepatic microenvironment. EMBO Mol Med. 2016;8:155-70 pubmed publisher
  328. Colonna L, Parry G, Panicker S, Elkon K. Uncoupling complement C1s activation from C1q binding in apoptotic cell phagocytosis and immunosuppressive capacity. Clin Immunol. 2016;163:84-90 pubmed publisher
  329. Wang X, Dai Z, Wu X, Wang K, Wang X. Distinct RNA transcriptome patterns are potentially associated with angiogenesis in Tie2-expressing monocytes. Gene. 2016;580:1-7 pubmed publisher
  330. Waschbisch A, Schröder S, Schraudner D, Sammet L, Weksler B, Melms A, et al. Pivotal Role for CD16+ Monocytes in Immune Surveillance of the Central Nervous System. J Immunol. 2016;196:1558-67 pubmed publisher
  331. Soh K, Tario J, Colligan S, Maguire O, Pan D, Minderman H, et al. Simultaneous, Single-Cell Measurement of Messenger RNA, Cell Surface Proteins, and Intracellular Proteins. Curr Protoc Cytom. 2016;75:7.45.1-7.45.33 pubmed publisher
  332. Younis R, Han K, Webb T. Human Head and Neck Squamous Cell Carcinoma-Associated Semaphorin 4D Induces Expansion of Myeloid-Derived Suppressor Cells. J Immunol. 2016;196:1419-29 pubmed publisher
  333. Heo J, Choi Y, Kim H, Kim H. Comparison of molecular profiles of human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue. Int J Mol Med. 2016;37:115-25 pubmed publisher
  334. Hamada D, Maynard R, Schott E, Drinkwater C, Ketz J, Kates S, et al. Suppressive Effects of Insulin on Tumor Necrosis Factor-Dependent Early Osteoarthritic Changes Associated With Obesity and Type 2 Diabetes Mellitus. Arthritis Rheumatol. 2016;68:1392-402 pubmed publisher
  335. Romani B, Baygloo N, Hamidi Fard M, Aghasadeghi M, Allahbakhshi E. HIV-1 Vpr Protein Induces Proteasomal Degradation of Chromatin-associated Class I HDACs to Overcome Latent Infection of Macrophages. J Biol Chem. 2016;291:2696-711 pubmed publisher
  336. Westman J, Papareddy P, Dahlgren M, Chakrakodi B, Norrby Teglund A, Smeds E, et al. Extracellular Histones Induce Chemokine Production in Whole Blood Ex Vivo and Leukocyte Recruitment In Vivo. PLoS Pathog. 2015;11:e1005319 pubmed publisher
  337. Zwolak A, Szuster Ciesielska A, Daniluk J, Słabczyńska O, Kandefer Szerszeń M. Hyperreactivity of Blood Leukocytes in Patients with NAFLD to Ex Vivo Lipopolysaccharide Treatment Is Modulated by Metformin and Phosphatidylcholine but Not by Alpha Ketoglutarate. PLoS ONE. 2015;10:e0143851 pubmed publisher
  338. He Y, Wang C, Yu Y, Qian J, Song K, Sun Q, et al. Tie2-Expressing Monocytes Are Associated with Identification and Prognoses of Hepatitis B Virus Related Hepatocellular Carcinoma after Resection. PLoS ONE. 2015;10:e0143657 pubmed publisher
  339. Leong M, Newell E. Multiplexed Peptide-MHC Tetramer Staining with Mass Cytometry. Methods Mol Biol. 2015;1346:115-31 pubmed publisher
  340. Notta F, Zandi S, Takayama N, Dobson S, Gan O, Wilson G, et al. Distinct routes of lineage development reshape the human blood hierarchy across ontogeny. Science. 2016;351:aab2116 pubmed publisher
  341. Vierboom M, Breedveld E, Kap Y, Mary C, Poirier N, t Hart B, et al. Clinical efficacy of a new CD28-targeting antagonist of T cell co-stimulation in a non-human primate model of collagen-induced arthritis. Clin Exp Immunol. 2016;183:405-18 pubmed publisher
  342. Viganò E, Diamond C, Spreafico R, Balachander A, Sobota R, Mortellaro A. Human caspase-4 and caspase-5 regulate the one-step non-canonical inflammasome activation in monocytes. Nat Commun. 2015;6:8761 pubmed publisher
  343. Venkatasubramanian S, Tripathi D, Tucker T, Paidipally P, Cheekatla S, Welch E, et al. Tissue factor expression by myeloid cells contributes to protective immune response against Mycobacterium tuberculosis infection. Eur J Immunol. 2016;46:464-79 pubmed publisher
  344. Byrareddy S, Little D, Mayne A, Villinger F, Ansari A. Phenotypic and Functional Characterization of Monoclonal Antibodies with Specificity for Rhesus Macaque CD200, CD200R and Mincle. PLoS ONE. 2015;10:e0140689 pubmed publisher
  345. Schulz A, Mälzer J, Domingo C, Jürchott K, Grützkau A, Babel N, et al. Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans. J Immunol. 2015;195:4699-711 pubmed publisher
  346. Sakthivel P, Grunewald J, Eklund A, Bruder D, Wahlström J. Pulmonary sarcoidosis is associated with high-level inducible co-stimulator (ICOS) expression on lung regulatory T cells--possible implications for the ICOS/ICOS-ligand axis in disease course and resolution. Clin Exp Immunol. 2016;183:294-306 pubmed publisher
  347. Gonzalez N, Wennhold K, Balkow S, Kondo E, Bölck B, Weber T, et al. In vitro and in vivo imaging of initial B-T-cell interactions in the setting of B-cell based cancer immunotherapy. Oncoimmunology. 2015;4:e1038684 pubmed
  348. Agu C, Soares F, Alderton A, Patel M, Ansari R, Patel S, et al. Successful Generation of Human Induced Pluripotent Stem Cell Lines from Blood Samples Held at Room Temperature for up to 48 hr. Stem Cell Reports. 2015;5:660-71 pubmed publisher
  349. Bego M, Côté Ã, Cohen Ã. Assessing the Innate Sensing of HIV-1 Infected CD4+ T Cells by Plasmacytoid Dendritic Cells Using an Ex vivo Co-culture System. J Vis Exp. 2015;: pubmed publisher
  350. Denkovskij J, Rudys R, Bernotiene E, Minderis M, Bagdonas S, Kirdaite G. Cell surface markers and exogenously induced PpIX in synovial mesenchymal stem cells. Cytometry A. 2015;87:1001-11 pubmed publisher
  351. Gómez M, Qin Q, Biancardi M, Galiguis J, Dumas C, MacLean R, et al. Characterization and Multilineage Differentiation of Domestic and Black-Footed Cat Mesenchymal Stromal/Stem Cells from Abdominal and Subcutaneous Adipose Tissue. Cell Reprogram. 2015;17:376-92 pubmed publisher
  352. Djurisic S, Skibsted L, Hviid T. A Phenotypic Analysis of Regulatory T Cells and Uterine NK Cells from First Trimester Pregnancies and Associations with HLA-G. Am J Reprod Immunol. 2015;74:427-44 pubmed publisher
  353. Kang R, Zhou Y, Tan S, Zhou G, Aagaard L, Xie L, et al. Mesenchymal stem cells derived from human induced pluripotent stem cells retain adequate osteogenicity and chondrogenicity but less adipogenicity. Stem Cell Res Ther. 2015;6:144 pubmed publisher
  354. Granja T, Schad J, Schüssel P, Fischer C, Häberle H, Rosenberger P, et al. Using six-colour flow cytometry to analyse the activation and interaction of platelets and leukocytes--A new assay suitable for bench and bedside conditions. Thromb Res. 2015;136:786-96 pubmed publisher
  355. Saliba J, Saint Martin C, Di Stefano A, Lenglet G, Marty C, Keren B, et al. Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies. Nat Genet. 2015;47:1131-40 pubmed publisher
  356. Eichin D, Laurila J, Jalkanen S, Salmi M. CD73 Activity is Dispensable for the Polarization of M2 Macrophages. PLoS ONE. 2015;10:e0134721 pubmed publisher
  357. Liu J, Brzeszczynska J, Samuel K, Black J, Palakkan A, Anderson R, et al. Efficient episomal reprogramming of blood mononuclear cells and differentiation to hepatocytes with functional drug metabolism. Exp Cell Res. 2015;338:203-13 pubmed publisher
  358. Genin M, Clement F, Fattaccioli A, Raes M, Michiels C. M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide. BMC Cancer. 2015;15:577 pubmed publisher
  359. Evans T, Li H, Schafer J, Klatt N, Hao X, Traslavina R, et al. SIV-induced Translocation of Bacterial Products in the Liver Mobilizes Myeloid Dendritic and Natural Killer Cells Associated With Liver Damage. J Infect Dis. 2016;213:361-9 pubmed publisher
  360. Yoon K, Byun S, Kwon E, Hwang S, Chu K, Hiraki M, et al. Control of signaling-mediated clearance of apoptotic cells by the tumor suppressor p53. Science. 2015;349:1261669 pubmed publisher
  361. Landa Solís C, Granados Montiel J, Olivos Meza A, Ortega Sánchez C, Cruz Lemini M, Hernández Flores C, et al. Cryopreserved CD90+ cells obtained from mobilized peripheral blood in sheep: a new source of mesenchymal stem cells for preclinical applications. Cell Tissue Bank. 2016;17:137-45 pubmed publisher
  362. Wostradowski T, Gudi V, Pul R, Gingele S, Lindquist J, Stangel M, et al. Effect of interferon-β1b on CXCR4-dependent chemotaxis in T cells from multiple sclerosis patients. Clin Exp Immunol. 2015;182:162-72 pubmed publisher
  363. Riou C, Tanko R, Soares A, Masson L, Werner L, Garrett N, et al. Restoration of CD4+ Responses to Copathogens in HIV-Infected Individuals on Antiretroviral Therapy Is Dependent on T Cell Memory Phenotype. J Immunol. 2015;195:2273-2281 pubmed publisher
  364. Ducret M, Fabre H, Farges J, Degoul O, Atzeni G, McGuckin C, et al. Production of Human Dental Pulp Cells with a Medicinal Manufacturing Approach. J Endod. 2015;41:1492-9 pubmed publisher
  365. Moslem M, Eberle I, Weber I, Henschler R, Cantz T. Mesenchymal Stem/Stromal Cells Derived from Induced Pluripotent Stem Cells Support CD34(pos) Hematopoietic Stem Cell Propagation and Suppress Inflammatory Reaction. Stem Cells Int. 2015;2015:843058 pubmed publisher
  366. Ripperger T, Manukjan G, Meyer J, Wolter S, Schambach A, Bohne J, et al. The heteromeric transcription factor GABP activates the ITGAM/CD11b promoter and induces myeloid differentiation. Biochim Biophys Acta. 2015;1849:1145-54 pubmed publisher
  367. Jobin C, Cloutier M, Simard C, Néron S. Heterogeneity of in vitro-cultured CD34+ cells isolated from peripheral blood. Cytotherapy. 2015;17:1472-84 pubmed publisher
  368. Amos J, Himes J, Armand L, Gurley T, Martinez D, Colvin L, et al. Rapid Development of gp120-Focused Neutralizing B Cell Responses during Acute Simian Immunodeficiency Virus Infection of African Green Monkeys. J Virol. 2015;89:9485-98 pubmed publisher
  369. O Brien E, Abdulahad W, Rutgers A, Huitema M, O Reilly V, Coughlan A, et al. Intermediate monocytes in ANCA vasculitis: increased surface expression of ANCA autoantigens and IL-1β secretion in response to anti-MPO antibodies. Sci Rep. 2015;5:11888 pubmed publisher
  370. Perriard G, Mathias A, Enz L, Canales M, Schluep M, Gentner M, et al. Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes. J Neuroinflammation. 2015;12:119 pubmed publisher
  371. Tasev D, van Wijhe M, Weijers E, van Hinsbergh V, Koolwijk P. Long-Term Expansion in Platelet Lysate Increases Growth of Peripheral Blood-Derived Endothelial-Colony Forming Cells and Their Growth Factor-Induced Sprouting Capacity. PLoS ONE. 2015;10:e0129935 pubmed publisher
  372. Lee J, Breton G, Aljoufi A, Zhou Y, PUHR S, Nussenzweig M, et al. Clonal analysis of human dendritic cell progenitor using a stromal cell culture. J Immunol Methods. 2015;425:21-6 pubmed publisher
  373. Grieco A, Billett H, Green N, Driscoll M, Bouhassira E. Variation in Gamma-Globin Expression before and after Induction with Hydroxyurea Associated with BCL11A, KLF1 and TAL1. PLoS ONE. 2015;10:e0129431 pubmed publisher
  374. Wang H, Sharma L, Lu J, Finch P, Fletcher S, Prochownik E. Structurally diverse c-Myc inhibitors share a common mechanism of action involving ATP depletion. Oncotarget. 2015;6:15857-70 pubmed
  375. Kerkman P, Fabre E, van der Voort E, Zaldumbide A, Rombouts Y, Rispens T, et al. Identification and characterisation of citrullinated antigen-specific B cells in peripheral blood of patients with rheumatoid arthritis. Ann Rheum Dis. 2016;75:1170-6 pubmed publisher
  376. Kim S, Theunissen J, Balibalos J, Liao Chan S, Babcock M, Wong T, et al. A novel antibody-drug conjugate targeting SAIL for the treatment of hematologic malignancies. Blood Cancer J. 2015;5:e316 pubmed publisher
  377. Boisson B, Laplantine E, Dobbs K, Cobat A, Tarantino N, Hazen M, et al. Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia. J Exp Med. 2015;212:939-51 pubmed publisher
  378. Tipton C, Fucile C, DARCE J, Chida A, Ichikawa T, Gregoretti I, et al. Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus. Nat Immunol. 2015;16:755-65 pubmed publisher
  379. McArthur M, Fresnay S, Magder L, Darton T, Jones C, Waddington C, et al. Activation of Salmonella Typhi-specific regulatory T cells in typhoid disease in a wild-type S. Typhi challenge model. PLoS Pathog. 2015;11:e1004914 pubmed publisher
  380. Xue J, Sharma V, Hsieh M, Chawla A, Murali R, Pandol S, et al. Alternatively activated macrophages promote pancreatic fibrosis in chronic pancreatitis. Nat Commun. 2015;6:7158 pubmed publisher
  381. Wang Z, Wan Y, Qiu C, Quiñones Parra S, Zhu Z, Loh L, et al. Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8⁺ T cells. Nat Commun. 2015;6:6833 pubmed publisher
  382. Lee J, Park J, Kim T, Jung B, Lee Y, Shim E, et al. Human bone marrow stem cells cultured under hypoxic conditions present altered characteristics and enhanced in vivo tissue regeneration. Bone. 2015;78:34-45 pubmed publisher
  383. Boer M, Prins C, van Meijgaarden K, van Dissel J, Ottenhoff T, Joosten S. Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults. Clin Vaccine Immunol. 2015;22:778-88 pubmed publisher
  384. Kinder M, Greenplate A, Strohl W, Jordan R, Brezski R. An Fc engineering approach that modulates antibody-dependent cytokine release without altering cell-killing functions. MAbs. 2015;7:494-504 pubmed publisher
  385. Berent Maoz B, Montecino Rodriguez E, Fice M, Casero D, Seet C, Crooks G, et al. The expansion of thymopoiesis in neonatal mice is dependent on expression of high mobility group a 2 protein (Hmga2). PLoS ONE. 2015;10:e0125414 pubmed publisher
  386. Deng N, Mosmann T. Optimization of the cytokine secretion assay for human IL-2 in single and combination assays. Cytometry A. 2015;87:777-83 pubmed publisher
  387. Anandasabapathy N, Breton G, Hurley A, Caskey M, Trumpfheller C, Sarma P, et al. Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteers. Bone Marrow Transplant. 2015;50:924-30 pubmed publisher
  388. Fromm J, Tagliente D, Shaver A, Neppalli V, Craig F. Case study interpretation: Report from the ICCS Annual Meeting, Seattle, 2014. Cytometry B Clin Cytom. 2015;88:413-24 pubmed publisher
  389. Dyring Andersen B, Bonefeld C, Bzorek M, Løvendorf M, Lauritsen J, Skov L, et al. The Vitamin D Analogue Calcipotriol Reduces the Frequency of CD8+ IL-17+ T Cells in Psoriasis Lesions. Scand J Immunol. 2015;82:84-91 pubmed publisher
  390. Mahmood Z, Muhammad K, Schmalzing M, Roll P, Dörner T, Tony H. CD27-IgD- memory B cells are modulated by in vivo interleukin-6 receptor (IL-6R) blockade in rheumatoid arthritis. Arthritis Res Ther. 2015;17:61 pubmed publisher
  391. Donis Maturano L, Sánchez Torres L, Cerbulo Vázquez A, Chacón Salinas R, García Romo G, Orozco Uribe M, et al. Prolonged exposure to neutrophil extracellular traps can induce mitochondrial damage in macrophages and dendritic cells. Springerplus. 2015;4:161 pubmed publisher
  392. Metcalf Pate K, Pohlmeyer C, Walker Sperling V, Foote J, Najarro K, Cryer C, et al. A Murine Viral Outgrowth Assay to Detect Residual HIV Type 1 in Patients With Undetectable Viral Loads. J Infect Dis. 2015;212:1387-96 pubmed publisher
  393. Pombo C, Wherry E, Gostick E, Price D, Betts M. Elevated Expression of CD160 and 2B4 Defines a Cytolytic HIV-Specific CD8+ T-Cell Population in Elite Controllers. J Infect Dis. 2015;212:1376-86 pubmed publisher
  394. Hjuler Nielsen M, Irvine H, Vedel S, Raungaard B, Beck Nielsen H, Handberg A. Elevated atherosclerosis-related gene expression, monocyte activation and microparticle-release are related to increased lipoprotein-associated oxidative stress in familial hypercholesterolemia. PLoS ONE. 2015;10:e0121516 pubmed publisher
  395. Inglis H, Danesh A, Shah A, Lacroix J, Spinella P, Norris P. Techniques to improve detection and analysis of extracellular vesicles using flow cytometry. Cytometry A. 2015;87:1052-63 pubmed publisher
  396. Cheah M, Chen J, Sahoo D, Contreras Trujillo H, Volkmer A, Scheeren F, et al. CD14-expressing cancer cells establish the inflammatory and proliferative tumor microenvironment in bladder cancer. Proc Natl Acad Sci U S A. 2015;112:4725-30 pubmed publisher
  397. Cang D, Guo K, Zhao F. Dendritic cells enhance UHMWPE wear particle-induced osteoclast differentiation of macrophages. J Biomed Mater Res A. 2015;103:3349-54 pubmed publisher
  398. Hong M, Sandalova E, Low D, Gehring A, Fieni S, Amadei B, et al. Trained immunity in newborn infants of HBV-infected mothers. Nat Commun. 2015;6:6588 pubmed publisher
  399. Kaifi J, Kunkel M, Das A, Harouaka R, Dicker D, Li G, et al. Circulating tumor cell isolation during resection of colorectal cancer lung and liver metastases: a prospective trial with different detection techniques. Cancer Biol Ther. 2015;16:699-708 pubmed publisher
  400. Misra R, Shah S, Fowell D, Wang H, Scheible K, Misra S, et al. Preterm cord blood CD4⁺ T cells exhibit increased IL-6 production in chorioamnionitis and decreased CD4⁺ T cells in bronchopulmonary dysplasia. Hum Immunol. 2015;76:329-338 pubmed publisher
  401. Ohnuma K, Hatano R, Aune T, Otsuka H, Iwata S, Dang N, et al. Regulation of pulmonary graft-versus-host disease by IL-26+CD26+CD4 T lymphocytes. J Immunol. 2015;194:3697-712 pubmed publisher
  402. Nambiar J, Clarke A, Shim D, Mabon D, Tian C, Windloch K, et al. Potent neutralizing anti-CD1d antibody reduces lung cytokine release in primate asthma model. MAbs. 2015;7:638-50 pubmed publisher
  403. Weldon A, Moldovan I, Cabling M, Hernandez E, Hsu S, Gonzalez J, et al. Surface APRIL Is Elevated on Myeloid Cells and Is Associated with Disease Activity in Patients with Rheumatoid Arthritis. J Rheumatol. 2015;42:749-59 pubmed publisher
  404. Boutard B, Vankerckhove S, Markine Goriaynoff N, Sarlet M, Desmecht D, McFadden G, et al. The α2,3-sialyltransferase encoded by myxoma virus is a virulence factor that contributes to immunosuppression. PLoS ONE. 2015;10:e0118806 pubmed publisher
  405. Marquardt N, Béziat V, Nyström S, Hengst J, Ivarsson M, Kekäläinen E, et al. Cutting edge: identification and characterization of human intrahepatic CD49a+ NK cells. J Immunol. 2015;194:2467-71 pubmed publisher
  406. Boyle M, Jagannathan P, Bowen K, McIntyre T, Vance H, Farrington L, et al. Effector Phenotype of Plasmodium falciparum-Specific CD4+ T Cells Is Influenced by Both Age and Transmission Intensity in Naturally Exposed Populations. J Infect Dis. 2015;212:416-25 pubmed publisher
  407. Johnson P, Challis R, Chowdhury F, Gao Y, Harvey M, Geldart T, et al. Clinical and biological effects of an agonist anti-CD40 antibody: a Cancer Research UK phase I study. Clin Cancer Res. 2015;21:1321-8 pubmed publisher
  408. Lee Y, Lim K, Oh J, Yoon A, Joo W, Kim H, et al. Development of porous PLGA/PEI1.8k biodegradable microspheres for the delivery of mesenchymal stem cells (MSCs). J Control Release. 2015;205:128-33 pubmed publisher
  409. Afshar M, Richards S, Mann D, Cross A, Smith G, Netzer G, et al. Acute immunomodulatory effects of binge alcohol ingestion. Alcohol. 2015;49:57-64 pubmed publisher
  410. Bettman N, Avivi I, Rosenbaum H, Bisharat L, Katz T. Impaired migration capacity in monocytes derived from patients with Gaucher disease. Blood Cells Mol Dis. 2015;55:180-6 pubmed publisher
  411. Watson M, Hedley D. Whole blood measurement of histone modifications linked to the epigenetic regulation of gene expression. Curr Protoc Cytom. 2015;71:6.36.1-9 pubmed publisher
  412. Kim H, Huang L, Critser P, Yang Z, Chan R, Wang L, et al. Notch ligand Delta-like 1 promotes in vivo vasculogenesis in human cord blood-derived endothelial colony forming cells. Cytotherapy. 2015;17:579-92 pubmed publisher
  413. Bacchetta J, Chun R, Gales B, Zaritsky J, Leroy S, Wesseling Perry K, et al. Antibacterial responses by peritoneal macrophages are enhanced following vitamin D supplementation. PLoS ONE. 2014;9:e116530 pubmed publisher
  414. Ito S, Barrett A, Dutra A, Pak E, Miner S, Keyvanfar K, et al. Long term maintenance of myeloid leukemic stem cells cultured with unrelated human mesenchymal stromal cells. Stem Cell Res. 2015;14:95-104 pubmed publisher
  415. Tsiantoulas D, Perkmann T, Afonyushkin T, Mangold A, Prohaska T, Papac Milicevic N, et al. Circulating microparticles carry oxidation-specific epitopes and are recognized by natural IgM antibodies. J Lipid Res. 2015;56:440-8 pubmed publisher
  416. Bigley V, McGovern N, Milne P, Dickinson R, Pagan S, Cookson S, et al. Langerin-expressing dendritic cells in human tissues are related to CD1c+ dendritic cells and distinct from Langerhans cells and CD141high XCR1+ dendritic cells. J Leukoc Biol. 2015;97:627-34 pubmed publisher
  417. Nemes E, Kagina B, Smit E, Africa H, Steyn M, Hanekom W, et al. Differential leukocyte counting and immunophenotyping in cryopreserved ex vivo whole blood. Cytometry A. 2015;87:157-65 pubmed publisher
  418. Hagberg N, Theorell J, Hjorton K, Spee P, Eloranta M, Bryceson Y, et al. Functional anti-CD94/NKG2A and anti-CD94/NKG2C autoantibodies in patients with systemic lupus erythematosus. Arthritis Rheumatol. 2015;67:1000-11 pubmed publisher
  419. Heninger A, Wentrup S, Al Saeedi M, Schiessling S, Giese T, Wartha F, et al. Immunomodulation of human intestinal T cells by the synthetic CD80 antagonist RhuDex®. Immun Inflamm Dis. 2014;2:166-80 pubmed publisher
  420. Campbell J, Ratai E, Autissier P, Nolan D, Tse S, Miller A, et al. Anti-?4 antibody treatment blocks virus traffic to the brain and gut early, and stabilizes CNS injury late in infection. PLoS Pathog. 2014;10:e1004533 pubmed publisher
  421. Powell J, Hess B, Hutchison J, Straub T. Construction of an in vitro primary lung co-culture platform derived from New Zealand white rabbits. In Vitro Cell Dev Biol Anim. 2015;51:433-40 pubmed publisher
  422. Li H, Evans T, Gillis J, Connole M, Reeves R. Bone marrow-imprinted gut-homing of plasmacytoid dendritic cells (pDCs) in acute simian immunodeficiency virus infection results in massive accumulation of hyperfunctional CD4+ pDCs in the mucosae. J Infect Dis. 2015;211:1717-25 pubmed publisher
  423. Weihrauch M, Richly H, von Bergwelt Baildon M, Becker H, Schmidt M, Hacker U, et al. Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours. Eur J Cancer. 2015;51:146-56 pubmed publisher
  424. Vadasz S, JENSEN T, Moncada C, Girard E, Zhang F, Blanchette A, et al. Second and third trimester amniotic fluid mesenchymal stem cells can repopulate a de-cellularized lung scaffold and express lung markers. J Pediatr Surg. 2014;49:1554-63 pubmed publisher
  425. Van Eyck L, Hershfield M, Pombal D, Kelly S, Ganson N, Moens L, et al. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency. J Allergy Clin Immunol. 2015;135:283-7.e5 pubmed publisher
  426. Meinke P, Schneiderat P, Srsen V, Korfali N, Lê Thành P, Cowan G, et al. Abnormal proliferation and spontaneous differentiation of myoblasts from a symptomatic female carrier of X-linked Emery-Dreifuss muscular dystrophy. Neuromuscul Disord. 2015;25:127-36 pubmed publisher
  427. Tungatt K, Bianchi V, Crowther M, Powell W, Schauenburg A, Trimby A, et al. Antibody stabilization of peptide-MHC multimers reveals functional T cells bearing extremely low-affinity TCRs. J Immunol. 2015;194:463-74 pubmed publisher
  428. Williams D, Anastos K, Morgello S, Berman J. JAM-A and ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV-infected individuals. J Leukoc Biol. 2015;97:401-12 pubmed publisher
  429. Chow I, Yang J, Gates T, James E, Mai D, Greenbaum C, et al. Assessment of CD4+ T cell responses to glutamic acid decarboxylase 65 using DQ8 tetramers reveals a pathogenic role of GAD65 121-140 and GAD65 250-266 in T1D development. PLoS ONE. 2014;9:e112882 pubmed publisher
  430. Vogelpoel L, Hansen I, Rispens T, Muller F, van Capel T, Turina M, et al. Fc gamma receptor-TLR cross-talk elicits pro-inflammatory cytokine production by human M2 macrophages. Nat Commun. 2014;5:5444 pubmed publisher
  431. Hoffmann J, Shmeleva E, Boag S, Fiser K, Bagnall A, Murali S, et al. Myocardial ischemia and reperfusion leads to transient CD8 immune deficiency and accelerated immunosenescence in CMV-seropositive patients. Circ Res. 2015;116:87-98 pubmed publisher
  432. Venalis P, Kumánovics G, Schulze Koops H, Distler A, Dees C, Zerr P, et al. Cardiomyopathy in murine models of systemic sclerosis. Arthritis Rheumatol. 2015;67:508-16 pubmed publisher
  433. Mandl M, Schmitz S, Weber C, Hristov M. Characterization of the CD14++CD16+ monocyte population in human bone marrow. PLoS ONE. 2014;9:e112140 pubmed publisher
  434. Mohanty S, Joshi S, Ueda I, Wilson J, Blevins T, Siconolfi B, et al. Prolonged proinflammatory cytokine production in monocytes modulated by interleukin 10 after influenza vaccination in older adults. J Infect Dis. 2015;211:1174-84 pubmed publisher
  435. Boltjes A, van Montfoort N, Biesta P, Op den Brouw M, Kwekkeboom J, van der Laan L, et al. Kupffer cells interact with hepatitis B surface antigen in vivo and in vitro, leading to proinflammatory cytokine production and natural killer cell function. J Infect Dis. 2015;211:1268-78 pubmed publisher
  436. Llosa N, Cruise M, Tam A, Wicks E, Hechenbleikner E, Taube J, et al. The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints. Cancer Discov. 2015;5:43-51 pubmed publisher
  437. Crooks M, Fahim A, Naseem K, Morice A, Hart S. Increased platelet reactivity in idiopathic pulmonary fibrosis is mediated by a plasma factor. PLoS ONE. 2014;9:e111347 pubmed publisher
  438. Ziblat A, Domaica C, Spallanzani R, Iraolagoitia X, Rossi L, Avila D, et al. IL-27 stimulates human NK-cell effector functions and primes NK cells for IL-18 responsiveness. Eur J Immunol. 2015;45:192-202 pubmed publisher
  439. Jansen D, Hameetman M, van Bergen J, Huizinga T, van der Heijde D, Toes R, et al. IL-17-producing CD4+ T cells are increased in early, active axial spondyloarthritis including patients without imaging abnormalities. Rheumatology (Oxford). 2015;54:728-35 pubmed publisher
  440. Lu H, Clauser K, Tam W, Fröse J, Ye X, Eaton E, et al. A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages. Nat Cell Biol. 2014;16:1105-17 pubmed publisher
  441. Cérbulo Vázquez A, Figueroa Damián R, Arriaga Pizano L, Hernández Andrade E, Mancilla Herrera I, Flores Mejía L, et al. Pregnant women infected with pandemic H1N1pdm2009 influenza virus displayed overproduction of peripheral blood CD69+ lymphocytes and increased levels of serum cytokines. PLoS ONE. 2014;9:e107900 pubmed publisher
  442. Yu C, Becker C, Metang P, Marches F, Wang Y, Toshiyuki H, et al. Human CD141+ dendritic cells induce CD4+ T cells to produce type 2 cytokines. J Immunol. 2014;193:4335-43 pubmed publisher
  443. Kurktschiev P, Raziorrouh B, Schraut W, Backmund M, Wächtler M, Wendtner C, et al. Dysfunctional CD8+ T cells in hepatitis B and C are characterized by a lack of antigen-specific T-bet induction. J Exp Med. 2014;211:2047-59 pubmed publisher
  444. Yu J, Zuo Z, Zhang W, Yang Q, Zhang Y, Tang Y, et al. Identification of immunophenotypic subtypes with different prognoses in extranodal natural killer/T-cell lymphoma, nasal type. Hum Pathol. 2014;45:2255-62 pubmed publisher
  445. Ezzelarab M, Ekser B, Azimzadeh A, Lin C, Zhao Y, Rodriguez R, et al. Systemic inflammation in xenograft recipients precedes activation of coagulation. Xenotransplantation. 2015;22:32-47 pubmed publisher
  446. Pritchard A, White O, Burel J, Carroll M, Phipps S, Upham J. Asthma is associated with multiple alterations in anti-viral innate signalling pathways. PLoS ONE. 2014;9:e106501 pubmed publisher
  447. Hu H, Eller M, Zafar S, Zhou Y, Gu M, Wei Z, et al. Preferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individuals. Proc Natl Acad Sci U S A. 2014;111:13439-44 pubmed publisher
  448. Toapanta F, Simon J, Barry E, Pasetti M, Levine M, Kotloff K, et al. Gut-Homing Conventional Plasmablasts and CD27(-) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans. Front Immunol. 2014;5:374 pubmed publisher
  449. Bhatti P, Zhang Y, Song X, Makar K, Sather C, Kelsey K, et al. Nightshift work and genome-wide DNA methylation. Chronobiol Int. 2015;32:103-12 pubmed publisher
  450. Matsuda K, Dang Q, Brown C, Keele B, Wu F, Ourmanov I, et al. Characterization of simian immunodeficiency virus (SIV) that induces SIV encephalitis in rhesus macaques with high frequency: role of TRIM5 and major histocompatibility complex genotypes and early entry to the brain. J Virol. 2014;88:13201-11 pubmed publisher
  451. Tsai H, Deng W, Lai W, Chiu W, Yang C, Tsai Y, et al. Wnts enhance neurotrophin-induced neuronal differentiation in adult bone-marrow-derived mesenchymal stem cells via canonical and noncanonical signaling pathways. PLoS ONE. 2014;9:e104937 pubmed publisher
  452. Chao Y, Kaliaperumal N, Chretien A, Tang S, Lee B, Poidinger M, et al. Human plasmacytoid dendritic cells regulate IFN-α production through activation-induced splicing of IL-18Rα. J Leukoc Biol. 2014;96:1037-46 pubmed publisher
  453. Davey M, Morgan M, Liuzzi A, Tyler C, Khan M, Szakmany T, et al. Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells. J Immunol. 2014;193:3704-3716 pubmed publisher
  454. Bennaceur K, Atwill M, Al Zhrany N, Hoffmann J, Keavney B, BREAULT D, et al. Atorvastatin induces T cell proliferation by a telomerase reverse transcriptase (TERT) mediated mechanism. Atherosclerosis. 2014;236:312-20 pubmed publisher
  455. Park D, Park J, Lee J, Kim T, Kim K, Jung B, et al. Effect of FGF-2 on collagen tissue regeneration by human vertebral bone marrow stem cells. Stem Cells Dev. 2015;24:228-43 pubmed publisher
  456. Kansy B, Dißmann P, Hemeda H, Bruderek K, Westerkamp A, Jagalski V, et al. The bidirectional tumor--mesenchymal stromal cell interaction promotes the progression of head and neck cancer. Stem Cell Res Ther. 2014;5:95 pubmed publisher
  457. Arlehamn C, Seumois G, Gerasimova A, Huang C, Fu Z, Yue X, et al. Transcriptional profile of tuberculosis antigen-specific T cells reveals novel multifunctional features. J Immunol. 2014;193:2931-40 pubmed publisher
  458. Bailon E, Ugarte Berzal E, Amigo Jiménez I, Van den Steen P, Opdenakker G, Garcia Marco J, et al. Overexpression of progelatinase B/proMMP-9 affects migration regulatory pathways and impairs chronic lymphocytic leukemia cell homing to bone marrow and spleen. J Leukoc Biol. 2014;96:185-99 pubmed publisher
  459. Dogan A, Demirci S, Sahin F. In vitro differentiation of human tooth germ stem cells into endothelial- and epithelial-like cells. Cell Biol Int. 2015;39:94-103 pubmed publisher
  460. Gaffney A, Santos Martinez M, Satti A, Major T, Wynne K, Gun ko Y, et al. Blood biocompatibility of surface-bound multi-walled carbon nanotubes. Nanomedicine. 2015;11:39-46 pubmed publisher
  461. Koido S, Homma S, Okamoto M, Takakura K, Mori M, Yoshizaki S, et al. Treatment with chemotherapy and dendritic cells pulsed with multiple Wilms' tumor 1 (WT1)-specific MHC class I/II-restricted epitopes for pancreatic cancer. Clin Cancer Res. 2014;20:4228-39 pubmed publisher
  462. McNally A, Anderson J. Phenotypic expression in human monocyte-derived interleukin-4-induced foreign body giant cells and macrophages in vitro: dependence on material surface properties. J Biomed Mater Res A. 2015;103:1380-90 pubmed publisher
  463. Buggert M, Tauriainen J, Yamamoto T, Frederiksen J, Ivarsson M, Michaelsson J, et al. T-bet and Eomes are differentially linked to the exhausted phenotype of CD8+ T cells in HIV infection. PLoS Pathog. 2014;10:e1004251 pubmed publisher
  464. Longman R, Diehl G, Victorio D, Huh J, Galan C, Miraldi E, et al. CX?CR1? mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22. J Exp Med. 2014;211:1571-83 pubmed publisher
  465. Balan S, Ollion V, Colletti N, Chelbi R, Montanana Sanchis F, Liu H, et al. Human XCR1+ dendritic cells derived in vitro from CD34+ progenitors closely resemble blood dendritic cells, including their adjuvant responsiveness, contrary to monocyte-derived dendritic cells. J Immunol. 2014;193:1622-35 pubmed publisher
  466. Kobie J, Treanor J, Ritchlin C. Transient decrease in human peripheral blood myeloid dendritic cells following influenza vaccination correlates with induction of serum antibody. Immunol Invest. 2014;43:606-15 pubmed publisher
  467. Campion S, Brodie T, Fischer W, Korber B, Rossetti A, Goonetilleke N, et al. Proteome-wide analysis of HIV-specific naive and memory CD4(+) T cells in unexposed blood donors. J Exp Med. 2014;211:1273-80 pubmed publisher
  468. Lepore M, de Lalla C, Gundimeda S, Gsellinger H, Consonni M, Garavaglia C, et al. A novel self-lipid antigen targets human T cells against CD1c(+) leukemias. J Exp Med. 2014;211:1363-77 pubmed publisher
  469. Headland S, Jones H, D Sa A, Perretti M, Norling L. Cutting-edge analysis of extracellular microparticles using ImageStream(X) imaging flow cytometry. Sci Rep. 2014;4:5237 pubmed publisher
  470. Steinsbø Ø, Henry Dunand C, Huang M, Mesin L, Salgado Ferrer M, Lundin K, et al. Restricted VH/VL usage and limited mutations in gluten-specific IgA of coeliac disease lesion plasma cells. Nat Commun. 2014;5:4041 pubmed publisher
  471. Kleppa E, Ramsuran V, Zulu S, Karlsen G, Bere A, Passmore J, et al. Effect of female genital schistosomiasis and anti-schistosomal treatment on monocytes, CD4+ T-cells and CCR5 expression in the female genital tract. PLoS ONE. 2014;9:e98593 pubmed publisher
  472. Fisher J, Yan M, Heuijerjans J, Carter L, Abolhassani A, Frosch J, et al. Neuroblastoma killing properties of Vδ2 and Vδ2-negative γδT cells following expansion by artificial antigen-presenting cells. Clin Cancer Res. 2014;20:5720-32 pubmed publisher
  473. Jitschin R, Braun M, Büttner M, Dettmer Wilde K, Bricks J, Berger J, et al. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood. 2014;124:750-60 pubmed publisher
  474. Bukh I, Calcedo R, Roy S, Carnathan D, Grant R, Qin Q, et al. Increased mucosal CD4+ T cell activation in rhesus macaques following vaccination with an adenoviral vector. J Virol. 2014;88:8468-78 pubmed publisher
  475. Mrosewski I, Jork N, Gorte K, Conrad C, Wiegand E, Kohl B, et al. Regulation of osteoarthritis-associated key mediators by TNF? and IL-10: effects of IL-10 overexpression in human synovial fibroblasts and a synovial cell line. Cell Tissue Res. 2014;357:207-23 pubmed publisher
  476. Wilson E, Singh A, Hullsiek K, Gibson D, Henry W, Lichtenstein K, et al. Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection. J Infect Dis. 2014;210:1396-406 pubmed publisher
  477. Barbosa R, Silva S, Silva S, Melo A, Pereira Santos M, Barata J, et al. Reduced BAFF-R and increased TACI expression in common variable immunodeficiency. J Clin Immunol. 2014;34:573-83 pubmed publisher
  478. Buggert M, Norstr m M, Salemi M, Hecht F, Karlsson A. Functional avidity and IL-2/perforin production is linked to the emergence of mutations within HLA-B*5701-restricted epitopes and HIV-1 disease progression. J Immunol. 2014;192:4685-96 pubmed publisher
  479. Fredriksson K, Mishra A, Lam J, Mushaben E, Cuento R, Meyer K, et al. The very low density lipoprotein receptor attenuates house dust mite-induced airway inflammation by suppressing dendritic cell-mediated adaptive immune responses. J Immunol. 2014;192:4497-509 pubmed publisher
  480. Shey M, Nemes E, Whatney W, de Kock M, Africa H, Barnard C, et al. Maturation of innate responses to mycobacteria over the first nine months of life. J Immunol. 2014;192:4833-43 pubmed publisher
  481. Cartwright E, McGary C, Cervasi B, Micci L, Lawson B, Elliott S, et al. Divergent CD4+ T memory stem cell dynamics in pathogenic and nonpathogenic simian immunodeficiency virus infections. J Immunol. 2014;192:4666-73 pubmed publisher
  482. Itoua Maïga R, Lemieux J, Roy A, Simard C, Néron S. Flow cytometry assessment of in vitro generated CD138+ human plasma cells. Biomed Res Int. 2014;2014:536482 pubmed publisher
  483. Brittan M, Barr L, Anderson N, Morris A, Duffin R, Marwick J, et al. Functional characterisation of human pulmonary monocyte-like cells in lipopolysaccharide-mediated acute lung inflammation. J Inflamm (Lond). 2014;11:9 pubmed publisher
  484. Prinz P, Mendler A, Brech D, Masouris I, Oberneder R, Noessner E. NK-cell dysfunction in human renal carcinoma reveals diacylglycerol kinase as key regulator and target for therapeutic intervention. Int J Cancer. 2014;135:1832-41 pubmed publisher
  485. Martin R, Saleem S, Folgosa L, Zellner H, Damle S, Nguyen G, et al. Mast cell histamine promotes the immunoregulatory activity of myeloid-derived suppressor cells. J Leukoc Biol. 2014;96:151-9 pubmed publisher
  486. Magri G, Miyajima M, Bascones S, Mortha A, Puga I, Cassis L, et al. Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. Nat Immunol. 2014;15:354-364 pubmed publisher
  487. Düvel A, Maaß J, Heppelmann M, Hussen J, Koy M, Piechotta M, et al. Peripheral blood leukocytes of cows with subclinical endometritis show an altered cellular composition and gene expression. Theriogenology. 2014;81:906-17 pubmed publisher
  488. Sleiman M, Brons N, Kaoma T, Dogu F, Villa Forte A, Lenoble P, et al. NK cell killer Ig-like receptor repertoire acquisition and maturation are strongly modulated by HLA class I molecules. J Immunol. 2014;192:2602-10 pubmed publisher
  489. Duggal N, Beswetherick A, Upton J, Hampson P, Phillips A, Lord J. Depressive symptoms in hip fracture patients are associated with reduced monocyte superoxide production. Exp Gerontol. 2014;54:27-34 pubmed publisher
  490. Ilander M, Kreutzman A, Rohon P, Melo T, Faber E, Porkka K, et al. Enlarged memory T-cell pool and enhanced Th1-type responses in chronic myeloid leukemia patients who have successfully discontinued IFN-? monotherapy. PLoS ONE. 2014;9:e87794 pubmed publisher
  491. Sereti I, Estes J, Thompson W, Morcock D, Fischl M, Croughs T, et al. Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration. PLoS Pathog. 2014;10:e1003890 pubmed publisher
  492. Kragstrup T, Jalilian B, Hvid M, Kjærgaard A, Østgård R, Schiøttz Christensen B, et al. Decreased plasma levels of soluble CD18 link leukocyte infiltration with disease activity in spondyloarthritis. Arthritis Res Ther. 2014;16:R42 pubmed publisher
  493. Ataide M, Andrade W, Zamboni D, Wang D, Souza M, Franklin B, et al. Malaria-induced NLRP12/NLRP3-dependent caspase-1 activation mediates inflammation and hypersensitivity to bacterial superinfection. PLoS Pathog. 2014;10:e1003885 pubmed publisher
  494. Salerno Goncalves R, Rezwan T, Sztein M. B cells modulate mucosal associated invariant T cell immune responses. Front Immunol. 2014;4:511 pubmed publisher
  495. Trist H, Tan P, Wines B, Ramsland P, Orlowski E, Stubbs J, et al. Polymorphisms and interspecies differences of the activating and inhibitory Fc?RII of Macaca nemestrina influence the binding of human IgG subclasses. J Immunol. 2014;192:792-803 pubmed publisher
  496. Zouk H, d Hennezel E, Du X, Ounissi Benkalha H, Piccirillo C, Polychronakos C. Functional evaluation of the role of C-type lectin domain family 16A at the chromosome 16p13 locus. Clin Exp Immunol. 2014;175:485-97 pubmed publisher
  497. Kumpel B, Hazell M, Guest A, Dixey J, Mushens R, Bishop D, et al. Accurate quantitation of D+ fetomaternal hemorrhage by flow cytometry using a novel reagent to eliminate granulocytes from analysis. Transfusion. 2014;54:1305-16 pubmed publisher
  498. Krishnan S, Wilson E, Sheikh V, Rupert A, Mendoza D, Yang J, et al. Evidence for innate immune system activation in HIV type 1-infected elite controllers. J Infect Dis. 2014;209:931-9 pubmed publisher
  499. Chicoine L, Rodino Klapac L, Shao G, Xu R, Bremer W, Camboni M, et al. Vascular delivery of rAAVrh74.MCK.GALGT2 to the gastrocnemius muscle of the rhesus macaque stimulates the expression of dystrophin and laminin ?2 surrogates. Mol Ther. 2014;22:713-24 pubmed publisher
  500. Miyashita T, Kimura K, Fukami T, Nakajima M, Yokoi T. Evaluation and mechanistic analysis of the cytotoxicity of the acyl glucuronide of nonsteroidal anti-inflammatory drugs. Drug Metab Dispos. 2014;42:1-8 pubmed publisher
  501. Svajger U, Obermajer N, Jeras M. IFN-?-rich environment programs dendritic cells toward silencing of cytotoxic immune responses. J Leukoc Biol. 2014;95:33-46 pubmed publisher
  502. He W, Wang Q, Srinivasan B, Xu J, Padilla M, Li Z, et al. A JNK-mediated autophagy pathway that triggers c-IAP degradation and necroptosis for anticancer chemotherapy. Oncogene. 2014;33:3004-13 pubmed publisher
  503. Pattacini L, Murnane P, Kahle E, Bolton M, Delrow J, Lingappa J, et al. Differential regulatory T cell activity in HIV type 1-exposed seronegative individuals. AIDS Res Hum Retroviruses. 2013;29:1321-9 pubmed publisher
  504. Pala P, Serwanga J, Watera C, Ritchie A, Moodie Z, Wang M, et al. Quantitative and qualitative differences in the T cell response to HIV in uninfected Ugandans exposed or unexposed to HIV-infected partners. J Virol. 2013;87:9053-63 pubmed publisher
  505. Kyoizumi S, Kubo Y, Kajimura J, Yoshida K, Imai K, Hayashi T, et al. Age-associated changes in the differentiation potentials of human circulating hematopoietic progenitors to T- or NK-lineage cells. J Immunol. 2013;190:6164-72 pubmed publisher
  506. Blomkalns A, Gavrila D, Thomas M, Neltner B, Blanco V, Benjamin S, et al. CD14 directs adventitial macrophage precursor recruitment: role in early abdominal aortic aneurysm formation. J Am Heart Assoc. 2013;2:e000065 pubmed publisher
  507. Parzych E, Li H, Yin X, Liu Q, Wu T, Podsakoff G, et al. Effects of immunosuppression on circulating adeno-associated virus capsid-specific T cells in humans. Hum Gene Ther. 2013;24:431-42 pubmed publisher
  508. Denecke B, Horsch L, Radtke S, Fischer J, Horn P, Giebel B. Human endothelial colony-forming cells expanded with an improved protocol are a useful endothelial cell source for scaffold-based tissue engineering. J Tissue Eng Regen Med. 2015;9:E84-97 pubmed publisher
  509. Canary L, Vinton C, Morcock D, Pierce J, Estes J, Brenchley J, et al. Rate of AIDS progression is associated with gastrointestinal dysfunction in simian immunodeficiency virus-infected pigtail macaques. J Immunol. 2013;190:2959-65 pubmed publisher
  510. Roubelakis M, Tsaknakis G, Pappa K, Anagnou N, Watt S. Spindle shaped human mesenchymal stem/stromal cells from amniotic fluid promote neovascularization. PLoS ONE. 2013;8:e54747 pubmed publisher
  511. McArthur M, Sztein M. Unexpected heterogeneity of multifunctional T cells in response to superantigen stimulation in humans. Clin Immunol. 2013;146:140-52 pubmed publisher
  512. Lelic A, Verschoor C, Ventresca M, Parsons R, Evelegh C, Bowdish D, et al. The polyfunctionality of human memory CD8+ T cells elicited by acute and chronic virus infections is not influenced by age. PLoS Pathog. 2012;8:e1003076 pubmed publisher
  513. Zimmerlin L, Donnenberg V, Rubin J, Donnenberg A. Mesenchymal markers on human adipose stem/progenitor cells. Cytometry A. 2013;83:134-40 pubmed publisher
  514. Wong W, Sigvardsson M, Astrand Grundström I, Hogge D, Larsson J, Qian H, et al. Expression of integrin ?2 receptor in human cord blood CD34+CD38-CD90+ stem cells engrafting long-term in NOD/SCID-IL2R?(c) null mice. Stem Cells. 2013;31:360-71 pubmed publisher
  515. Dale R, Pillai S, Brilot F. Cerebrospinal fluid CD19(+) B-cell expansion in N-methyl-D-aspartate receptor encephalitis. Dev Med Child Neurol. 2013;55:191-3 pubmed publisher
  516. Gaur R, Suhosk M, Banaei N. In vitro immunomodulation of a whole blood IFN-? release assay enhances T cell responses in subjects with latent tuberculosis infection. PLoS ONE. 2012;7:e48027 pubmed publisher
  517. Reuter M, Yuan S, Marx P, Kutzler M, Weiner D, Betts M. DNA-based HIV vaccines do not induce generalized activation in mucosal tissue T cells. Hum Vaccin Immunother. 2012;8:1648-53 pubmed publisher
  518. Gillespie E, Raychaudhuri N, Papageorgiou K, Atkins S, Lu Y, Charara L, et al. Interleukin-6 production in CD40-engaged fibrocytes in thyroid-associated ophthalmopathy: involvement of Akt and NF-?B. Invest Ophthalmol Vis Sci. 2012;53:7746-53 pubmed publisher
  519. Nausch N, Louis D, Lantz O, Peguillet I, Trottein F, Chen I, et al. Age-related patterns in human myeloid dendritic cell populations in people exposed to Schistosoma haematobium infection. PLoS Negl Trop Dis. 2012;6:e1824 pubmed publisher
  520. Daigneault M, de Silva T, Bewley M, Preston J, Marriott H, Mitchell A, et al. Monocytes regulate the mechanism of T-cell death by inducing Fas-mediated apoptosis during bacterial infection. PLoS Pathog. 2012;8:e1002814 pubmed publisher
  521. Kvistborg P, Shu C, Heemskerk B, Fankhauser M, Thrue C, Toebes M, et al. TIL therapy broadens the tumor-reactive CD8(+) T cell compartment in melanoma patients. Oncoimmunology. 2012;1:409-418 pubmed
  522. Qi Y, Operario D, Georas S, Mosmann T. The acute environment, rather than T cell subset pre-commitment, regulates expression of the human T cell cytokine amphiregulin. PLoS ONE. 2012;7:e39072 pubmed publisher
  523. McArthur M, Sztein M. Heterogeneity of multifunctional IL-17A producing S. Typhi-specific CD8+ T cells in volunteers following Ty21a typhoid immunization. PLoS ONE. 2012;7:e38408 pubmed publisher
  524. Roth M, Will B, Simkin G, Narayanagari S, Barreyro L, Bartholdy B, et al. Eltrombopag inhibits the proliferation of leukemia cells via reduction of intracellular iron and induction of differentiation. Blood. 2012;120:386-94 pubmed publisher
  525. Li X, Miao H, Henn A, Topham D, Wu H, Zand M, et al. Ki-67 expression reveals strong, transient influenza specific CD4 T cell responses after adult vaccination. Vaccine. 2012;30:4581-4 pubmed publisher
  526. Ambarus C, Noordenbos T, de Hair M, Tak P, Baeten D. Intimal lining layer macrophages but not synovial sublining macrophages display an IL-10 polarized-like phenotype in chronic synovitis. Arthritis Res Ther. 2012;14:R74 pubmed publisher
  527. Lyke K, Dabo A, Arama C, Daou M, Diarra I, Wang A, et al. Reduced T regulatory cell response during acute Plasmodium falciparum infection in Malian children co-infected with Schistosoma haematobium. PLoS ONE. 2012;7:e31647 pubmed publisher
  528. Phadwal K, Alegre Abarrategui J, Watson A, Pike L, Anbalagan S, Hammond E, et al. A novel method for autophagy detection in primary cells: impaired levels of macroautophagy in immunosenescent T cells. Autophagy. 2012;8:677-89 pubmed publisher
  529. Barcena A, Muench M, Kapidzic M, Gormley M, Goldfien G, Fisher S. Human placenta and chorion: potential additional sources of hematopoietic stem cells for transplantation. Transfusion. 2011;51 Suppl 4:94S-105S pubmed publisher
  530. Vargas Inchaustegui D, Demberg T, Robert Guroff M. A CD8?(-) subpopulation of macaque circulatory natural killer cells can mediate both antibody-dependent and antibody-independent cytotoxic activities. Immunology. 2011;134:326-40 pubmed publisher
  531. Luiza Silva M, Campi Azevedo A, Batista M, Martins M, Avelar R, da Silveira Lemos D, et al. Cytokine signatures of innate and adaptive immunity in 17DD yellow fever vaccinated children and its association with the level of neutralizing antibody. J Infect Dis. 2011;204:873-83 pubmed publisher
  532. Ruffell B, Au A, Rugo H, Esserman L, Hwang E, Coussens L. Leukocyte composition of human breast cancer. Proc Natl Acad Sci U S A. 2012;109:2796-801 pubmed publisher
  533. Dale R, Tantsis E, Merheb V, Brilot F. Cerebrospinal fluid B-cell expansion in longitudinally extensive transverse myelitis associated with neuromyelitis optica immunoglobulin G. Dev Med Child Neurol. 2011;53:856-860 pubmed publisher
  534. Clement M, Ladell K, Ekeruche Makinde J, Miles J, Edwards E, Dolton G, et al. Anti-CD8 antibodies can trigger CD8+ T cell effector function in the absence of TCR engagement and improve peptide-MHCI tetramer staining. J Immunol. 2011;187:654-63 pubmed publisher
  535. Li H, Lasaro M, Jia B, Lin S, Haut L, High K, et al. Capsid-specific T-cell responses to natural infections with adeno-associated viruses in humans differ from those of nonhuman primates. Mol Ther. 2011;19:2021-30 pubmed publisher
  536. Scheible K, Zhang G, Baer J, Azadniv M, Lambert K, Pryhuber G, et al. CD8+ T cell immunity to 2009 pandemic and seasonal H1N1 influenza viruses. Vaccine. 2011;29:2159-68 pubmed publisher
  537. Berthoud T, Hamill M, Lillie P, Hwenda L, Collins K, Ewer K, et al. Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1. Clin Infect Dis. 2011;52:1-7 pubmed publisher
  538. Chui K, Trivedi A, Cheng C, Cherbavaz D, Dazin P, Huynh A, et al. Characterization and functionality of proliferative human Sertoli cells. Cell Transplant. 2011;20:619-35 pubmed publisher
  539. Schmetterer K, Seidel M, Körmöczi U, Rottal A, Schwarz K, Matthes Martin S, et al. Two newly diagnosed HLA class II-deficient patients identified by rapid vector-based complementation analysis reveal discoordinate invariant chain expression levels. Int Arch Allergy Immunol. 2010;152:390-400 pubmed publisher
  540. Fung E, Esposito L, Todd J, Wicker L. Multiplexed immunophenotyping of human antigen-presenting cells in whole blood by polychromatic flow cytometry. Nat Protoc. 2010;5:357-70 pubmed publisher
  541. Marino J, Tan C, Taylor A, Bentley C, Van De Wiele C, Ranne R, et al. Differential IL-7 responses in developing human thymocytes. Hum Immunol. 2010;71:329-33 pubmed publisher
  542. Strickland L, Ross J, Williams S, Ross S, Romero M, Spencer S, et al. Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinoma. J Pathol. 2009;218:380-90 pubmed publisher
  543. Kapoor V, Hakim F, Rehman N, Gress R, Telford W. Quantum dots thermal stability improves simultaneous phenotype-specific telomere length measurement by FISH-flow cytometry. J Immunol Methods. 2009;344:6-14 pubmed publisher
  544. Zhao R, Follows G, Beer P, Scott L, Huntly B, Green A, et al. Inhibition of the Bcl-xL deamidation pathway in myeloproliferative disorders. N Engl J Med. 2008;359:2778-89 pubmed publisher
  545. Wang J, Kobie J, Zhang L, Cochran M, Mosmann T, Ritchlin C, et al. An 11-color flow cytometric assay for identifying, phenotyping, and assessing endocytic ability of peripheral blood dendritic cell subsets in a single platform. J Immunol Methods. 2009;341:106-16 pubmed publisher
  546. Sathler Avelar R, Vitelli Avelar D, Massara R, de Lana M, Pinto Dias J, Teixeira Carvalho A, et al. Etiological treatment during early chronic indeterminate Chagas disease incites an activated status on innate and adaptive immunity associated with a type 1-modulated cytokine pattern. Microbes Infect. 2008;10:103-13 pubmed publisher
  547. Lee D, Sieling P, Ochoa M, Krutzik S, Guo B, Hernandez M, et al. LILRA2 activation inhibits dendritic cell differentiation and antigen presentation to T cells. J Immunol. 2007;179:8128-36 pubmed
  548. Laudanski K, De A, Miller Graziano C. Exogenous heat shock protein 27 uniquely blocks differentiation of monocytes to dendritic cells. Eur J Immunol. 2007;37:2812-24 pubmed
  549. Mageed A, Pietryga D, DeHeer D, West R. Isolation of large numbers of mesenchymal stem cells from the washings of bone marrow collection bags: characterization of fresh mesenchymal stem cells. Transplantation. 2007;83:1019-26 pubmed
  550. Ramirez R, Carracedo J, Merino A, Nogueras S, Alvarez Lara M, Rodriguez M, et al. Microinflammation induces endothelial damage in hemodialysis patients: the role of convective transport. Kidney Int. 2007;72:108-13 pubmed
  551. Siliciano J, Siliciano R. Enhanced culture assay for detection and quantitation of latently infected, resting CD4+ T-cells carrying replication-competent virus in HIV-1-infected individuals. Methods Mol Biol. 2005;304:3-15 pubmed
  552. Contamin H, Loizon S, Bourreau E, Michel J, Garraud O, Mercereau Puijalon O, et al. Flow cytometry identification and characterization of mononuclear cell subsets in the neotropical primate Saimiri sciureus (squirrel monkey). J Immunol Methods. 2005;297:61-71 pubmed
  553. Canonico B, Zamai L, Burattini S, Granger V, Mannello F, Gobbi P, et al. Evaluation of leukocyte stabilisation in TransFix-treated blood samples by flow cytometry and transmission electron microscopy. J Immunol Methods. 2004;295:67-78 pubmed
  554. Asin S, Fanger M, Wildt Perinic D, Ware P, Wira C, Howell A. Transmission of HIV-1 by primary human uterine epithelial cells and stromal fibroblasts. J Infect Dis. 2004;190:236-45 pubmed
  555. Stacchini A, Demurtas A, Godio L, Martini G, Antinoro V, Palestro G. Flow cytometry in the bone marrow staging of mature B-cell neoplasms. Cytometry B Clin Cytom. 2003;54:10-8 pubmed
  556. Hertel L, Lacaille V, Strobl H, Mellins E, Mocarski E. Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus. J Virol. 2003;77:7563-74 pubmed
  557. Muench M, Suskind D, Barcena A. Isolation, growth and identification of colony-forming cells with erythroid, myeloid, dendritic cell and NK-cell potential from human fetal liver. Biol Proced Online. 2002;4:10-23 pubmed
  558. Manz M, Miyamoto T, Akashi K, Weissman I. Prospective isolation of human clonogenic common myeloid progenitors. Proc Natl Acad Sci U S A. 2002;99:11872-7 pubmed
  559. Belge K, Dayyani F, Horelt A, Siedlar M, Frankenberger M, Frankenberger B, et al. The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J Immunol. 2002;168:3536-42 pubmed
  560. Hajishengallis G, Martin M, Sojar H, Sharma A, Schifferle R, DeNardin E, et al. Dependence of bacterial protein adhesins on toll-like receptors for proinflammatory cytokine induction. Clin Diagn Lab Immunol. 2002;9:403-11 pubmed
  561. Semnani R, Sabzevari H, Iyer R, Nutman T. Filarial antigens impair the function of human dendritic cells during differentiation. Infect Immun. 2001;69:5813-22 pubmed
  562. Matasic R, Dietz A, Vuk Pavlovic S. Maturation of human dendritic cells as sulfasalazine target. Croat Med J. 2001;42:440-5 pubmed
  563. Matasic R, Dietz A, Vuk Pavlovic S. Cyclooxygenase-independent inhibition of dendritic cell maturation by aspirin. Immunology. 2000;101:53-60 pubmed
  564. McRae B, Nagai T, Semnani R, van Seventer J, van Seventer G. Interferon-alpha and -beta inhibit the in vitro differentiation of immunocompetent human dendritic cells from CD14(+) precursors. Blood. 2000;96:210-7 pubmed
  565. Eckenberg R, Rose T, Moreau J, Weil R, Gesbert F, Dubois S, et al. The first alpha helix of interleukin (IL)-2 folds as a homotetramer, acts as an agonist of the IL-2 receptor beta chain, and induces lymphokine-activated killer cells. J Exp Med. 2000;191:529-40 pubmed
  566. Giavedoni L, Velasquillo M, Parodi L, Hubbard G, Hodara V. Cytokine expression, natural killer cell activation, and phenotypic changes in lymphoid cells from rhesus macaques during acute infection with pathogenic simian immunodeficiency virus. J Virol. 2000;74:1648-57 pubmed
  567. Le Cleach L, Delaire S, Boumsell L, Bagot M, Bourgault Villada I, Bensussan A, et al. Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors. Clin Exp Immunol. 2000;119:225-30 pubmed
  568. Lee B, Sharron M, Montaner L, Weissman D, Doms R. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc Natl Acad Sci U S A. 1999;96:5215-20 pubmed
  569. Schiff D, Rae J, Martin T, Davis B, Curnutte J. Increased phagocyte Fc gammaRI expression and improved Fc gamma-receptor-mediated phagocytosis after in vivo recombinant human interferon-gamma treatment of normal human subjects. Blood. 1997;90:3187-94 pubmed
  570. Yeaman G, Guyre P, Fanger M, Collins J, White H, Rathbun W, et al. Unique CD8+ T cell-rich lymphoid aggregates in human uterine endometrium. J Leukoc Biol. 1997;61:427-35 pubmed